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SUMMARY
Inorganic arsenic and elevated glucose concentrations increase endothelial production 
o f superoxide, which impairs endothelium-derived nitric oxide bioavailability and 
associated nitric oxide-dependent arterial relaxations. However, there is now evidence 
in animal models of diabetes mellitus that relaxations attributed to endothelium- 
dependent smooth muscle hyperpolarization or endothelium-derived hyperpolarizing 
factor (EDHF) may be augmented and serve to compensate for the loss of nitric oxide, 
thereby maintaining arterial responsiveness. The effects of arsenite and elevated 
glucose concentrations on “EDHF-type” relaxations were thus investigated in isolated 
rabbit iliac artery rings using the G-protein-coupled agonist acetylcholine and the 
sarcoendoplasmic reticulum Ca2+ ATPase inhibitor cyclopiazonic acid. Arsenite and 
elevated glucose both potentiated EDHF-type relaxations evoked by cyclopiazonic 
acid. Differential effects of arsenite and glucose against EDHF-type responses to 
acetylcholine were identified in that arsenite attenuated relaxation, whereas glucose 
potentiated relaxation. Further experiments showed that the arsenite- and glucose- 
augmented components of relaxation were reversed to control levels by the hydrogen 
peroxide scavenger catalase and the NADPH oxidase inhibitor apocynin. Arsenite- 
augmented responses were also reversed by the cell-permeable superoxide 
dismutase/catalase mimetic manganese porphyrin. It follows that hydrogen peroxide 
derived from NADPH oxidase may augment EDHF-type relaxations in diabetes 
mellitus and arsenic toxicity, thus maintaining endothelial control of arterial tone 
when nitric oxide bioavailability is impaired by oxidative stress. These results are 
consistent with the demonstrations that hydrogen peroxide augments EDHF-type 
relaxations in the rabbit iliac artery by promoting endothelial Ca2+ mobilization and 
enhancing the opening of endothelial Ca2+-activated K+ channels, and that the 
increased activity of these channels underpins augmented EDHF-type arterial 
relaxations in animal models of diabetes.
ABBREVIATIONS
ACE angiotensin converting enzyme
ACh acetylcholine
ApoE apolipoprotein E
ATP adenosine triphosphate
BH4 tetrahydrobiopterin
Bk bradykinin
cAMP cyclic adenosine monophosphate
cGMP cyclic guanosine monophosphate
COX cyclooxygenase
CPA cyclopiazonic acid
DEA diethylamine
(p)EC50 (negative log) half maximal effective concentration
EDCF endothelium-derived contracting factor
EDH endothelium-dependent hyperpolarization
EDHF endothelium-derived hyperpolarizing factor
EDR endothelium-dependent relaxation
EDRF endothelium-derived relaxing factor
EET epoxyeicosatrienoic acid
eNOS endothelial nitric oxide synthase
ER endoplasmic reticulum
ESR electron spin resonance
GK Goto-Kakizaki
H2 O2 hydrogen peroxide
HG high glucose
(p)IC50 (negative log) half maximal inhibitory concentration
InsP3(R) inositol 1,4,5-trisphosphate (receptor)
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Kv voltage-gated \C  channel
LDL low density lipoprotein
L-NAME L10 nitro-arginine methyl ester
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hexanamine
MCP-1 monocyte chemoattractant protein 1
MEGJ myoendothelial gap junction
MnTMPyP Mn(IlI)-tetrakis-( 1 -methyl-4-pyridyl-porphyrin)tetratosylate hydroxide
(manganese porphyrin)
mPTP mitochondrial permeability transition pore
MR muscarinic receptor
NADPH nicotinamide adenine dinucleotide phosphate
nNOS neuronal nitric oxide synthase
NO nitric oxide
NOX nicotinamide adenine dinucleotide phosphate oxidase
o 2* superoxide radical
ODQ 1 H-( 1,2,4)oxadiazolo(4,3-a)quinoxalin-1 -one
OH hydroxyl radical
OLETF Otsuka Long-Evans Tokushima fatty rat
oxLDL oxidized low density lipoprotein
OZFR obese Zucker fatty rat
PDE3 phosphodiesterase 3
PE phenylephrine
phox phagocytic oxidase
PKA protein kinase A
PKC protein kinase C
PKG protein kinase G
PMCA plasma membrane Ca2+-ATPase
PMVD peripheral microvascular disease
RIA rabbit iliac artery
Rmax maximal response
ROS reactive oxygen species
SEM standard error o f the mean
SERCA sarcoendoplasmic reticulum Ca2+-ATPase
sGC soluble guanylyl cyclase
SHR spontaneously hypertensive rat
SIN-1 5-amino-3-(4-morphonilyl)-1,2,3-oxadiazolium chloride
SNAP S-nitroso-N-acetyl penicillamine
SNP sodium nitroprusside
SOC store-operated Ca2+ channel
SOCE store-operated Ca2+ entry
SOD superoxide dismutase
STIM1 stromal interaction protein 1
STZ streptozotocin
TEA tetraethylammonium
TRPC transient receptor potential canonical type channels
TRPV4 transient receptor vallinoid type 4 channels
VCAM-1 vascular cell adhesion molecule 1
VEGF vascular endothelial growth factor
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CHAPTER 1
GENERAL INTRODUCTION 
1.1 Background
Environmental arsenic exposure and diabetes mellitus are major health concerns in 
numerous countries across the world. The impact of arsenic toxicity and diabetes 
mellitus is fully illustrated on the World Health Organisation (WHO) website with 
alarming statistics. While the dangers of arsenic are now fully appreciated, the 
implementation of preventative measures is an extremely slow process. Diabetes 
mellitus, including its associated risk of cardiovascular complications, is a condition 
that is rapidly becoming an epidemic with increasing neglect of diet and physical 
activity.
1.1.1 Arsenic -  “The Largest Poisoning of a Population in History”
Excessive quantities of inorganic arsenic species in drinking water has been correlated 
with an increased risk of a number of diseases including cancer, atherosclerosis and 
peripheral microvascular disease (PMVD) (States et al., 2009). In addition, arsenic is 
now used clinically in the treatment of acute promyelocytic leukaemia, where its pro- 
apoptopic properties can lead to the destruction of cancerous stem cells (Tallman, 
2008). Arsenic is plentiful in the earth’s crust and poor drinking water is now 
recognised as the highest risk source. This has become a major public health concern 
in the United States of America, Taiwan, Chile, Mexico, China, Argentina, India and 
Bangladesh. An estimated 140 million people worldwide are at serious risk of 
exposure (www.who.int/topics/arsenic/en/). However, described as “the largest 
poisoning of a population in history”, the current situation in Bangladesh is 
unprecedented and has been of increasing concern since the early 1990s (Smith et al.,
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2000). There, ironically, drinking water was originally obtained from rivers and 
ponds that contained little or no arsenic, but were contaminated with infectious water­
borne diseases including cholera, hepatitis and typhoid (Smith et al., 2000). Attempts 
to install new and “safe” sources of drinking water unveiled arsenic as a new health 
concern. The tubewells, first constructed in Bangladesh in the 1940s as a safeguard 
against water-borne infection, obtained water from around 200 metres below ground. 
However, at this time, arsenic in drinking water was not recognised as a health risk 
and national water testing procedures did not include an appropriate protocol 
(www.unicef.org/arsenic, 1999). The alarm was first raised in neighbouring West 
Bengal, India, in 1983 when medical staff correlated cases of skin lesions with 
arsenic-contaminated tubewell water supplying a local population of 1.5 million 
(Mandal et al., 1998). Despite similar cases being reported in Bangladesh, it was not 
until 1993 that contamination of water from the tubewells was confirmed (Khan et al., 
1997). The epidemiologist Allan Smith (of the University of California and World 
Health Organisation) published findings based on visits to Bangladesh between 1997 
and 1998. These predicted that between 35 and 77 million of Bangladesh’s 125 
million population were at serious risk from drinking water contaminated with arsenic 
and it was urged that a public health emergency be declared (Smith et al., 2000). 
Subsequent studies in an emerging field have shown that exposure to arsenic increases 
the risk of cancers of the bladder (Simeonova et al., 2000; Steinmaus et al., 2006), 
kidney (Parrish et al., 1999; Yang et al., 2004), lung (Posey et al., 2008) and skin 
(Yeh et al., 1968; Tseng et al., 1968; Germolec et al., 1998) as well as cardiovascular 
disease (Chang et al., 2004; Yang et al., 2006; Chiu et al., 2007) and diabetes mellitus 
(Diaz-Villasenor et al., 2006; Coronado-Gonzalez et al., 2007). These diseases may 
manifest over a number of years or even decades.
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While a long-term supply of fresh uncontaminated water appears to be the most 
effective preventative measure for arsenic-associated disorders, evident from the 
decline in cases of Blackfoot disease in Taiwan (www.who.int/topics/arsenic/en/), the 
task and cost involved in testing samples from all 1.3 million of Bangladesh’s 
tubewells is enormous and still ongoing.
1.1.2 Arsenic and the Blackfoot Disease Epidemic
Blackfoot disease is a unique condition endemic to the south-western coast of Taiwan. 
It is characterized as a severe form of PMVD affecting the lower limbs which leads to 
gangrene (“black feet“). Drinking water in this area was previously supplied by 
artesian wells which contained high levels of arsenic. These wells, like the tubewells 
in Bangladesh, drew water from around 200 metres below ground where arsenic-rich 
rocks prevailed. This was later correlated with increased risk of PMVD with only a 
50% survival rate 16 years after the onset of the disease (Tseng, 1961; 1977). 
Preclinical PMVD in these cases was found to be related to arsenic exposure in a 
dose-dependent manner with symptoms including impaired subcutaneous 
microcirculation (Tseng, 1977; Tseng et al., 1995; Chiou et al., 1997). Prevalence of 
the disease in the endemic villages was 7-19 per 1000 individuals (Tseng, 2002). 
Arsenic-accelerated atherogenesis has also been demonstrated experimentally in the 
widely-employed apolipoprotein E(‘ ^ mouse model of atherosclerosis (Simeonova et 
al., 2003; Bunderson et al., 2004; Srivastava et al., 2007).
1.1.3 Diabetes Mellitus and Cardiovascular Disease
Diabetes mellitus, like chronic arsenic exposure, dramatically increases the risk of 
cardiovascular disease. It is a chronic disease that occurs when either the pancreas 
does not synthesize and secrete insulin (type I diabetes mellitus; affecting 10% of 
sufferers) or when normal insulin levels are offset by the body’s insensitivity to the
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hormone (type II diabetes mellitus; affecting 90% of sufferers). The result is elevated 
serum glucose levels which poses major health complications if uncontrolled. With 
approximately 180 million people worldwide affected by diabetes, this figure is 
expected to double within just 20 years (www.who.int/topics/diabetes-mellitus/en/). 
In 2005 1.1 million people worldwide died from a diabetes-related complication and 
this annual figure is expected to increase by 50% within the next 10 years 
(www.who.int/topics/diabetes-mellitus/en/). Furthermore, the figure for deaths by a 
diabetes-related cause is likely to be significantly higher than that projected since 
deaths that are attributed to cardiovascular diseases are often not correctly correlated 
with the condition. Diabetic retinopathy is one of the world’s leading causes of 
blindness with 2% of diabetics suffering complete visual impairment after 15 years 
from the initial onset of the disease and 10-20% affected by some degree of visual 
impairment (www.who.int/topics/diabetes-mellitus/en/; Gariano & Gardner, 2005). 
Diabetes-associated neuropathy affects 50% of sufferers with symptoms including 
tingling, pain, numbness or weakness in the feet and hands 
(www.who.int/topics/diabetes-mellitus/en/; Casellini & Vinik, 2007). Diabetes is also 
among the leading causes of kidney failure, claiming the lives of 20-40% of sufferers 
(Radbill et al., 2008). However, the most detrimental clinical manifestation of 
diabetes is cardiovascular disease which claims the lives of more than 50% of 
sufferers (www.who.int/topics/diabetes-mellitus/en/; Danaei et al., 2006). Chronic 
elevated blood glucose levels are correlated with an accelerated onset of 
atherosclerosis and microvascular disease (Massi-Benedetti & Federici, 1999; 
Cardoso et al., 2008), a phenomenon that has, like arsenic, been extensively 
demonstrated in animal models (for review see: Wu et al., 2007).
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1.2 Atherosclerosis
Atherosclerosis is a chronic and progressive inflammatory and occlusive disease 
characterized by the accumulation of lipid deposits in the walls of medium and large 
arteries. In regions of vessel curvature or branching, where the flow of blood is 
disturbed, the endothelium is more permeable to low density lipoprotein (LDL) and 
thus it is these sites that are particularly susceptible to atherosclerotic lesion formation 
(for review see: Lusis, 2000). Accumulating LDL in the vessel wall undergoes 
oxidative modifications by reactive oxygen species (ROS) originating from the 
surrounding vascular cells resulting in the formation of oxidized low density 
lipoproteins (oxLDL), which trigger an inflammatory response. Here, circulating 
monocytes migrate paracellularly from the lumen to the vessel wall where they 
rapidly absorb oxLDL (but not native LDL). The resulting “foam cells” then rupture, 
thereby promoting further monocyte migration via a positive feedback effect (for 
review see: Stocker & Keaney, 2004). Atherosclerosis is the principal causative factor 
of morbidity and mortality in the Western world, claiming more lives every year than 
all types of cancer combined, and is the underlying cause of most cardiovascular 
complications including stroke, coronary artery disease including myocardial 
infarction, and PMVD.
Although a major problem in developed nations, the World Health Organisation 
predicts that, with increasing economic prosperity in the Third World and the 
subsequent tendency to adopt a Western lifestyle, atherosclerosis will inevitably also 
become an epidemic in developing countries. While its onset is correlated with 
increasing age (beginning in the second or third decade of life), risk is accelerated by 
a number of factors. These include hypertension, diabetes mellitus, obesity, cigarette 
smoking, high serum LDL levels and, as previously outlined, chronic arsenic
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exposure (see 1.1.1 and 1.1.2). Despite a multitude of distinct risk factors, endothelial 
oxidative stress and dysfunction is now appreciated to be a unifying preceding event 
and has provided an important focus for research. Oxidative stress is known to 
promote atherogenic signalling events in endothelial cells (for review see: Harrison et 
al., 2003). Elucidation of the ROS-generating systems and redox signalling events 
which drive this phenomenon could potentially identify novel targets for 
pharmacological intervention. The recently identified pleiotropic antioxidant 
properties of statins in humans and animals have heightened this interest (Karatzis et 
al., 2005; Mastalerz-Migas et al., 2007; Verreth et al., 2007; Schupp et al., 2008). 
Thus, arsenic and hyperglycaemia have both been postulated to promote 
atherogenesis via pro-oxidative mechanisms, that stimulate platelet activation and 
vascular cell proliferation as well as endothelial production of vascular cell-adhesion 
molecule-1 (VCAM-1), monocyte chemoattractant protein-1 (MCP-1) and vascular 
endothelial growth factor (VEGF) (Lee et al., 2002; Simeonova et al., 2003; Lee et 
al., 2005; Nuntharatanapong et al., 2005; Tsou et al., 2005; Pereira et al., 2007; Scalia 
et al., 2007; Piga et al., 2007; Haubner et al., 2007; Luppi et al., 2008; Undas et al., 
2008; Al-Shabrawey et al., 2008).
1.3 Oxidative Stress: a Definition
While the role of ROS in disease is now appreciated, the emerging field of “redox 
signalling” has lead to a revised definition of “oxidative stress” (Sies, 1991). 
Previously described as an “imbalance in the pro-oxidant/antioxidant equilibrium in 
favour of the pro-oxidants”, the same author later modified this definition to “an 
imbalance between oxidants and antioxidants in favour of the oxidants, potentially 
leading to damage” (Sies, 1997). The latter definition appreciates that increased
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cellular levels of ROS do not necessarily evoke “oxidative damage” and can, in fact, 
mediate physiological responses (for review see: Touyz, 2005). In terms of vascular 
health and disease, oxidative stress may be reflected as a shift in endothelial redox 
status in favour of pro-oxidants leading to physiological signalling events or 
potentially, if uncontrolled, to cellular damage and dysfunction. Indeed, research in 
recent years has uncovered the important role of hydrogen peroxide (H2O2) as an 
endogenous mediator of arterial tone under normal conditions (Matoba et al., 2000; 
2002; Chaytor et al., 2003; Larsen et al., 2008; 2009; Edwards et al., 2008).
1.4 The Endothelium
The entire circulation, including the heart, is lined by an endothelial monolayer on its 
luminal surface. The enormous surface area this generates, approximately 4000 - 7000 
m2 in a human adult, enables the endothelium to interact efficiently and optimally 
with all tissues of the body including cardiac and smooth muscle cells (Sumpio et al., 
2002). In capillaries, which are devoid of smooth muscle cells, the endothelium 
regulates delivery of essential nutrients to the target tissue. Initially thought to be 
merely a selective barrier between blood and tissue, the importance of the 
endothelium in the control of vascular tone has come to the fore since pioneering 
work in the 1970s and 1980s (see 1.4.2). Even to the present day, researchers are still 
deciphering the complexity of the interdependent mechanisms by which this 
monolayer is able to regulate vasomotor tone and hence provide efficient and optimal 
tissue perfusion.
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1.4.1 Role as a Selective Barrier
The function of the endothelium as a selective barrier is determined by intercellular 
junctions, a negatively-charged glycocalyx surface layer and a vesicular system. Such 
regulation facilitates the efficient transfer of signalling molecules and nutrients, either 
by direct uptake via the plasma membrane or by paracellular transport, whilst 
restricting the entry of large plasma proteins thereby maintaining blood osmolarity, 
volume and viscosity (Pries & Keubler, 2006). Endothelial cells contain actin and 
myosin filaments that are components of intercellular junctions and stress fibres that 
“resist” the shearing effect of blood flow (Levick, 2000). Additionally, actin 
remodelling controls the integrity of interendothelial adhesive junctions (both tight 
and adherens junctions), thereby regulating the permeability of the endothelial barrier 
(for review see: Vandenbroucke et al., 2008). Endothelial dysfunction and abnormal 
increases in endothelial permeability are associated with the accelerated onset of 
atherosclerosis (see 1.2). Correspondingly, the endothelium synthesizes and releases 
anti- and pro-thrombotic mediators that regulate platelet aggregation (nitric oxide 
(NO) and von Willebrand factor, respectively, for example) in addition to mediators 
o f inflammatory cell adhesion, such as VCAM-1 and MCP-1 (Poredos, 2001).
1.4.2 Endothelial Control of Arterial Tone
In 1976 Vane and colleagues reported the ability of blood vessels to produce an 
unstable compound from prostaglandin endoperoxides that potently inhibited platelet 
aggregation and adhesion to endothelial cells (Moncada et al., 1976). This compound, 
later identified as 6-keto-PGFia (prostacyclin), was subsequently reported to relax 
vascular smooth muscle (Whittaker et al., 1976; Dusting et al., 1977). In 1982, Vane 
was awarded the Nobel Prize for Physiology or Medicine jointly with Bergstrom and
Samuelsson for their earlier work on the isolation and molecular structure of 
prostaglandins (Bergstrom & Samuelsson, 1962; Nugteren et al., 1966).
Subsequently, a seminal report by Furchgott and Zawadzki (1980) demonstrated the 
obligatory role of endothelial cells in the relaxation of vascular smooth muscle in 
response to acetylcholine, and thus the existence of an endothelium-derived relaxing 
factor (EDRF). Following this, the identity of EDRF was variously proposed as a 
product of lipooxygenase (De Mey et al., 1982; Furchgott, 1983; Rapoport et al., 
1984; Forstermann & Neufang, 1985) or a short-lived carbonyl-containing compound 
with a biological half-life of ~6 seconds in oxygenated buffer (Griffith et al., 1984). It 
was also reported that the bioavailability of EDRF was attenuated by superoxide 
anions (O2’ ) and potentiated by superoxide dismutase (SOD), which catalyses the 
single electron reduction of O2 ’ to form H2O2 (Rubanyi & Vanhoutte, 1986; 
Gryglewski et al., 1986; Moncada et al., 1986; de Nucci et al., 1988), observations 
that would later prove fundamental to the study of endothelial dysfunction and 
cardiovascular disease (also see 1.2).
The obligatory role of cyclic guanosine monophosphate (cGMP) in the EDRF-type 
response was then established and followed, in 1986, by the independent proposals by 
Ignarro and Furchgott that EDRF was NO (Rapoport & Murad, 1983; Griffith et al., 
1985; Furchgott, 1988; Ignarro et al., 1988). The close resemblance of EDRF to NO 
was confirmed in the following year (Ignarro et al., 1987; Palmer et al., 1987; for 
review see: Moncada & Palmer, 1988). Notably, the smooth muscle relaxant effects 
of nitrodilators, such as sodium nitroprusside (SNP), and the involvement of cGMP in 
these responses had been reported during the previous decade (Schultz et al., 1977; 
Murad et al., 1978; Kukovetz et al., 1979). In 1998, the Nobel Prize for Physiology or
9
Medicine was awarded jointly to Furchgott, Ignarro and Murad for their discovery of 
NO production by the vascular endothelium and its effects on smooth muscle tone.
As described in detail in Section 1.5, the endothelium is also able to mediate smooth 
muscle relaxation by promoting smooth muscle hyperpolarization, a phenomenon that 
was first described in the 1980s and appears to be quite distinct from its ability to 
synthesize NO and prostanoids (Bolton et al., 1984; Feletou & Vanhoutte, 1988; Beny 
& Brunet, 1988; Chen et al., 1988).
1.4.3 The Importance of Ca2+ Signalling
The divalent cation Ca2+ controls numerous endothelial signalling mechanisms in 
response to chemical messengers (Tran & Watanabe, 2006). Specifically, agonist- 
induced release of endothelium-derived vasodilators, such as NO and prostanoids, is 
critically reliant on increases in [Ca2+]i (Griffith et al., 1986; Gryglewski et al., 2002; 
Simonsen et al., 2009), whereas the role of endothelial Ca2+ mobilization in 
mechanical responses evoked by physical forces such as shear stress (flow) is 
controversial. For example, some authors claim that flow-induced endothelial NO 
synthesis is Ca2+-independent, and mediated by Akt/protein kinase B (PKB)- 
dependent phosphorylation of serine 1177 of endothelial nitric oxide synthase 
(eNOS), whereas others suggest that extracellular Ca2+ influx via plasma membrane- 
bound mechanosensitive transient receptor potential vallinoid type 4 (TRPV4) 
channels is critical for shear stress-evoked NO-dependent dilatation (Dimmeler et al., 
1999; Hartmannsgruber et al., 2004; Kohler et al., 2006; Perez et al., 2009). 
Endothelial Ca2+ mobilization in response to agonists is mediated by receptor- 
operated Ca24 channels and an inositol 1,4,5-trisphosphate (InsP3)-sensitive 
intracellular Ca2+ store. Depletion of the InsP3-sensitive intracellular store may 
subsequently trigger a small and sustained influx of Ca2+ from the extracellular space
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via store-operated Ca2+ entry (SOCE) (Griffith, 2004). Correspondingly, it is now 
established that following depletion of the endoplasmic reticulum (ER) Ca2+ store the 
ER Ca2+ sensor stromal interaction protein 1 (STIM1) and the store-operated Ca2+ 
channel protein Orail redistribute from the ER to the plasma membrane where the 
highly conserved 107 amino acid activation domain of STIM1 directly binds to the N 
and C termini of Orai 1 causing clustering of individual Orai 1 subunits and opening of 
the assembled channel. Refilling of the ER stores via the sarcoendoplasmic reticulum 
Ca2+ ATPase (SERCA) causes dissociation of the STIM1 -Orail complex and 
disassembly of the channel (Park et al., 2009; Sampieri et al., 2009). The STIMl-Orai 
interaction has been reported to be important for SOCE in endothelial cells 
(Abdullaev et al., 2008; Femandez-Rodriguez et al., 2009). Furthermore, it has also 
been reported that canonical-type TRP channels (TRPC) may contribute to SOCE by 
associating with Orai 1 to form heteromeric channel complexes (Liao et al., 2009).
Ca2+ efflux to the extracellular space is facilitated by the plasma membrane Ca2+- 
ATPase (PMCA) and the Na+/Ca2+ exchanger, the latter of which utilizes the 
electrochemical gradient as a driving force for Na+ entry and hence Ca2+ efflux 
(Szewczyk et al., 2007). It has recently been reported that PMCA may be localised at 
caveolae, invaginations of the plasma membrane (Zhang et al., 2009).
l.S The EDHF Phenomenon and its Characterization
The residual component of endothelium-dependent relaxations observed in the 
presence of inhibitors of eNOS (e.g. Nw-Nitro-L-arginine methyl ester, L-NAME) and 
COX (e.g. indomethacin) is now attributed to endothelium-dependent smooth muscle 
hyperpolarization (Griffith, 2004; Feletou & Vanhoutte, 2006). Such responses are
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critical to the regulation of tissue perfusion due to their predominance in small vessels 
and the resistance vasculature (Shimokawa et al., 1996; Berman et al., 2002).
1.5.1 Endothelium-Dependent Smooth Muscle Hyperpolarization
The phenomenon of endothelium-dependent smooth muscle hyperpolarization was 
first described in guinea pig mesenteric arteries, rat aorta and main pulmonary artery, 
canine coronary small arteries and rabbit aorta (Bolton et al., 1984; Feletou & 
Vanhoutte, 1988; Beny & Brunet, 1988; Chen et al., 1988). One possibility is that 
agonist-stimulated endothelial cells release a freely diffusible endothelium-derived 
hyperpolarizing factor (EDHF) that causes hyperpolarization and relaxation by 
promoting smooth muscle K+ efflux. Various factors, including H2O2 , K+ ions, 
epoxyeicosatrienoic acid (EET) metabolites of arachidonic acid and C-type natriuretic 
peptide, have been demonstrated to act as EDHFs in specific arteries (Campbell et al., 
1996; Edwards et al., 1998; Matoba et al., 2000; 2002; Chauhan et al., 2003). 
However, evidence implicating a single factor as a universal EDHF has failed to 
emerge. The apparent species- and vessel-specific actions of each proposed mediator 
has thus divided opinions on the nature of the EDHF phenomenon. Indeed, an 
alternative hypothesis is that the phenomenon is mediated by electrotonic signalling, 
whereby agonist-stimulated endothelial hyperpolarization is transmitted through the 
arterial media via myoendothelial and homocellular smooth muscle gap junctions that 
provide electrical continuity between the different layers of the vessel wall (for 
reviews see: Griffith, 2004; Griffith et al., 2004).
1.5.2 Role of Gap Junctional Communication
Gap junctions play a pivotal role in direct chemical and electrical intercellular 
communication and are formed by the docking of two membrane-associated hemi- 
channels (connexons) at points of cell-to-cell contact, creating an aqueous pore, which
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confers electrical and chemical (up to 1 kDa) continuity. Whole gap junction units 
aggregate, often in many hundreds, in plaque-like structures of a hexagonal array to 
increase intercellular communication (Griffith, 2004). Plaques have been visualised 
by electron microscopy at points of hetero- and homocellular contact between 
endothelial and smooth muscle cells (Spagnoli et al., 1982; Sandow & Hill, 2000), 
with a correlation between plaque size and electrical coupling and dye transfer being 
evident (Bukauskas et al., 2000). In addition, an increased frequency of gap junction 
plaques at points of cell-cell contact between endothelial and smooth muscle cells 
with decreasing vessel diameter (Aydin et al., 1991; Kristek & Gerova, 1992; Sandow 
& Hill, 2000) may underpin the widely acknowledged dominant role of endothelium- 
dependent smooth muscle hyperpolarization in small vessels, as noted previously (see 
1.4.2).
The mammalian vasculature expresses connexins 37, 40, 43 and, in certain vessel 
types, connexin 45 (each classified according to its molecular mass in kDa) which can 
form hexamers (hemi-channels/connexons) containing various combinations of 
connexin proteins. Immunohistochemical studies in our laboratory have confirmed the 
presence of connexins 37, 40 and 43 in the rabbit iliac artery. It was found that 
connexins 37 and 40 were predominantly expressed in homocellular interendothelial 
gap junction plaques, with connexin 43 predominantly expressed in homocellular 
smooth muscle gap junction plaques in the media (Chaytor et al., 2003). The 
composition of myoendothelial gap junction plaques remains unknown.
In addition to “classical” pharmacological uncouplers of gap junctional 
communication, such as 18a-glycyrrhetinic acid and carbenoxolone, the recent 
development of novel “connexin-mimetic peptides” has enabled researchers to 
dissociate the relative contribution of individual connexin subtypes to gap junctional
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communication. The peptides 37,43Gap 27, 40Gap27 and 43Gap26 are short amino acid 
sequences homologous to connexin-specific variations in the Gap26 and Gap27 
domains (1st and 2nd extracellular loops, respectively) of these proteins. Our 
laboratory has previously demonstrated the role of gap junctional communication in 
endothelial-dependent smooth muscle hyperpolarization and relaxation in rabbit 
arteries, with “EDHF-type” relaxations evoked by ACh being essentially abolished by 
a triple combination of the above peptides (Chaytor et al., 2003). In addition, EDHF- 
type responses to cyclopiazonic acid (CPA), a compound that promotes SOCE by 
inhibiting Ca2+ reuptake into the ER via SERCA thus depleting the intracellular store, 
are abolished by 43Gap26 in the rabbit iliac artery (Edwards et al., 2007; 2008; Garry 
et al., 2009). Correspondingly, 37,43Gap27 causes retention of the dye calcein within 
the intima following intraluminal perfusion and preferential endothelial loading with 
its cell-permeant precursor calcein-AM by inhibiting the radial diffusion of calcein, 
formed by cleavage of the AM moiety, into the media via myoendothelial gap 
junctions (Griffith et al., 2002).
While the molecular mechanism of action of these peptides is unclear, they are likely 
to interrupt channel gating, rather than junction and plaque stability, as wash-out of 
the peptide restores electrical coupling and dye transfer (Chaytor et al., 1998; 2001; 
Martin et al., 2005). Any possible non-junctional effects of these peptides have been 
discounted on the basis that agonist-evoked endothelial hyperpolarizations are not 
affected (Griffith et al., 2005) without alteration in smooth muscle responsiveness to 
NO donors, K+ channel openers and vasoconstrictor agonists (Chaytor et al., 1997; 
1998; Dora et al., 1999; Richards et al., 2001; Chaytor et al., 2001; Sandow et al., 
2002; Ujiie et al., 2002). Furthermore, non-specific effects of these peptides on 
endothelial NO biosynthesis in rabbit arteries can also dismissed as sandwich
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bioassay experiments revealed that ACh induces an NO-dependent/37,43Gap27- 
insensitive relaxation of a juxtaposed, but electrically uncoupled, smooth muscle strip 
indicating that NO transfer from donor endothelium to recipient smooth muscle is 
unaffected by the uncoupling of myoendothelial gap junctional communication 
(Chaytor et al., 1998). Other studies, using different mammalian vessels and relaxant 
agonists, have also demonstrated a dominant role of gap junctional communication in 
EDHF-type relaxant responses (Edwards et al., 1999; 2000; Doughty et al., 2000; 
Allen et al., 2002; Sandow et al., 2002; Xu et al., 2002).
1.5.3 The Integrated Role of Kc* Channels
The activation of endothelial calcium-activated K+ channels (Kca) is pivotal to 
endothelium-dependent smooth muscle hyperpolarization and relaxation mediated via 
gap junctions (Kagota et al., 1999; Brandes et al., 2000; Hill et al., 2000; Taylor et 
a l,  2001; Chaytor et al., 2001; 2002; Ujiie et al., 2002; Ungvari et a l,  2002; Dora et 
al., 2003; Sandow et a l,  2003; 2004; Griffith, 2004; Edwards et al., 2008). The 
vascular endothelium expresses small- and intermediate-conductance Kca channels 
(SKca and IKca, respectively) that are activated by rises in endothelial [Ca2+]j in 
response to agonists or shear stress (Dube & Canty, 2001; Miura et al., 2001; Griffith, 
2004). The sustained opening of these channels is now accepted to be dependent on 
SOCE from the extracellular space following intracellular store depletion (Marchenko 
& Sage, 1993; Sedova et al., 2000; Nilius & Droogmans, 2001). While large- 
conductance BKca channels predominate in smooth muscle cells they are variably 
expressed in the endothelium in some artery types (Kagota et al., 1999; Ungvari et al., 
2002; Brakemeier et al., 2003; Hilgers et a l ,  2006). The individual and integrated role 
of these different Kca channel subtypes in EDHF-type responses appears to be vessel- 
and species-specific with different artery types displaying variable susceptibilities to
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individual and combined Kca channel blockade, which may be agonist-specific 
(Freiden et a l ,  1999; Marrelli et al., 2003; Eichler et al., 2003; Gluais et al., 2005). 
Our laboratory has recently demonstrated an integrated role of these channels in gap 
junction-dependent EDHF-type relaxant responses in the rabbit iliac artery (Edwards 
et al., 2008). Specific blockers of SKca, IKca and BKca channels (apamin, TRAM-34 
and iberiotoxin, respectively) revealed interdependence of these channels in the 
EDHF-type relaxant response following store depletion by CPA on the basis that 
apamin or TRAM-34 alone was ineffective, whereas their combination or iberiotoxin
alone attenuated relaxation from ~86%  to ~60%  of induced tone. Only a triple 
combination of these blockers markedly reduced relaxation to ~35% with residual
relaxation further attenuated to ~20% in the presence of catalase, an enzyme that
destroys H2O2 . This effect on CPA-evoked EDHF-type relaxation was 
indistinguishable from parallel experiments where gap junctional communication was 
interrupted with 43Gap26, thereby implicating a crucial role of Kca channels in gap 
junction-dependent EDHF-type relaxant responses in this vessel. Furthermore, the 
additional attenuation of residual apamin+TRAM+iberiotoxin-insensitive relaxation 
by catalase was not due to H2 O2 functioning as a freely diffusible EDHF because 
authentic H2 O2 causes minimal smooth muscle hyperpolarization in the rabbit iliac 
artery (Chaytor et a l ,  2003).
1.6 Hydrogen Peroxide and the EDHF Phenomenon
H2O2 has been proposed as a contributing mediator to vascular responses as diverse as 
coronary autoregulation, the myogenic response, flow-induced dilatation and reactive 
hyperaemia (Wolin et al., 1990; Nowicki et al., 2001; Koller & Bagi, 2004; Liu et al.,
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2006; Yada et al., 2006; 2008). Furthermore, H2O2 has also been demonstrated to act 
as an EDHF and an EDRF (Matoba et al., 2000; 2002; Chaytor et al., 2003).
H2 O2 was first implicated as an EDHF in mouse and human mesenteric arteries on the 
basis that EDHF-type arterial relaxations and smooth muscle hyperpolarizations to 
ACh were sensitive to catalase (Matoba et al., 2000; 2002). In these artery types, 
relaxation evoked by ACh was attributed to the endothelial production of H2 O2 
following stimulation by the agonist. Subsequent studies have shown inconsistency 
with a role of H2O2 as a freely diffusible EDHF. For example, our laboratory has 
shown that in the rabbit iliac artery, EDHF-type relaxation to A23187 (a Ca2+ 
ionophore), but not endothelium-dependent smooth muscle hyperpolarization, is 
sensitive to catalase. In the presence of catalase, endothelium-dependent smooth 
muscle hyperpolarization and the residual EDHF-type relaxation to A23187 was, 
however, abolished by connexin mimetic peptides. In addition, ACh itself only 
weakly stimulated H2O2 release from the endothelium (Chaytor et al., 2003).
A further difficulty in implicating H2 O2 as an EDHF is the observation that in a wide 
variety of human, rat, mouse, rabbit and pig arteries exogenous H2O2 only evokes 
smooth muscle hyperpolarizations and relaxations at “supraphysiological” 
concentrations, relative to the extracellular accumulation of H2O2 following agonist 
stimulation (Beny & von der Weid, 1991; Karasu et al., 1999; Matoba et al., 2000; 
Fujimoto et al., 2001; Hattori et al., 2003; Chaytor et al., 2003; Gao et al., 2003; 
Miura et al., 2003). Indeed, measurements of extracellular H2O2 of the rat aorta 
(following stimulation with A23187) and human coronary arterioles (in response to 
flow) have revealed concentrations of just 10 -  100 nM and 200 nM in organ bath 
experiments, respectively (Cosentino et al., 1998; Liu et al., 2003). Conversely, while 
H2O2 is membrane diffusible, it has been estimated that only 1 -  15% of H2O2 applied
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extracellularly is likely to be biologically available inside the cell (Schroder & Eaton, 
2008). Additionally, intracellular H2 O2 production and subsequent “redox-signalling” 
may speculatively involve microdomains of this ROS that are enzymatically- 
generated in proximity to their site of action. Correspondingly, accumulating evidence 
suggests that the specific subcellular localization of ROS-generating enzymes may be 
intricately linked to their function. For example, NADPH oxidase 4, which produces 
mostly H2O2 rather than O2 ", is predominantly expressed in the ER membrane of 
endothelial and smooth muscle cells, and is critical for the oxidative regulation of the 
ER resident protein tyrosine phosphatase IB (Hilenski et al., 2004; Petry et al., 2006; 
Chen et al., 2008). The intracellular concentrations of H2 O2 achieved following 
agonist or shear stress stimulation in the endothelium remain to be established.
H2O2 has previously been shown to mobilize endothelial Ca2+ via mechanisms that are 
variably dependent (Volk et al., 1997) or independent (Hu et al., 1998; 2000; Zheng 
& Shen, 2005) of phospholipase C activity. However, until recently, H2C>2-evoked 
endothelial Ca2+ mobilization had not been investigated in the context of the EDHF 
phenomenon. Indeed, there is a growing appreciation of the dependency of EDHF- 
type relaxation responses on H202-generating enzymes such as cytosolic SOD 
(Cu/Zn-SOD) with attenuated EDHF-type relaxant responses having been reported in 
humans and animals either following pharmacological blockade of the enzyme or in 
Cu/Zn-SOD( * mice (Cooke & Davidge, 2003; Morikawa et al., 2003; 2004). In 
addition, the SOD-mimetic tempol restores EDHF-type relaxant responses blunted by 
enhanced O2* production in hypertensive rats (Adeagbo et al., 2003; Ozawa et al., 
2004; Christensen et al., 2007).
Our group has shown that H2O2 enhances electrotonically-mediated EDHF-type 
relaxations evoked by CPA and ACh in the rabbit iliac artery (Edwards et al., 2008;
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Garry et al., 2009). Here, measurements of endothelial [Ca2+]i and ER store Ca2+ 
concentration ([Ca2+]ER) revealed that H2O2 enhanced endothelial Ca2+ mobilization 
evoked by CPA. Administration of 100 pM H2O2 alone affected neither [Ca2+]i nor 
[ C a 2+]nR. However, dual administration of 100 pM H2O2 and 10 pM CPA evoked an
2 “b 2  +elevation of [Ca ] i  and reduction of [Ca ] e r  to levels indistinguishable from those 
observed when maximal responses were evoked by 30 pM CPA alone. This 
synergism may reflect oxidation and sensitization of the InsP3 receptor by H2O2 on 
the basis that (i) elevations in [Ca2+]i correlated with store depletion, (ii) the 
endothelium-specific isoform of the SERCA pump (SERCA3) is insensitive to H2O2 
at concentrations <500 pM (Liu et al., 1997; Grover et al., 1997), and (iii) the thiol 
reagent thimerosal closely mimicked the effect of H2O2 . Thimerosal has been shown 
to oxidize InsP3 receptors and promote ER Ca2+ depletion (Bootman et al., 1992; 
Parekh & Penner, 1995; Montero et al., 2001; Bultynck et al., 2004). In addition, 
although cumulative concentration-relaxation responses to H2 O2 were 
indistinguishable between intact and endothelium-denuded rings, a potentiation was 
observed in intact rings in the presence of 10 pM CPA. This was partially reversed by 
blockade of BKca channels (with iberiotoxin) and abolished after dual blockade of 
SKca and IKca (with apamin and TRAM-34, respectively), indicating downstream 
activation of endothelial Kca channels and subsequent hyperpolarization. Therefore, in 
the rabbit iliac artery, H2O2 potentiates EDHF-type vasorelaxation by promoting 
endothelial Ca2+ mobilization, probably by sensitizing the InsP3 receptor, with 
downstream hyperpolarization and relaxation of smooth muscle mediated by Kca 
channels and electrotonic signalling via gap junctions (Edwards et al., 2008).
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1.7 Direct Smooth Muscle Actions of Hydrogen Peroxide
Distinct from the endothelial actions of H2 O2 recently described in the rabbit iliac 
artery (Edwards et al., 2008), this ROS is also able to modulate arterial smooth 
muscle tone directly. Indeed, the enhancing effect of exogenous H2O2 on EDHF-type 
relaxation in the rabbit iliac artery is superimposed on a direct smooth muscle relaxant 
action (Edwards et a l , 2008). However, smooth muscle responses to exogenous H2O2 
in mammalian arteries display marked heterogeneity. For example, in contrast to the 
rabbit iliac artery, the responses of rat arteries to H2O2 are biphasic with low 
concentrations evoking constriction and high concentrations evoking relaxation (Gao 
et al., 2003; Cseko et al., 2004; Samora et al., 2008; Garcia-Redondo et al., 2009). 
The constrictor effects of H2O2 in the rat superior mesenteric artery are endothelium- 
independent (Gao et al., 2003), but in 3rd order mesenteric arteries and skeletal muscle 
arterioles constriction is attenuated (not abolished) by removal of the endothelium 
(Cseko et al., 2004; Samora et al., 2008; Garcia-Redondo et al., 2009). Endothelium- 
independent constriction to H2O2 in all of these artery types is abolished by inhibitors 
of COX or thromboxane A2 synthesis (Gao et al., 2003; Cseko et al., 2004; Samora et 
al., 2008; Garcia-Redondo et al., 2009). H2O2 relaxations in the rat superior 
mesenteric artery are also endothelium-independent and are abolished by high [K+]0 
or attenuated by tetraethylammonium (TEA), consistent with a direct action of H2O2 
on smooth muscle Kca channels (Gao et al., 2003). Similarly, endothelium- 
independent relaxation to H2O2 in skeletal muscle arterioles is also mediated, in part, 
by Kca channels although, in contrast to the superior mesenteric artery, this is 
superimposed on an endothelium-dependent component that involves the production 
of NO (Cseko et al., 2004; Samora et al., 2008).
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Relaxation of pig coronary arterial smooth muscle by H20 2 is partly mediated by 
BKca channels, although this is via a secondary mechanism which involves activation 
of phopholipase A2 and the production of lipooxygenase-derived arachidonate 
metabolites (Barlow et al., 1998; 2000). The above observations contrast with 
corresponding responses of the rabbit iliac artery which do not appear to involve any 
of the three Kca channels subtypes (Chaytor et al., 2003; Edwards et al., 2008). 
Correspondingly, 1 mM H20 2 only weakly hyperpolarizes (~7.5 mV) rabbit iliac 
arterial smooth muscle (Chaytor et al., 2003), whereas the same treatment 
hyperpolarizes rat superior mesenteric arterial smooth muscle by -15 mV (Gao et al.,
2003). Furthermore, while H20 2 induces Ca2+ mobilization and augmented Kca 
channel current in isolated endothelial cells, it has been reported that this ROS 
directly blocks BKca at millimolar concentrations, probably via oxidation of cysteine 
911 in the Ca2+ binding region of the a  subunit of the channel thus impairing the 
binding of Ca2+ (Doan et al., 1994; Hu et al., 1998; Bychkov et al., 1999; Brakemeier 
et al., 2003; Tang et al., 2004; Zheng et al., 2005; Mergler et al., 2005; Lu et al.,
2006).
While the studies of Gao et al (2003), Cseko et al (2004), Samora et al (2008) and 
Garcia-Redondo et al (2009) have highlighted heterogeneity in the responses of rat 
arteries to H20 2, this may be particularly evident in the human circulation. For 
example, in coronary arterioles H20 2-evoked relaxation is endothelium-independent 
and abolished by either high [K+]0 or apamin in combination with the non-specific 
IKca and BKca blocker charybdotoxin (Miura et al., 2003). Furthermore, H20 2 evokes 
hyperpolarization of human coronary arteriolar smooth muscle (Matoba et al., 2003). 
In contrast, H20 2-evoked relaxations of gut submucosal microvessels are 
endothelium-dependent with only a constrictor response observed in endothelium-
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denuded preparations, despite the fact that EDHF-type relaxations in this vessel type 
are, like those of the mesenteric artery and coronary arterioles, sensitive to catalase 
(Matoba et al., 2002; Hatoum et al., 2005; Larsen et al., 2008). While H2O2 has been 
postulated to be an EDHF in the human mesenteric artery and coronary arterioles 
(Matoba et al., 2002; Miura et al., 2003; Larsen et al., 2008), the study of Hatoum and 
co-workers suggests that, in gut submucosal microvessels, H2 O2 may be involved in 
the release of a chemically-distinct EDHF (Hatoum et al., 2005). A further example of 
intraspecies heterogeneity is the dynamic range of vascular responsiveness to 
exogenous H2O2 . For example, in mice, H2O2 relaxation in cerebral arteries occurs in 
the nanomolar range whereas micromolar concentrations are required in mesenteric 
arteries (Matoba et al., 2000; Drouin et al., 2007).
H2O2 -evoked relaxations in rabbits are endothelium-independent, as demonstrated in 
the iliac and the superior and small mesenteric arteries (Fujimoto et al., 2001; 
Edwards et al., 2008). Furthermore, relaxations to H2O2 in these arteries may be 
explained by a decreased sensitivity of the smooth muscle contractile apparatus to 
Ca2+, as has been reported in the rabbit aorta (Iesaki et al., 1996). Furthermore, recent 
evidence has uncovered another mechanism by which H2O2 is able to mediate direct 
smooth muscle relaxation. Burgoyne and colleagues have identified a novel cysteine 
redox sensor (Cys42) of protein kinase G (PKG) that, upon application of exogenous 
H2O2 , forms disulphide bridges between PKG monomers to form dimers, thereby 
increasing the affinity of this enzyme for its target substrates. Correspondingly, 
exogenous H2O2 triggered a relaxation of the rat thoracic aorta that was abolished by 
inhibition of PKG with Rp-8-Br-cGMP, but not by inhibition of soluble guanylyl 
cyclase (sGC) with lH-(l,2,4)oxadiazolo(4,3-a)quinoxalin-l-one (ODQ) (Burgoyne 
et al., 2007). This finding is in stark contrast to observations in mouse cerebral and
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porcine coronary arteries, where relaxation to H20 2, though endothelium-independent, 
is attenuated by ODQ, thus suggesting a mechanism involving the activation of sGC 
rather than a direct downstream action on PKG (Hayabuchi et al., 1998; Drouin et al.,
2007).
Taken together, it is apparent from the evidence discussed that H20 2 cannot be 
described unambiguously as an EDHF, and that the mechanisms through which it 
mediates direct smooth muscle relaxation require further clarification.
1.8 Arsenic, Glucose and the EDHF Phenomenon
Arsenic and hyperglycaemia both induce endothelial oxidative stress and impaired 
NO bioavailability. However, modulation of the EDHF phenomenon by arsenic has 
not yet been investigated, whilst the effect of diabetes on EDHF-type responses, 
despite fifteen years of investigation, remains controversial. Improving EDHF-type 
responses has recently been proposed as a novel potential drug target for the treatment 
of diabetes-associated impairments in tissue perfusion (Feletou, 2009). Therefore, 
elucidation of the mechanisms through which the EDHF phenomenon may 
compensate for impaired NO bioavailability, as has been demonstrated in diabetic 
models, may provide an important focus for pharmaceutical effort (Thomsen et a l,  
2001; Timar-Peregrin & Guy, 2002; Shen et al., 2003; Yousif et al., 2005; Shi et al., 
2006; Malakul et al., 2008; MacKenzie et al., 2008; Pataricza et al., 2008).
1.8.1 Arsenic- and Hyperglycaemia-Evoked ROS Production in Endothelial 
Cells: Implications for Modulation of the EDHF Phenomenon 
As previously highlighted (see 1.2), arsenic and hyperglycaemia have been implicated 
in the accelerated onset of atherosclerosis, and several studies have suggested that 
enhanced ROS production and subsequent endothelial dysfunction contribute to their
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pro-atherogenic action (Nakagami et al., 2005; Jindal et al., 2008). However, the 
ROS-generating systems involved in arsenic- and glucose-evoked changes in 
endothelial redox status remain to be fully established.
Endothelial cells are capable of generating ROS via a number of systems including 
NADPH oxidase, uncoupled eNOS, xanthine oxidase, COX, cytochrome P4 5 0  and the 
mitochondrial electron transport chain (Wolin, 2000). While some authors suggest 
NADPH oxidase is principal source of ROS in the healthy endothelium (Griendling et 
al., 2000; Ushio-Fukai et al., 2002), it remains to be elucidated whether this enzyme 
is the dominant system involved in arsenic- and glucose-mediated ROS production. 
Indeed, arsenic has been shown to activate NADPH oxidase via a mechanism 
involving the translocation of Racl, the GTPase essential for activation of the enzyme 
complex, to membrane fractions in endothelial cells (Smith et al., 2001). Glucose is 
thought to activate this enzyme via a protein kinase C (PKC)-dependent mechanism, 
possibly involving phosphorylation of Racl (Cosentino et al., 2003; Inoguchi et al., 
2003; Cave et al., 2006; Ceolotto et al., 2007). Glucose has also been reported to 
evoke O2* release from the mitochondrial electron transport chain as a by product of 
oxidative metabolism (Nishikawa et al., 2000; Quijano et al., 2007). Arsenic may also 
facilitate ROS release from isolated mitochondria via direct interaction with vicinal 
thiols of the mitochondrial permeability transition pore (mPTP), although this has not 
yet been studied in endothelial cells (Larochette et al., 1999; Tian et al., 2005).
The production of ROS in endothelial cells under hyperglycaemic conditions and in 
the presence of arsenic has implications for modulation of the EDHF phenomenon.
For example, glucose increases O2* levels in endothelial cells in a concentration-
2+
dependent manner which correlates with rises in [Ca ]j (Wascher et al., 1994; Graier 
et al., 1996; 1997; Wu et al., 1999). In addition, both arsenic and elevated glucose
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promote endothelial production of H2 O2 (Barchowsky et al., 1999; Guo et a l,  2000; 
Lee et al., 2008). As previously discussed (see 1.6), our laboratory has recently shown
1
that H2O2 promotes endothelial Ca mobilization and enhances EDHF-type 
relaxation in the rabbit iliac artery (Edwards et al., 2008). While arsenite elevates 
[Ca2+]i in multiple cell types, this has not yet been demonstrated in endothelial cells 
(Shen et al., 2002; Mehta et al., 2006; Sandoval et al., 2007; Vahidnia et al., 2008; Li 
et al., 2009). Shen et al reported that low micromolar levels of arsenic mobilized 
intracellular Ca2+ stores of an oesophageal epithelial cell line, with peaks consistently 
reached after just 15 minutes (Shen et al., 2002). Furthermore, Li and colleagues have 
recently demonstrated that arsenic-evoked vascular smooth muscle Ca2+ mobilization 
is mediated by a mechanism involving ROS (Li et al., 2009).
Taken together, the acute effects of arsenic and elevated glucose on endothelial H2 O2 
production suggest that they might be capable of modulating EDHF-type relaxation in 
vessel types where H2O2 is known to participate in this phenomenon.
1.8.2 Arsenic, Hyperglycaemia and Endothelium-Dependent Arterial Relaxation 
The effects of arsenic on endothelium-dependent arterial relaxation remain poorly 
understood. Indeed, to the author’s knowledge, there are only four published articles 
investigating the effects of arsenic. Furthermore, despite over twenty years of 
investigation, the effects of hyperglycaemia remain controversial.
1.8.2.1 Impaired NO-Dependent Relaxation Following Arsenic Exposure 
Attenuation by arsenic of endothelium-dependent relaxation to ACh in the rat aorta 
has been variously attributed to reduced eNOS expression and reduced NO 
bioavailability mediated by oxidative stress (Lee et al., 2003; Jindal et al., 2008). 
Srivastava and colleagues (2007) also reported that arsenic impaired NO-dependent 
relaxations evoked by ACh in the mouse aorta, but did not investigate the nature of
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the mechanisms involved. By contrast, Bilszta and co-workers (2006) reported that 
arsenic failed to alter relaxations of rat aorta and renal artery to ACh despite 
constrictor responses to phenylephrine being potentiated due reduced basal NO 
bioavailability.
1.8.2.2 Impaired NO-Dependent Relaxation in Diabetes
Impaired NO bioavailability due to oxidative stress is the most consistently reported 
phenomenon in studies of the modulation of endothelial function in diabetes, although 
several reports suggest that in the early stages of diabetes NO bioavailability may 
actually be increased, possibly via oxidant-induced Ca2+ mobilization (Wascher et al., 
1994; Graier et al., 1996; 1997a; 1997b; 1998; Pieper et al., 1999; Sercombe et al.,
2004). A number of studies have suggested that ROS derived from NADPH oxidase 
impair NO bioavailability in arteries from diabetic animals (Kim et al., 2002; Coppey 
et al., 2003; Sercombe et al., 2004; Hayashi et al., 2005; Bitar et al., 2005; Tawfik et 
al., 2006; Matsumoto et al., 2007; Su et al., 2008; Shukla et al., 2008; Lopez-Lopez et 
al., 2008), although the mitochondrial electron transport chain (Bagi et al., 2004; 
Rosen and Wiemsperger, 2006) and cytochrome P450 (Elmi et al., 2008) may be 
functionally significant sources in certain vascular beds. Furthermore, a number of 
studies have revealed the potential of SOD and its cell-permeable mimetic, tempol, to 
restore relaxant responses (Hattori et al., 1991; Nassar et al., 2002). It is also apparent 
that the effect of diabetes on NO-dependent relaxation may differ depending on the 
mode of endothelial stimulation (White & Carrier, 1986; Kamata & Hosokawa, 1997).
1.8.2.3 Altered Prostanoid Production in Diabetes
It was apparent from early studies of vascular function in diabetes that the condition 
may cause alterations in the production of dilator and/or constrictor prostanoids that 
may contribute to altered vascular responsiveness. For example, Mayhan and
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colleagues reported that impaired endothelium-dependent relaxation of streptozotocin 
(an agent that induces type I diabetes by causing pancreatic 13 cell necrosis) (STZ)- 
induced diabetic rat cerebral arterioles was mediated, at least in part, by the increased 
production of the endothelium-derived contracting factor (EDCF) thromboxane A2 , as 
indicated by the restoration of relaxant responses by the COX inhibitor indomethacin 
or a thromboxane A2 receptor antagonist (Mayhan et al., 1991). It was subsequently 
suggested that hyperglycaemia-evoked increases in endothelial thromboxane A2 
production may be mediated by a mechanism involving elevated ROS production 
(Kobayashi & Kamata, 2002; Cosentino et al., 2003; Erdei et al., 2007). By contrast, 
Alabadi et al (2001) reported that an increased production of dilator prostanoids in 
rabbit renal arteries during acute exposure to elevated glucose potentiated relaxant 
responses to ACh. However, studies of other vessel types have not provided evidence 
for functionally significant effect of COX inhibitors on endothelium-dependent 
relaxations in diabetes (Hattori et al., 1991; Shi et al., 2006).
1.8.2.4 Attenuation of the EDHF Phenomenon in Diabetes
A number of mechanisms have been postulated to contribute to impaired EDHF-type 
relaxation in diabetes. Fukao and colleagues (1997) reported impaired EDHF-type 
relaxations and endothelium-dependent smooth muscle hyperpolarizations to ACh in 
the mesenteric artery of STZ-diabetic rats, an effect that did not appear to involve 
ROS because responses were unaffected by SOD (Fukao et al., 1997). By contrast, it 
was reported in the same artery type that either the individual application of SOD or 
the combined administration of SOD and catalase restored EDHF-type relaxations to 
ACh blunted by acute exposure to high glucose (Ozkan & Uma, 2005).
In small mesenteric arteries from STZ-treated apolipoprotein E null mice impaired 
EDHF-type relaxation to ACh involves, in part, decreased expression of SKca
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channels (Ding et al., 2005). However, it was subsequently reported that impaired 
EDHF-type responses in the obese type II diabetic rat mesenteric artery were 
associated with the decreased activity, but not expression, of SKca (Burnham et al., 
2006a). Additionally, these authors demonstrated that Ca2+-dependent activation of 
BKca channels located on the smooth muscle cells of these arteries was impaired in 
the same animal model of type II diabetes, and suggested that increased production of 
H2O2 may have accounted for the blockade of BKca channels via the mechanism 
described by Tang and colleagues, whereby oxidation by H2O2 of the cysteine911 
residue located in the Ca2+ bowl region of the a subunit virtually eliminated 
physiological activation of the channel (Tang et al., 2004; Burnham et al., 2006b). 
Alternatively, it has been proposed that the reduced Ca2+ sensitivity of BKca channels 
of STZ-diabetic rat retinal arteriolar smooth muscle is mediated by the reduced 
expression of the 131 subunit (McGahon et al., 2007).
A number of studies have also demonstrated that gap junctional communication may 
be impaired in diabetes. For example, the reduced expression of connexin 40 mediates 
impaired EDHF-type relaxations in the STZ-diabetic mouse coronary and type II 
diabetic rat mesenteric arteries (Makino et al., 2008; Young et al., 2008). 
Furthermore, the reduced expression of connexin 37 accounts, in part, for impaired 
EDHF-type relaxation in STZ-diabetic mouse small mesenteric arteries (Ding et al.,
2005). It has also been reported that elevated glucose evokes PKC-dependent 
phosphorylation of connexin 43 and impairs gap junction permeability in isolated 
aortic endothelial and smooth muscle cells (Inoguchi et al., 1995; Kuroki et al., 1998). 
Additionally, Matsumoto and colleagues have reported that impaired gap junction- 
dependent EDHF-type relaxations to ACh in STZ-diabetic rat mesenteric arteries are 
mediated by the reduced accumulation of cAMP resulting from the increased
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expression of phosphodiesterase 3 and/or the reduced expression of adenylyl cyclase 
(Matsumoto et al., 2003; 2004; 2005). Indeed, cAMP is known to play a permissive 
role in EDHF-type relaxations that involve gap junctional communication by 
modulating connexin functionality (Taylor et al., 2001; Griffith et al., 2002; Chaytor 
et al., 2002; Griffith et al., 2005).
1.8.2.5 Augmentation of the EDHF Phenomenon in Diabetes
Endo and colleagues were the first to report that EDHF-type relaxations may be 
resistant to diabetes and thus did not account for impaired endothelium-dependent 
relaxation in the STZ-diabetic rat aorta (Endo et al., 1995). It was subsequently 
reported that in STZ-diabetic rat cremaster arterioles and the db/db (leptin receptor 
knockout) type II diabetic mouse small mesenteric artery EDHF-type relaxations were 
augmented and served to compensate for impaired NO bioavailability (Timar- 
Peregrin & Guy, 2001; Pannirselvam et al., 2002). Following this, the studies of 
Thomsen and colleagues (2002) and Shen and colleagues (2003) provided evidence 
that augmentation of the EDHF phenomenon in diabetes was associated with an 
enhanced contribution of Kca channels, as demonstrated in STZ-diabetic rat sciatic 
nerve arterioles and the STZ-diabetic mouse aorta, respectively. These findings were 
later substantiated by Shi and co-workers (2006), who demonstrated augmented 
apamin+charybdotoxin-sensitive EDHF-type relaxations in the mesenteric and 
femoral arteries of STZ-diabetic rats. The reasons for the differential modulation of 
EDHF-type relaxation observed by the studies of Fukao et al and Shi et al are unclear 
as both groups analysed responses in the same artery of the same diabetic rat model 
after a similar duration of disease.
Malakul and co-workers (2008) later reported the existence of an EDHF-type relaxant 
response, mediated by apamin+charybdotoxin-sensitive Kca channels, in the aorta of
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the STZ-diabetic rat, with such responses being absent from healthy animals. In 
addition, these authors reported that hypercholesterolaemia also revealed the 
contribution of an apamin+charybdotoxin-sensitive EDHF-type relaxant response, 
with the combination of diabetes and hypercholesterolaemia synergistically increasing 
NADPH oxidase activity and additively augmenting the EDHF phenomenon. These 
observations appear inconsistent with the previously mentioned findings of Endo and 
colleagues (1995), where EDHF-type responses were evident in healthy animals, and 
were unaffected by diabetes. Indeed, other authors have variously demonstrated the 
existence or absence of EDHF-type relaxations in the rat aorta under normal 
conditions (Chen et al., 1988; Wu et al., 1993; Iranami et al., 1997).
MacKenzie and colleagues also reported augmented EDHF-type relaxations to 
bradykinin in human mesenteric arteries acutely exposed to high glucose, an artery 
type where H2 O2 contributes to the EDHF phenomenon under control conditions 
(Matoba et al., 2002; MacKenzie et al., 2008). Pataricza and colleagues also reported 
an enhanced contribution of Kca channels to endothelium-dependent relaxation (in the 
absence of eNOS and COX inhibitors) to ACh in coronary arteries of alloxan-diabetic 
dogs that served to fully preserve vascular function (Pataricza et al., 2008). 
Furthermore, Park and co-workers have recently reported that EDHF-type relaxations 
are abolished by catalase or apamin+charybdotoxin in coronary arterioles from type II 
diabetic mice, whereas these treatments only partially attenuate such responses in 
healthy mice (Park et al., 2008). This observation appears to be consistent with the 
report of Edwards and colleagues (2008) that endogenous H2 O2 may modulate 
concerted Kca channel activity and thus contribute to the EDHF phenomenon in the 
rabbit iliac artery.
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Several reports have demonstrated an increased functional role of H2 O2 in diabetic 
vessels. For example, H2O2 compensates for impaired NO bioavailability during ACh- 
evoked relaxant responses in aortae of STZ-diabetic rats (Karasu, 2000). However, it 
was not determined whether this was mediated via an EDHF-type mechanism. 
Furthermore, it has also been reported that exogenous H2 O2 evokes more potent 
relaxation in the STZ-diabetic rat aorta, although the mechanism remains to be 
elucidated (Pieper & Gross, 1988; Karasu, 1999).
1.9 Cross-Talk Between the EDHF Phenomenon and NO
Several groups have suggested the existence of a reciprocal relation between NO- 
dependent and EDHF-type responses. Such “cross-talk” may facilitate a dynamic 
augmentation of the EDHF phenomenon when NO bioavailability is reduced. Thus, in 
canine coronary arterioles EDHF-type relaxations can completely offset the NO 
component (Nishikawa et al., 2000b), whereas EDHF-type responses may be blunted 
by exogenous NO or under conditions where an excess of NO is released from the 
endothelium e.g. during sepsis (Beach et al., 2001; Griffith et al., 2005). NO has been 
reported to promote Ca2+ sequestration via S-glutathiolation of the SERCA pump 
while, downstream from NO, PKG may impair SOCE either via a direct mechanism 
involving phosphorylation of SOC or indirectly via phosphorylation of 
phospholamban leading to enhanced store refilling via the SERCA pump (Trepakova 
et al., 1999; Mundina-Weilenmann et al., 2000; Dora et al., 2001; Adachi et al., 
2002). Therefore, reductions in NO bioavailability in diabetes could in theory 
augment the EDHF phenomenon directly.
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1.10 Summary and Aims
From the evidence discussed above, it is apparent that NO bioavailability may be 
impaired by oxidative stress during diabetes and arsenic toxicity. Correspondingly, 
compelling evidence suggests that the increased endothelial production of ROS in 
diabetes and arsenic toxicity originates from NADPH oxidase. While the effect of 
arsenic on the EDHF phenomenon remains to be investigated, the modulation of 
EDHF-type relaxation during diabetes remains controversial despite extensive study. 
At the time of the last review of the EDHF phenomenon in diabetes in 2005 it was 
thought that this phenomenon was predominantly impaired in mammalian arteries, 
with the possible exception of mice (Fitzgerald et al., 2005). However, studies 
subsequent to this review have provided evidence for augmented EDHF-type 
relaxations during diabetes in animals other than mice, including humans, rats and 
dogs (Shi et al., 2006; MacKenzie et al., 2008; Pataricza et al., 2008; Malakul et al.,
2008). Furthermore, the recent study of Park and colleagues suggests that the 
contribution of H2O2 to EDHF-type relaxations may become increasingly significant
in diabetes (Park et al., 2008). Correspondingly, our group has demonstrated that
2+authentic H2O2 potentiates the EDHF phenomenon by promoting endothelial Ca 
mobilization in the rabbit iliac artery (Edwards et al., 2008). However, it remains to 
be determined whether H2O2 plays a direct role in the augmentation of EDHF-type 
relaxations when NO-dependent responses are blunted by oxidative stress in diabetes 
and arsenic toxicity.
Considering these observations, it was thus hypothesized that arsenic and glucose 
might potentiate the EDHF phenomenon in the rabbit iliac artery via production of 
H2O2 . The aim of the current study was to compare the effects of acute exposure to 
arsenic and elevated glucose on NO-dependent and EDHF-type relaxation responses
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to receptor-dependent and receptor-independent endothelial stimulation. Further 
investigations were undertaken to elucidate the role of ROS, particularly H2 O2 , and 
NADPH oxidase in these responses.
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CHAPTER 2
GENERAL METHODS 
2.1 Iliac Artery Dissection
Male New Zealand White rabbits (2-2.5 kg) were sacrificed with sodium 
pentobarbitone (Euthatal; 150 mg kg'1) administered intravenously via a marginal ear 
vein and inspected for nervous reflexes (in keeping with the Animal and Scientific 
Procedures Act, 1986). The tissue containing the iliac arteries, including surrounding 
skeletal muscle and adipose tissue (see Figure 2.1), was dissected and placed in ice 
cool Holman’s buffer (composition in mM: 120 NaCl, 5 KC1, 2.5 CaCl, 1.3 NaH2P0 4 , 
25 N aH C03, 11 glucose and 10 sucrose) for transit back to the laboratory. External 
iliac arteries were subsequently dissected from the tissue section and any excess 
adipose tissue adjacent to the adventitial surface was carefully removed.
2.2 Ring Segment Preparation and Tension Recording Procedure
The iliac artery was cut into ring segments (2-3 mm wide) and mounted in a Mulvany 
type Myograph (Model 400, Danish Myotechnology, Aarhus, Denmark) containing 
oxygenated (95% O2 , 5% CO2) Holman’s buffer and maintained at 37°C (see Figure
2.2). Recording of tension was then commenced using Myodaq software (Danish 
Myotechnology, Aarhus, Denmark). The arterial segment diameter was gradually (in 
a step-wise fashion) increased over an equilibration period of 1 hour until a resting 
tension of 1 mN was established. The buffer in each channel was then replaced and 
the tension readjusted following stress relaxation. To study EDHF-type relaxations 
preparations were then incubated for 30 minutes with the cyclooxygenase inhibitor 
indomethacin (10 pM) and a concentration of the eNOS inhibitor L-NAME (300 pM)
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that has previously been shown to abolish endothelium-dependent accumulation of 
cGMP in rabbit iliac arteries (Taylor et al., 2001). Some preparations, where 
appropriate, were incubated with one of these inhibitors individually.
Subsequent incubation with other pharmacological agents is specified in each 
Chapter. Tone was induced with the ai adrenoreceptor agonist phenylephrine (PE, 1 
pM) and the preparations then allowed to reach a stable plateau over approximately 
15 minutes. PE was specifically selected as the ai adrenoreceptor is expressed in 
smooth muscle but not in the endothelium, thereby preventing direct activation of 
endothelial cells prior to the addition of relaxants (Dora et al., 2000). Endothelium- 
dependent relaxations were then studied by constructing cumulative concentration- 
response curves for ACh (1 nM -  10 pM) or CPA (100 nM -  100 pM). Endothelium- 
independent responses to MAHMA NONOate (1 nM -  10 pM) were studied in iliac 
artery preparations that had been denuded of their endothelium.
This was achieved by rubbing the luminal surface with a wooden rod. Rings were 
then mounted and prepared for isometric analyses as described for endothelium-intact 
preparations (see above). Firstly, tone was induced by PE and successful removal of 
the endothelium confirmed by the absence of the relaxant response to 1 pM ACh 
(normally -90%  in intact preparations; see Chapters 3 and 4 for appropriate 
examples). Preparations were then washed repeatedly with fresh Holman’s buffer 
(every 10 minutes) for 1 hour to remove PE and ACh. Tone was then readjusted to 
maintain a resting tension of 1 mN in preparation for further study.
2.3 Data Collection
The Myodaq-recorded experiment file was then analysed using Myodata software. 
Tension values were collected for the baseline, for the addition of PE (plateau) and for
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each concentration of the cumulative concentration-response curves to ACh, CPA or 
MAHMA NONOate. Data were entered into Excel software and the PE-induced 
increase in tone calculated (tension at PE plateau minus baseline tension). Each data 
point on the cumulative concentration-response curves for ACh, CPA and MAHMA 
NONOate was then subtracted from the baseline tension and calculated as a percentage 
reversal of PE-induced tone (% relaxation). This data was then entered into Graphpad 
Prism Version 4.0 software for curve construction and statistical analysis.
2.4 Statistical Analysis.
A small constrictor response evoked by low concentrations of CPA prior to the onset 
of EDHF-type relaxations meant that sigmoidal curves could not be plotted for these 
data. Therefore, the concentration of this agent giving 50% reversal of PE-induced 
tone (IC5 0) was determined as an alternative to 50% maximal relaxation (as 
determined for ACh and MAHMA NONOate; EC5 0). In addition, PE-induced tone 
and its maximal reversal (Rmax) were determined and average PE-induced tone, Rmax 
and PIC50/EC50 (negative log molar IC50/EC 5 0) were calculated as means±SEM. 
Normality was confirmed using the D ’Agostino and Pearson omnibus test. Results 
were then compared using the Student’s t-test for paired data or one-way ANOVA 
with Bonferroni multi-comparison post-tests as appropriate. Further comparisons of 
individual data points of concentration-response curves were obtained using the 
Student’s t-test or two-way ANOVA with Bonferroni multi-comparison where 
appropriate. Variation was considered significant at P<0.05.
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2.5 Reagent Information
All constituents of Holman’s buffer were purchased from Fischer Scientific. Details 
of all other reagents studied in this thesis are provided in Table 2.1.
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pFigure 2.1 Schematic of the initial target dissection area. Initially, tissue containing 
the iliac arteries, including surrounding skeletal muscle and adipose tissue (indicated 
by dashed red box), was dissected for transit back to the laboratory before the arteries 
were finely-dissected and prepared for the experiment. Note that the initial tissue 
segment dissected includes the lower abdominal aorta and upper femoral artery to 
minimize damage to the iliac artery.
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Figure 2.2 Schematic of a single channel of the Mulvany Myograph (original 
diagram). Photograph obtained from Danish Myotechnology, Aarhus, Denmark.
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Full name Short-name (in text) Purchased from Solvent
Acetovanillone Apocynin Sigma-Aldrich Absolute Ethanol
Acetylcholine chloride ACh Sigma-Aldrich Holman’s
Catalase (from bovine liver) Catalase Sigma-Aldrich Holman’s
Cyclopiazonic Acid CPA Sigma-Aldrich DMSO
D-glucose D-glucose Fisher Scientific Holman’s
Indomethacin Indomethacin/Indo Sigma-Aldrich Absolute Ethanol
L-glucose L-glucose Sigma-Aldrich Holman’s
Mn(III)-tetrakis-( 1 -methyl-4-pyridyl) 
porphyrin, tetratosylate, hydroxide 
(Manganese Porphyrin)
MnTMPyP Calbiochem Holman’s
N<J-Nitro-L-arginine methyl ester 
hydrochloride
L-NAME Sigma-Aldrich Holman’s
NOC-9. 6-(2-Hydroxy-1 -methy 1-2-
nitrosohydrazino)-N-methyl-
hexanamine
MAHMA NONOate Sigma-Aldrich dH.O
Phenylephrine hydrochloride PE Sigma-Aldrich Holman’s
Sodium-meta-Arsenite Arsenite Sigma-Aldrich Holman’s
Table 2.1 Reagent Information
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CHAPTER 3
MODULATION OF ENDOTHELIUM-DEPENDENT ARTERIAL 
RELAXATION BY ARSENITE
3.1 Introduction
Arsenic is well recognised as an environmental toxin, whose atherosclerosis- 
accelerating properties have been confirmed in animal models (Simeonova et al., 
2003; Bunderson et al., 2004; Srivastava et al., 2007). Endothelial “dysfunction” 
resulting from chronic oxidative stress is associated with a number of cardiovascular 
risk factors, including arsenic exposure, hypertension, hyperlipidaemia and diabetes, 
and is now widely thought to underpin the early onset of atherosclerosis (for reviews 
see; Stocker & Keaney, 2004; States et al., 2009). Correspondingly, the trivalent 
arsenical, arsenite (the predominant species in arsenic-contaminated drinking water), 
has been reported to activate the O2* -generating enzyme NADPH oxidase in 
endothelial and vascular smooth muscle cells leading to increased ROS production 
(Barchowsky et al., 1999; Lynn et al., 2000; Smith et al., 2001; Qian et al., 2005; 
Straub et al., 2008). O2’ is known to inactivate NO via a reaction that results in the 
production of the species peroxynitrite, which is directly toxic to endothelial cells. 
Furthermore, the associated reduction in NO bioavailability impairs endothelium- 
dependent relaxation and promotes prothrombotic mechanisms (for review see: 
Schafer & Bauersachs, 2008).
Despite comprehensive study and characterization of arsenite-mediated ROS 
production in endothelial cells, its effects on endothelium-dependent arterial 
relaxation remain poorly understood. Indeed, it appears that only four published 
studies have addressed this issue. Furthermore, none of these studies have addressed
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the effect of arsenite on endothelium-dependent relaxations that are independent of 
the activation of G-protein coupled receptors, e.g. mediated by SERCA inhibition. 
The studies of Jindal et al (2008) and Lee et al (2003) demonstrated impaired relaxant 
responses of rat aorta to ACh that were attributed to impaired NO bioavailability 
mediated by oxidative stress and reduced eNOS expression, respectively. In addition, 
Srivastava et al (2007) demonstrated that arsenite impaired NO-dependent relaxation 
to ACh in the mouse aorta. However, only a single study has investigated the effect of 
arsenite on endothelium-dependent relaxations that are independent of the action of 
NO. Bilszta et al (2006) analysed the reactivity of isolated rat aorta and renal artery to 
PE and ACh after intravenous infusion of arsenite (6 mg kg'1 for 4 hours). These 
authors found that relaxation to ACh was unaffected by arsenite, either in the absence 
or presence of L-NAME, despite PE-induced tone being potentiated as a consequence 
of reduced basal levels of NO (Bilszta et al., 2006). It should be noted that these 
authors did not employ a COX inhibitor in combination with L-NAME in their 
experiments, and as a result these responses cannot, by definition, be described as 
EDHF-type relaxations.
The effect of arsenite on EDHF-type arterial relaxation in organ bath experiments has 
not previously been investigated. One study examined the effect of chronic 
administration of inorganic arsenic on the formation of vascular gap junctions, and 
demonstrated reduced expression of connexins 37, 40 and 43 in endothelial cells 
(Chou et al., 2007), and a single study has investigated the effects of arsenite on Kca 
channel activity, demonstrating augmented TEA-sensitive currents in HeLa cells 
(Dong et al., 2005). However, increases in [Ca2f]j in response to arsenite have been 
reported in a variety of cell types, albeit not in endothelial cells (Shen et al., 2002; 
Mehta & Shaha, 2006; Sandoval et al., 2007; Vahidnia et al., 2008). For example, Li
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and colleagues have recently reported that arsenite enhances vascular smooth muscle 
[Ca2"]j which correlated with increased ROS production (Li et al., 2009). Indeed, 
arsenite is widely acknowledged to increase endothelial and smooth muscle cell 
production of H2O2, which in this context is probably the end-product of the 
dismutation of O2’ derived from NADPH oxidase (Barchowsky et al., 1999; Lynn et 
al., 2000; Smith et al., 2001; Tsai et al., 2001; Yeh et al., 2002). The fact that 
endogenous H2O2 contributes to the EDHF phenomenon in a number of artery types 
and, when applied exogenously, potentiates EDHF-type relaxation in the rabbit iliac 
artery, therefore justifies analysis of the effect of arsenite on the EDHF phenomenon 
(Matoba et al., 2000; 2002; Kimura et al., 2002; Lacza et al., 2002; Larsen et al., 
2008; Edwards et al., 2008; Garry et al., 2009).
The aim of the current Chapter was therefore to characterize the acute effects of 
arsenite on endothelium-dependent arterial relaxation in the rabbit iliac artery. Time- 
and concentration-dependent effects on the relaxing actions of ACh (receptor- 
dependent) and CPA (receptor-independent) were investigated in the absence and 
presence of inhibitors of eNOS and COX (L-NAME and indomethacin, respectively). 
This study was thus directed at dissociating the effects of arsenite on NO/prostanoid- 
dependent and EDHF-type relaxant responses.
3.2 Methods
Male New Zealand White rabbits were sacrificed and arterial rings studied 
isometrically as described in 2.1 and 2.2. The rings were maintained at a resting 
tension of 1 mN over a 1 hour equilibration period and the buffer repeatedly replaced, 
with any subsequent alterations in baseline tension due to stress relaxation corrected. 
Preparations were then incubated for 30 minutes in the absence or presence of L-
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NAME (300 pM) and indomethacin (10 pM) to compare the effects of arsenite on 
EDHF-type relaxation. Arsenite (as 30 or 100 pM sodium arsenite dissolved in 
Holman’s) was added for 30, 90 or 180 minutes prior to constriction with PE (1 pM). 
Once PE-induced tone had reached a stable plateau (after approximately 15 minutes) 
relaxant responses were studied by constructing cumulative concentration-response 
curves to ACh (1 nM -  10 pM) or CPA (100 nM -  100 pM). Data was collected and 
analysed as described in 2.3 and 2.4.
3.3 Results
3.3.1 Effects of arsenite on responses to CPA in the absence of L- 
NAME/indomethacin
Incubation with 100 pM arsenite for 30, 90 or 180 minutes did not affect relaxant 
responses to CPA (n=4-5; Figure 3.1 A, B, C; Table 3.1). Time-matched control data 
was obtained with preparations incubated for similar periods in the absence of 
arsenite. Neither maximal relaxation (Rmax) to CPA (Table 3.1) nor PE-induced tone 
(Table 3.2) was affected by incubation with arsenite.
3.3.2 Effects of arsenite on EDHF-type responses to CPA
In the presence of L-NAME and indomethacin, 30 minutes incubation with 30 pM 
arsenite did not affect EDHF-type relaxations evoked by CPA (n=5; Figure 3.2A; 
Table 3.1), whereas 100 pM arsenite potentiated these responses, and shifted the 
concentration-response curve to the left (pIC.^o: from 4.79±0.04 to 5.07±0.05; 
^<0.001; n=45; Figure 3.2A; Table 3.1). 90 minutes incubation with either 30 or 100 
pM arsenite potentiated EDHF-type relaxations, and shifted the concentration-
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response curve to the left in each case (pIC50: from 4.85±0.04 to 5.19±0.05 and from 
4.89±0.10 to 5.31±0.12; ^<0.01 and .P<0.05, respectively; Figure 3.2B; Table 3.1). 
180 minutes incubation with 100 pM arsenite also potentiated EDHF-type relaxations, 
and shifted the concentration-response curve to the left relative to time-matched 
control data (pIC50: from 4.79±0.09 to 5.18±0.04; /><0.001; Figure 3.2C; Table 3.1). 
Rmax to CPA was not affected by incubation with arsenite (see Table 3.1). PE-induced 
tone was unaffected by incubation with L-NAME+indomethacin and/or arsenite 
(Table 3.2).
3.3.3 Effects of arsenite on responses to ACh in the absence of L- 
NAME/indomethacin
30 minutes incubation with 100 pM arsenite did not affect relaxations to ACh (n=6; 
Figure 3.3A; Table 3.3), with 90 minutes incubation with either 30 or 100 pM arsenite 
also being ineffective (n=7 and 6, respectively; Figure 3.3B; Table 3.3). While 180 
minutes incubation with 30 pM arsenite did not affect responses after 180 minutes 
incubation (n=5; Figure 3.3C; Table 3.3), 100 pM arsenite attenuated relaxation at 
this time point, reducing Rmax relative to the time-matched control data (from 
75.0±2.5 to 37.6±3.6%; P<0.001; n=7; Figure 3.3C; Table 3.3). Neither pEC50 (Table
3.3) nor PE-induced tone (Table 3.2) was affected by incubation with arsenite.
3.3.4 Effects of arsenite on EDHF-type responses to ACh
In the presence of L-NAME and indomethacin, 30 minutes incubation with 100 pM 
arsenite did not affect EDHF-type relaxations evoked by ACh (n=6; Figure 3.4A). 90 
minutes incubation with 100 pM arsenite attenuated maximal EDHF-type relaxations 
to ACh (Rmax- from 68.6±3.4 to 43.9±2.5%; /><0.001; n=6; Figure 3.4B; Table 3.3),
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whereas 30 pM arsenite did not affect responses at this time point (n=4; Figure 3.4B; 
Table 3.3). 180 minutes incubation with 30 or 100 pM arsenite attenuated relaxation 
to ACh, reducing Rmax from 60.1±3.4 to 36.9±3.0% and from 59.2±3.7 to 23.4±2.0% 
(PO.OOl for each; n=5 for each; Figure 3.4C; Table 3.3), respectively. pECso was not 
affected by incubation with arsenite (Table 3.3). PE-induced tone was not affected by 
incubation with L-NAME+indomethacin and/or arsenite (Table 3.2).
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Figure 3.1 Effect of arsenite on relaxations evoked by CPA in the absence of L-NAME 
and indomethacin. Concentration-response curves were unaffected by 100 pM arsenite 
after (A) 30, (B) 90 or (C) 180 minutes incubation, n denotes the number of animals 
studied.
48
% Relaxation
o roooo ooo o
§  .
O
“0>
cln ai
'O
"201 
180 
m
ins 
-drControl
■ArArsenite 100 
pM
log10[CPA] (M
) 
log10[CPA] (M
)
% Relaxation
rooo>ooooo
> o
cn
® ~
00% Relaxation
roorooO)oooooo oo
> o
o
Figure 3.2 Effects of arsenite on relaxations evoked by CPA in the presence of L- 
NAME and indomethacin. (A) Concentration-response curves revealed that arsenite at 
100 pM, but not 30 pM, augmented EDHF-type relaxations after 30 minutes 
incubation. (B) EDHF-type relaxations were augmented by both 30 and 100 pM 
arsenite after 90 minutes incubation. (C) Potentiation by 100 pM arsenite was still 
evident after 180 minutes incubation. * and *** denote P<0.05 and P<0.001 compared 
with time-matched preparations incubated in the absence of arsenite. n denotes the 
number of animals studied.
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Figure 3.3 Effects of arsenite on relaxations evoked by ACh in the absence of L- 
NAME and indomethacin. (A) Concentration-response curves were unaffected by 100 
pM arsenite after 30 minutes incubation. (B) Relaxation was unaffected by either 30 
or 100 pM arsenite after 90 minutes incubation. (C) Relaxation was attenuated by 100 
pM, but not 30 pM, arsenite after 180 minutes incubation. * and *** denote P<0.05 
and P<0.001 compared with time-matched preparations incubated in the absence of 
arsenite. n denotes the number of animals studied.
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Figure 3.4 Effects of arsenite on relaxations evoked by ACh in the presence of L- 
NAME and indomethacin. (A) Concentration-response curves were unaffected by 100 
pM arsenite after 30 minutes incubation. (B) EDHF-type relaxations were attenuated by 
100 pM but not 30 pM arsenite after 90 minutes incubation. (C) EDHF-type relaxations 
were attenuated by both 30 and 100 pM arsenite after 180 minutes incubation. *, ** and 
*** denote P<0.05, P<0.01 and PO.OOl compared with time-matched preparations 
incubated in the absence of arsenite. n denotes the number of animals studied.
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Table 3.1 Time- and concentration-dependent effects of arsenite on endothelium- 
dependent arterial relaxation evoked by CPA. Experiments were performed in the 
absence and presence of L-NAME (300 pM) and indomethacin (10 pM) and the 
effect of arsenite (30 or 100 pM) was subsequently determined. Potency (negative 
loglCso) and maximal responses (Rmax) are given as means±SEM. *, ** and *** 
denote P<0.05, P<0.01 and .P<0.001 compared with time-matched preparations 
incubated in the absence of arsenite. n denotes the number of animals studied.
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Intervention n pIC50 Rmax %
30 minutes Arsenite incubation
Control
Arsenite 100 |xM
4 5.17±0.07
5.22±0.06
95.8±3.5
94.7±2.4
L-NAME + Indo
L-NAME + Indo + Arsenite 30 fiM
5 4.85±0.04
4.82±0.03
85.9±2.7
81.7±3.2
L-NAME + Indo
L-NAME + Indo + Arsenite 100 i^M
45 4.79±0.04
5.07±0.05***
82.8±1.6
82.2±1.7
90 minutes Arsenite incubation
Control
Arsenite 100 i^M
5 5.16±0.06
5.16±0.09
93.6±1.7
92.4±1.7
L-NAME + Indo
L-NAME + Indo + Arsenite 30 ^M
6 4.85±0.04
5.19±0.05**
81.8±2.6
85.6±2.7
L-NAME + Indo
L-NAME + Indo + Arsenite 100 (iM
7 4.89±0.10
5.31±0.12*
77.8±4.6
76.6±3.5
180 minutes incubation
Control
Arsenite 100 jxM
5 5.22±0.05
5.20±0.05
91.3±2.7
91.8±2.9
L-NAME + Indo
L-NAME + Indo + Arsenite 100 ^M
5 4.79±0.09
5.18±0.04***
81.0±6.5
83.6±3.3
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Table 3.2 Effects of L-NAME/indomethacin and arsenite on rabbit iliac arterial tone 
induced by PE. It was determined that L-NAME/indomethacin and/or arsenite did not 
alter PE-induced tone compared to time-matched preparations incubated for similar 
periods without these treatments. Data given as means±SEM. n denotes the number of 
animals studied (data pooled from Tables 3.1 and 3.3).
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Intervention n PE-induced tone (mN)
30 minutes Arsenite incubation
Control 10 37.2+3.2
Arsenite 100 10 34.8+4.9
L-NAME+Indo 56 39.9+1.9
L-NAME+Indo + Arsenite 30 fiM 5 36.1+5.9
L-NAME+Indo + Arsenite 100 |iM 51 39.1+1.5
90 minutes Arsenite incubation
Control 18 38.2+3.3
Arsenite 30 |iM 7 32.9+5.2
Arsenite 100 |iM 11 37.6+2.8
L-NAME+Indo 23 36.2+2.4
L-NAME+Indo + Arsenite 30 fiM 10 34.2+6.1
L-NAME+Indo + Arsenite 100 }iM 13 31.4+4.8
180 minutes Arsenite incubation
Control 18 39.7+3.1
Arsenite 30 ^M 6 34.6+5.3
Arsenite 100 i^M 12 30.6+6.7
L-NAME+Indo 15 35.7+2.7
L-NAME+Indo + Arsenite 30 ^M 5 31.8+6.9
L-NAME+Indo + Arsenite 100 ^M 10 29.9+5.3
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Table 3.3 Time- and concentration-dependent effects of arsenite on endothelium- 
dependent arterial relaxation evoked by ACh. Experiments were performed in the 
absence and presence of L-NAME (300 pM) and indomethacin (10 pM) and the 
effect of arsenite (30 and 100 pM) was subsequently determined. Potency (negative 
logECso) and maximal responses (Rmax) are given as means±SEM. *** denotes 
P 0 .0 0 1  compared with time-matched preparations incubated in the absence of 
arsenite. n denotes the number of animals studied.
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Intervention n pEC 5o Rmax %
30 minutes Arsenite incubation
Control
Arsenite 100 \iM
6 7.56±0.03
7.74±0.07
87.5±1.8
83.9±2.4
L-NAME + Indo
L-NAME + Indo + Arsenite 100 ^M
6 7.06±0.13
7.30±0.11
72.8±4.6
65.0±3.1
90 minutes Arsenite incubation
Control
Arsenite 30 i^M
7 7.18±0.04
7.30±0.06
91.5±2.0
86.0±2.4
Control
Arsenite 100 i^M
6 7.18±0.04
6.88±0.07
77.1±1.8
69.4±2.2
L-NAME + Indo
L-NAME + Indo + Arsenite 30 |iM
4 6.79±0.08
6.81±0.09
72.2±3.0
79.7±4.3
L-NAME + Indo
L-NAME + Indo + Arsenite 100 i^M
6 7.44±0.08
7.05±0.10
68.6±3.4
43.9±2.5***
180 minutes Arsenite incubation
Control
Arsenite 30 \iM
6 7.33±0.06
7.60±0.07
91.9±2.8
86.2±2.2
Control
Arsenite 100 ^M
7 7.08±0.06
7.07±0.19
75.0±2.5
37.6±3.6***
L-NAME + Indo
L-NAME + Indo + Arsenite 30 ^M
5 6.75±0.09
6.87±0.14
60.1±3.4
36.9±3.0***
L-NAME + Indo
L-NAME + Indo + Arsenite 100 jiM
5 6.87±0.11 
7.38±0.36
59.2±3.7
23.4±2.0***
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3.4 Discussion
Investigations into modulation of endothelium-dependent relaxation by arsenite in the 
rabbit iliac artery unveiled differential effects between two pharmacologically distinct 
modes of endothelial stimulation. In the absence of L-NAME and indomethacin, 
arsenite (at 100 pM) was without effect on relaxations to CPA over the 180 minute 
incubation period studied. However, when the EDHF-type component was isolated by 
the addition of L-NAME and indomethacin, the same concentration of arsenite 
increased the potency of CPA after just 30 minutes, with subsequent experiments 
confirming this augmentatory effect was sustained at incubation intervals of 90 and 
180 minutes. A time- and concentration-dependent augmentation was confirmed by 
experiments showing that 30 pM arsenite was without effect after 30 minutes but 
potentiated EDHF-type relaxations by CPA after 90 mins.
By contrast, in the absence of L-NAME and indomethacin, though 30 pM arsenite 
was ineffective after 180 minutes incubation, 100 pM arsenite attenuated maximal 
relaxations to ACh (without influencing its potency) after 180 minutes. Further 
experiments demonstrated that 30 pM arsenite attenuated EDHF-type relaxations to 
ACh after 180 minutes incubation (to -60%  of that observed in time-matched 
controls), whereas 100 pM arsenite attenuated relaxations after just 90 minutes 
incubation (to -55%  of that observed in time-matched controls).
While both ACh and CPA evoke rises in endothelial Ca2+, increases in [Ca2+]i in
response to ACh are mediated principally by InsP3-induced Ca release from the ER
2+
store, whereas CPA evokes SOCE secondary to depletion of the ER Ca store 
following SERCA inhibition (Griffith, 2004; Edwards et al., 2008; Garry et al., 2009). 
Therefore, the results of this Chapter suggest that arsenite may promote depletion of 
the ER Ca2+ store and/or evoke an antagonistic effect on the ACh receptor and/or its
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downstream signalling mechanism. Indeed, arsenite has been shown to inhibit 
muscarinic receptors directly via interaction with critical thiols on the basis that (i) the 
affinity of the receptor for the antagonist (3H)quinuclidinyl benzilate was impaired 
(IC50 increased), and (ii) this effect of arsenite was only apparent during co­
administration of the thiol reductant dithiothreitol (Fonseca et a l, 1991). 
Investigations to determine whether arsenite interferes with the coupling of 
muscarinic receptors to phospholipase C via G-proteins, which underpins the 
synthesis of InsP3 following the binding of ACh, have not yet been undertaken.
The effects of arsenite on vascular function are largely unexplored. Indeed, it was not 
until 2003 that this issue was first investigated, when Lee et al (2003) demonstrated 
that arsenite impaired NO-dependent relaxation to ACh in the rat aorta, which they 
attributed to reduced bioavailability of NO. Jindal et al (2008) also observed impaired 
relaxation to ACh, though impaired NO bioavailability in their study was attributed to 
elevated intracellular levels of O2*, whereas Lee et al found that this was mediated by 
reduced expression and/or activity of eNOS, as indicated by the reduced conversion 
of L-arginine to L-citrulline (Lee et al., 2003; Jindal et al., 2008). However, the only 
investigation into the effect of arsenite on endothelium-dependent relaxation that was 
independent of eNOS activity (although, by definition, these were not EDHF-type 
responses as COX activity had not been inhibited) concluded that there was no effect 
in the aorta and renal artery of the rat (Bilszta et al., 2006).
In studies of isolated endothelial and vascular smooth muscle cells, a number of 
authors have proposed that arsenite activates NADPH oxidase leading to increased 
endothelial O2* production, thereby (i) impairing NO bioavailability and increasing 
peroxynitrite formation (measured as nitration of tyrosine residues) and (ii) increasing 
endothelial production of H2 O2 subsequent to the dismutation of NADPH oxidase-
63
derived O2 " (Wang et al., 1996; Barchowsky et a l,  1996; Wang et al., 1997; 
Barchowsky et al., 1999; Liu & Jan, 2000; Smith et al., 2001; Bunderson et al., 2002; 
Yeh et al., 2002; Hirano et al., 2003; Bunderson et al., 2006; Straub et al., 2008). 
While such alterations in endothelial redox status play a pathological role in impairing 
NO function, subsequent parallel elevations of H2O2 may represent a novel 
mechanism by which vascular function can be preserved during oxidative stress.
The results of the current Chapter have demonstrated that arsenite may augment 
EDHF-type relaxations, and this effect only becomes apparent during a mode of 
endothelial stimulation that bypasses membrane receptor and second messenger 
mechanisms involving InsP3 by directly inhibiting the SERCA pump. From the 
experiments with CPA it was apparent that arsenite potentiated EDHF-type relaxation 
while having no net effect on endothelial function in the absence of L-NAME and 
indomethacin. This suggests that the augmented EDHF-type component may offset an 
impaired NO/prostanoid component, thereby preserving endothelium-dependent 
vascular function. It should be stressed, however, that while it has been demonstrated 
that the EDHF phenomenon may acutely preserve arterial responsiveness in arsenic 
toxicity, it is uncertain whether such mechanisms compensate for the 
vasculoprotective effects of NO that normally limit atheroma formation, such as its 
ability to reduce endothelial permeability, thrombogenesis and inflammatory cell 
adhesion and migration.
Accumulating reports of arsenite-evoked endothelial oxidative stress and recent 
observations demonstrating the ability of exogenous H2 O2 to potentiate the EDHF 
phenomenon in the rabbit iliac artery (Edwards et al., 2008) warrant further 
investigation into the role of this ROS in responses modulated by arsenite. 
Investigations in models of hyperglycaemia and diabetes have also demonstrated
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oxidant stress-mediated impairment of NO bioavailability and associated NO- 
dependent relaxations (Coppey et al., 2003; Sercombe et al., 2004; Bitar et al., 2005; 
Hayashi et al., 2005; Tawfik et al., 2006; Reyes-Toso et al., 2007; Matsumoto et al., 
2007; 2008; Lopez-Lopez et al., 2008; Shukla et a l,  2008; Su et al., 2008; Elmi et al., 
2008). Additionally, a number of studies have postulated a compensatory role of the 
EDHF phenomenon in diabetes that may serve to offset impaired NO function 
(Thomsen et al., 2001; Timar-Peregrin & Guy, 2002; Shen et al., 2003; Yousif et al., 
2005; Shi et al., 2006; Pataricza et al., 2008; MacKenzie et al., 2008; Malakul et al., 
2008). However, it remains to be determined whether arsenite and elevated D-glucose 
modulate vascular function, in particular the EDHF phenomenon, via similar 
mechanisms. Investigation of the effects of glucose on vascular function is the subject 
of the following Chapter and will form the basis of comparative analyses in 
subsequent Chapters.
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CHAPTER 4
MODULATION OF ENDOTHELIUM-DEPENDENT ARTERIAL 
RELAXATION BY D-GLUCOSE
4.1 Introduction
Diabetes mellitus affects around 200 million people worldwide and is responsible for 
approximately 5% of all deaths each year. Diabetes-associated fatalities are likely to 
double in the next 10 years with growing neglect of diet and physical inactivity 
(www.who.int/topics/diabetes-mellitus/en/). High plasma glucose concentrations 
(hyperglycaemia) are, like arsenic, associated with an increased risk of atherosclerosis 
(for review see: Schaefer & Bauersachs, 2008). Furthermore, hyperglycaemia- 
accelerated atheroma formation, like arsenic, is now appreciated to be the result of 
chronic endothelial oxidative stress and cell dysfunction. Endothelial oxidative stress 
results in impaired NO bioavailability and associated NO-dependent arterial 
relaxations (Schaefer & Bauersachs, 2008). In contrast to the lack of studies with 
arsenic, the influence of diabetes on endothelium-dependent arterial relaxation has 
been extensively investigated.
Early studies of the modulation of NO-dependent relaxation in diabetes provided 
evidence for impaired responses in the aortae of biobreeding rats, which 
spontaneously develop type I diabetes (Durante et al., 1988; Kappagoda et al., 1989). 
A study by Pieper demonstrated that NO-dependent relaxations in the aorta of STZ- 
diabetic rats may be increased during the early stages of STZ-induced diabetes, with 
responses progressively decreasing with disease duration (Pieper, 1999). The 
involvement of O2’" in impaired responses was first evidenced by the studies of Pieper
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et al (1988) and Hattori et al (1991) in aortae from STZ-diabetic rats, the latter of 
which demonstrated that these responses could be recovered by incubation with SOD. 
Correspondingly, there is now compelling evidence that in chronic diabetes NADPH 
oxidase-derived O2 *’ production is increased and contributes to impaired NO- 
dependent relaxations in animals (Kim et al., 2002; Kanie & Kamata, 2002; Coppey 
et al., 2003; Sercombe et a l , 2004; Hayashi et a l , 2005; Bitar et a l,  2005; Ling et a l,  
2005; Tawfik et a l,  2006; Matsumoto et a l,  2007; Lopez-Lopez et a l,  2008; Shukla 
et a l,  2008; Su et a l, 2008) and humans (Guzik et a l,  2000; 2002).
Modulation of EDHF-type relaxation in diabetes nevertheless remains controversial, 
as evidenced by observations of enhanced, resistant and impaired responses. 
Confounding opinions were evident from the earliest studies, the first of which 
demonstrated that the EDHF phenomenon was not impaired in the STZ-diabetic rat 
aorta, and thus did not contribute to depressed endothelium-dependent relaxations 
(Endo et a l,  1995). By contrast, it was demonstrated that EDHF-type relaxations and 
endothelium-dependent smooth muscle hyperpolarizations to ACh were impaired in 
the mesenteric artery of STZ-diabetic rats, although this has since been contested by 
another group (Fukao et a l,  1997; Shi et a l,  2006). Furthermore, studies of isolated 
endothelial cells conducted by the group of Graier provided evidence that 
hyperglycaemia-mediated oxidative stress may actually promote the mobilization of
7-+-intracellular Ca stores in response to agonists and SERCA inhibitors (Wascher et 
a l,  1994; Graier et a l,  1996; 1997), with similar findings having since been reported 
by other authors (Wu et a l,  1999; Dragonmir et a l,  2004; Tamareille et a l,  2006). 
Correspondingly, a number of groups have now provided evidence that the EDHF 
phenomenon may be augmented during diabetes and serve to offset impaired NO 
bioavailability and preserve relaxation (Timar-Peregrin & Guy; 2001; Thomsen et a l,
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2002; Yousif et al., 2002; Pannirselvam et al., 2002; Shen et al., 2003; Shi et al., 
2005; Malakul et al., 2008; MacKenzie et al., 2008; Pataricza et al., 2008). The 
promotion of endothelial Ca mobilization by ROS during diabetes could in theory 
potentiate the EDHF phenomenon, with our group having shown that exogenous H2 O2 
potentiates EDHF-type relaxation in the rabbit iliac artery via a mechanism involving 
enhanced Ca mobilization (Edwards et al., 2008).
Diabetes has also been demonstrated to alter prostanoid production by COX, with 
evidence of increases in both vasodilator (Alabadi et al., 2001) and constrictor 
products, such as thromboxane A2 (Mayhan et al., 1991; Taylor and Poston, 1994; 
Kamata et al., 2004; Akamine et al., 2006; Cheng et al., 2007; Csanyi et al., 2007). 
Taken together, such diversity may be indicative of interactions between competing or 
complementary EDRF, EDHF-type and EDCF activities that superimpose to modulate 
vascular function. Furthermore, a disease duration-dependent effect of diabetes on 
vascular function was observed in the aorta of STZ- and alloxan-treated rats. The 
study of Pieper (1999) observed a triphasic effect of the diabetic state, with NO- 
dependent relaxations increased 24 hours after STZ injection, unaltered after 1-2 
weeks and impaired after 8 weeks. This appears to be consistent with studies where 
acute exposure of endothelial cells to elevated glucose increased the activity of the 
Ca2+/NO pathway (Graier et al., 1993; Wascher et al., 1994; Graier et al., 1996; 
1997).
The aim of the current Chapter was to characterize acute time- and concentration- 
dependent effects of D-glucose on endothelium-dependent relaxation in the rabbit 
iliac artery in a similar fashion to the experiments described for arsenite in Chapter 3. 
Furthermore, in addition to experiments with or without the combination of L-NAME 
and indomethacin conducted according to the protocols described in Chapter 3, these
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inhibitors were administered individually in order to dissociate potential alterations in 
prostanoid synthesis that have previously been demonstrated to modulate relaxation in 
animal models of diabetes.
4.2 Methods
Male New Zealand White rabbits were sacrificed and arterial rings studied 
isometrically as described in 2.1 and 2.2. The rings were maintained at a resting 
tension of 1 mN over a 1 hour equilibration period, after which the buffer was 
replaced and any subsequent alteration in baseline tension due to stress relaxation 
corrected. Preparations were then incubated for 30 minutes in the absence or presence 
of L-NAME (300 pM) and/or indomethacin (10 pM). Additional D-Glucose was then 
added (22 or 33 mM to give total buffer concentrations of 33 or 44 mM, respectively) 
for 30, 180 or 360 minutes prior to constriction with PE (1 pM). Once PE-induced 
tone had reached a stable plateau (after approximately 15 minutes) relaxant responses 
were studied by constructing cumulative concentration-response curves to ACh (1 nM 
-  10 pM) or CPA (100 nM -  100 pM). Data was collected and analysed as described 
in 2.3 and 2.4.
4.3 Results
4.3.1 Effects of D-glucose on responses to CPA in the absence of L-NAME
Incubation with 44 mM D-glucose for 30, 180 or 360 minutes, either in the absence or 
presence of indomethacin, did not affect relaxant responses to CPA (n=4-10; Figure
4.1 A, B, C; Table 4.1). Control data was obtained from preparations incubated for 
similar periods in standard Holman’s buffer containing 11 mM D-glucose. Neither the
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Rmax for CPA (Table 4.1) nor PE-induced tone (Table 4.2) was affected by incubation 
with indomethacin and/or D-glucose.
4.3.2 Effects of D-glucose on responses to CPA in the presence of L-NAME
In the presence of L-NAME, 30 minutes incubation with 44 mM D-glucose 
potentiated relaxations evoked by CPA, either in the absence or presence of 
indomethacin, and shifted the concentration-response curve to the left in each case 
(pICso: from 4.87±0.05 to 5.11±0.05 and from 4.85±0.04 to 5.10±0.04, respectively; 
P<0.001 for each; Figure 4.2A; Table 4.1). 30 minutes incubation with 33 mM D- 
glucose did not affect EDHF-type relaxations (n=16; Figure 4.2A; Table 4.1). 180 
minutes incubation with 44 mM D-glucose, either in the absence or presence of 
indomethacin, potentiated relaxations evoked by CPA, and shifted the concentration- 
response curve to the left in each case (pICso: from 4.84±0.03 to 5.10±0.04 and from 
4.83±0.02 to 5.23±0.07, respectively; P<0.001 for each; Figure 4.2B; Table 4.1). 180 
minutes incubation with 33 mM D-glucose also potentiated EDHF-type relaxations 
evoked by CPA, and shifted the concentration-response curve to the left (pICso: from 
4.79±0.06 to 5.12±0.07; P<0.05; Figure 4.2B; Table 4.1). 360 minutes incubation 
with 44 mM D-glucose, either in the absence or presence of indomethacin, potentiated 
relaxation evoked by CPA, and shifted the concentration-response curve to the left in 
each case (pICso: from 4.85±0.06 to 5.30±0.11 and from 4.78±0.06 to 5.33±0.08, 
respectively; P<0.001 for each; Figure 4.2C; Table 4.1). Neither the Rmax for CPA 
(Table 4.1) nor PE-induced tone (Table 4.2) was affected by incubation with 
indomethacin and/or D-glucose. L-NAME did not affect PE-induced tone relative to 
time-matched preparations incubated in the absence of L-NAME (Table 4.2).
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4.3.3 Effects of D-glucose on responses to ACh in the absence of L-NAME
Incubation with 44 mM D-glucose for 30, 180 or 360 minutes, either in the absence or 
presence of indomethacin, did not affect relaxation to ACh (n=5 for each; Figure 
4.3A, B, C; Table 4.3). Time-matched control data was obtained with preparations 
incubated for similar periods in standard Holman’s buffer containing 11 mM D- 
glucose. Neither the Rmax for ACh (Table 4.3) nor PE-induced tone (Table 4.2) was 
affected by incubation with indomethacin and/or D-glucose. Concentration-response 
curves, constructed either in the absence or presence of 44 mM D-glucose, were 
unaffected by indomethacin relative to equivalent preparations incubated for similar 
periods in the absence of indomethacin (Table 4.3).
4.3.4 Effects of D-glucose on responses to ACh in the presence of L-NAME
In the presence of L-NAME, 30 minutes incubation with 44 mM D-glucose 
potentiated relaxations evoked by ACh either in the absence or presence of 
indomethacin (Rmax: from 57.3±3.6 to 79.2±2.9% and from 51.5±2.1 to 70.5±2.0%; 
PcO.Ol and P<0.001; n=6 and 13, respectively; Figure 4.4A; Table 4.3), without 
significantly altering pECso values (Table 4.3). This effect of 44 mM D-glucose was 
sustained following 180 minutes incubation (Rmax: from 50.9±2.5 to 69.1±3.0% and 
from 52.5±3.7 to 69.0±2.6%; P<0.05 and P<0.001; n=5 and 15, respectively; Figure 
4.4B; Table 4.3) and 360 minutes incubation (Rmax: from 28.7±3.2 to 46.4±4.5% and 
from 20.0±1.7 to 48.4±4.8%, respectively; P<0.01, n=6 for each; Figure 4.4C; Table
4.3). Indomethacin did not alter L-NAME-insensitive control relaxations to ACh or 
their potentiation by 44 mM D-glucose (Table 4.3). It should be noted, however, that 
maximal NO-independent control relaxations to ACh in preparations incubated for 
360 minutes, either in the absence or presence of indomethacin, were impaired
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relative to equivalent preparations incubated for 30 minutes (P<0.01 for each; Table
4.3). As a result, relaxations in preparations incubated in the presence of 44 mM D- 
glucose for 360 minutes were potentiated to a level comparable with control 
preparations incubated for 30 minutes (Table 4.3). A time- and concentration- 
dependent potentiation of EDHF-type relaxation was confirmed in preparations 
incubated with 33 mM D-glucose, with responses being unaffected after 30 minutes 
but potentiated following 180 minutes incubation (Rmax: from 58.3±3.0 to 76.2±3.2%; 
P<0.05; n=6; Figure 4.4A, B; Table 4.3). PE-induced tone was not altered by L- 
NAME and/or indomethacin and/or D-glucose relative to time-matched preparations 
incubated in the absence of L-NAME (Table 4.2).
4.3.5 Effects of low D-glucose concentrations on EDHF-type responses to ACh
EDHF-type relaxations evoked by ACh were unaffected by 30 minutes incubation 
with either 1.1 or 5.5 mM D-glucose relative to time-matched preparations incubated 
for similar periods in standard Holman’s buffer containing 11 mM D-glucose (n=4; 
Figure 4.5; Table 4.4). PE-induced tone was unaffected by incubation with either 1.1 
or 5.5 mM D-glucose (Table 4.2).
4.3.6 Effects of L-glucose on EDHF-type responses to ACh
Neither 30 nor 180 minutes incubation with 33 mM L-glucose (to give a total of 44 
mM glucose as 11 mM D-glucose was present in the buffer at all times) affected 
EDHF-type relaxations evoked by ACh (n=5-15; Figure 4.6A, B; Table 4.4). PE- 
induced tone was not altered by incubation with L-glucose (Table 4.2).
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Figure 4.1 Effects of D-glucose on relaxations evoked by CPA in the absence of L- 
NAME. Concentration-response curves were unaffected by 44 mM D-glucose, either 
in the absence or presence of indomethacin, after (A) 30, (B) 180 or (C) 360 minutes 
incubation, n denotes the number of animals studied.
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Figure 4.2 Effects of D-glucose on relaxations evoked by CPA in the presence of L- 
NAME. Concentration-response curves revealed that 44 mM D-glucose augmented 
relaxation, either in the absence or presence of indomethacin after (A) 30, (B) 180 and 
(C) 360 minutes incubation. Additional experiments confirmed a time- and 
concentration-dependent augmentation of EDHF-type relaxation by D-glucose, with 
33 mM being ineffective after 30 minutes (A) but potentiating responses after 180 
minutes incubation (B). *, ** and *** denote P<0.05, P<0.01 and P<0.001 compared 
with time-matched control preparations incubated in standard Holman’s buffer 
containing 11 mM D-glucose. n denotes the number of animals studied.
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Figure 4.3 Effects of D-glucose on relaxations evoked by ACh in the absence of L- 
NAME. Concentration-response curves were unaffected by 44 mM D-glucose, either 
in the absence or presence of indomethacin, after (A) 30, (B) 180 or (C) 360 minutes 
incubation, n denotes the number of animals studied.
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Figure 4.4 Effects of D-glucose on relaxations evoked by ACh in the presence of L- 
NAME. Concentration-response curves revealed that 44 mM D-glucose augmented 
relaxation, either in the absence or presence of indomethacin, after (A) 30, (B) 180 
and (B) 360 minutes incubation. Additional experiments confirmed a time- and 
concentration-dependent augmentation of EDHF-type relaxation by D-glucose, with 
33 mM D-glucose being ineffective after (A) 30 minutes but potentiating responses 
after (B) 180 minutes incubation. *, ** and *** denote P<0.05, PO .O l and P<0.001 
compared with time-matched control preparations incubated in standard Holman’s 
buffer containing 11 mM D-glucose. n denotes the number of animals studied.
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Figure 4.5 Effects of low concentrations of D-glucose on EDHF-type relaxations 
evoked by ACh. Concentration-response curves were unaffected by 30 minutes 
incubation with either 1.1 or 5.5 mM D-glucose. n denotes the number of animals 
studied.
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Figure 4.6 Effects of L-glucose on EDHF-type relaxations evoked by ACh. 
Concentration-response curves were unaffected by 33 mM L-glucose (totalling 44 
mM glucose with the 11 mM D-glucose normally present in the buffer) after (A) 30 
minutes or (B) 180 minutes incubation, n denotes the number of animals studied.
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Table 4.1 Time- and concentration-dependent effects of D-glucose on endothelium- 
dependent arterial relaxation evoked by CPA. Experiments were performed in the 
absence and presence of L-NAME (300 pM) and/or indomethacin (10 pM) and the 
effect of D-glucose (33 or 44 mM) was subsequently determined. Potency (negative 
loglCso) and maximal responses (Rmax) are given as means±SEM. * and *** denote 
P<0.05 and PO.OOl compared with time-matched preparations incubated in standard 
Holman’s buffer containing 11 mM D-glucose. n denotes the number of animals 
studied.
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Intervention n pICso Rmax %
30 minutes D-glucose incubation
Control
D-glucose 44 mM
10 5.24±0.08
5.27±0.10
95.6±3.1
93.2±3.5
Indo
Indo + D-glucose 44 mM
10 5.31±0.09
5.28±0.14
92.6±3.3
98.7±2.0
L-NAME
L-NAME + D-glucose 44 mM
6 4.87±0.05 
5.11±0.05***
88.9±1.7
84.1±2.1
L-NAME + Indo
L-NAME + Indo + D-glucose 44 mM
24 4.85±0.04
5.10±0.04***
81.7±2.2
82.8±2.1
L-NAME + Indo
L-NAME + Indo + D-glucose 33 mM
16 4.85±0.04
4.96±0.04
81.7±2.2
82.8±2.2
180 minutes D-glucose incubation
Control
D-glucose 44 mM
5 5.11±0.05 
5.05±0.06
81.3±4.8
79.9±6.6
Indo
Indo + D-glucose 44 mM
4 5.37±0.07
5.25±0.08
90.6±2.2
96.7±0.8
L-NAME
L-NAME + D-glucose 44 mM
5 4.84±0.03
5.10±0.04***
90.6±2.4
92.1±2.3
L-NAME + Indo
L-NAME + Indo + D-glucose 44 mM
6 4.83±0.02
5.23±0.07***
82.5±3.3
89.6±3.4
L-NAME + Indo
L-NAME + Indo + D-glucose 33 mM
6 4.79±0.06
5.12±0.07*
79.4±2.7
84.4±2.5
360 minutes D-glucose incubation
Control
D-glucose 44 mM
4 5.07±0.04
5.17±0.07
87.3±2.0
91.0±1.9
Indo
Indo + D-glucose 44 mM
4 5.24±0.13
5.13±0.06
95.4±1.3
94.8±1.4
L-NAME
L-NAME + D-glucose 44 mM
4 4.85±0.06 
5.30±0.11***
88.9±4.3
90.2±3.0
L-NAME + Indo
L-NAME + Indo + D-glucose 44 mM
4 4.78±0.06
5.33±0.08***
83.1±6.6
86.1±4.5
86
Table 4.2 Effects of L-NAME, indomethacin and D-glucose on arterial tone induced 
by PE. It was determined that L-NAME and/or indomethacin and/or D-glucose or L- 
glucose did not alter PE-induced tone compared with time-matched preparations 
incubated for similar periods without these treatments. Data given as means±SEM. n 
denotes the number of animals studied (data pooled from Tables 4.1, 4.3 and 4.4).
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Intervention n_________PE-induced tone (mN)
30 mins D-Glucose incubation
Control 15 35.5+2.3
D-glucose 44 mM 15 34.8+3.1
Indo 15 36.2+2.9
Indo+ D-glucose 44 mM 15 35.6+4.0
L-NAME 12 37.8+4.1
L-NAME + D-glucose 44 mM 12 36.2+2.2
L-NAME+Indo 80 37.7+0.8
L-NAME+Indo + D-glucose 1.1 mM 4 36.9+5.9
L-NAME+Indo + D-glucose 5.5 mM 4 34.6+4.8
L-NAME+Indo + D-glucose 33 mM 24 36.4+2.7
L-NAME+Indo + D-glucose 44 mM 37 33.6+2.0
L-NAME+Indo + L-glucose 33 mM 15 37.2+3.3
180 mins D-Glucose incubation
Control 10 38.2+3.7
D-glucose 44 mM 10 36.2+2.9
Indo 9 37.8+3.2
Indo+ D-glucose 44 mM 9 33.5+2.6
L-NAME 10 36.5+2.2
L-NAME + D-glucose 44 mM 10 31.5+3.6
L-NAME+Indo 37 35.4+1.3
L-NAME+Indo + D-glucose 33 mM 12 36.7+3.6
L-NAME+Indo + D-glucose 44 mM 21 33.4+2.5
L-NAME+Indo + L-glucose 33 mM 5 35.3+5.9
360 mins D-Glucose incubation
Control 9 34.2+4.4
D-glucose 44 mM 9 33.2+5.0
Indo 9 35.3+3.0
Indo+ D-glucose 44 mM 9 33.9+2.9
L-NAME 10 36.4+1.9
L-NAME + D-glucose 44 mM 10 34.7+3.4
L-NAME+Indo 10 38.8+2.7
L-NAME+Indo + D-glucose 44 mM 10 36.1+1.1
88
Table 4.3 Time- and concentration-dependent effects of D-glucose on endothelium- 
dependent arterial relaxation evoked by ACh. Experiments were performed in the 
absence and presence of L-NAME (300 pM) and/or indomethacin (10 pM) and the 
effect of D-glucose (33 or 44 mM) was subsequently determined. Potency (negative 
logECso) and maximal responses (Rmax) are given as means±SEM. *, ** and *** 
denote P<0.05, P<0.01 and PO.OOl compared with time-matched preparations 
incubated in standard Holman’s containing 11 mM D-glucose. f t  denotes P<0.01 
compared to corresponding preparations incubated for 30 minutes, n denotes the 
number of animals studied.
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Intervention n pEC50 R-max %
30 minutes D-glucose incubation
Control
D-glucose 44 mM
5 7.23±0.08
7.20±0.07
88.3±3.5
88.9±3.2
Indo
Indo + D-Glucose 44 mM
5 7.22±0.06
7.19±0.06
89.5±2.8
87.1±2.5
L-NAME
L-NAME + D-Glucose 44 mM
6 6.58±0.09
6.64±0.06
57.3±3.6
79.2±2.9**
L-NAME + Indo
L-NAME + Indo + D-glucose 44 mM
13 6.48±0.05
6.55±0.04
51.5±2.1
70.5±2.0***
L-NAME + Indo
L-NAME + Indo + D-glucose 33 mM
8 6.52±0.08
6.42±0.05
54.3±2.9
50.6±2.1
180 minutes D-glucose incubation
Control
D-glucose 44 mM
5 7.29±0.09
7.20±0.06
88.1±3.6
88.4±2.7
Indo
Indo + D-Glucose 44 mM
5 7.22±0.07
7.21±0.06
89.0±3.2
89.7±2.6
L-NAME
L-NAME + D-Glucose 44 mM
5 6.44±0.06
6.58±0.06
50.9±2.5
69.1±3.0*
L-NAME + Indo
L-NAME + Indo + D-glucose 44 mM
15 6.64±0.11 
6.82±0.06
52.5±3.7
69.0±2.6**
L-NAME + Indo
L-NAME + Indo + D-glucose 33 mM
6 6.52±0.07
6.63±0.06
58.3±3.0
76.2±3.2*
360 minutes D-glucose incubation
Control
D-glucose 44 mM
5 7.27±0.13
7.18±0.07
82.7±5.1
83.4±3.0
Indo
Indo + D-glucose 44 mM
5 7.18±0.03
7.23±0.03
84.5±1.4
86.0±1.3
L-NAME
L-NAME + D-glucose 44 mM
6 6.56±0.12
6.75±0.16
28.7±3.2tt
46.4±4.5**
L-NAME + Indo
L-NAME + Indo + D-glucose 44 mM
6 6.51±0.12
6.67±0.16
20.0±1.7tt
48.4±4.8**
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Table 4.4 Effects of L-glucose and low concentrations of D-glucose on EDHF-type 
relaxation evoked by ACh. All experiments were performed in the presence of L- 
NAME (300 pM) and indomethacin (10 pM) and the effects of L-glucose (33 mM; 
totalling 44 mM glucose) and D-glucose (1.1 or 5.5 mM) were subsequently 
determined. Potency (negative logECso) and maximal responses (Rmax) are given as 
means±SEM. n denotes the number of animals studied.
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Intervention n pEC5Q RmaX %
30 minutes D/L-glucose incubation__________
L-NAME + Indo + D-glucose 11 mM (control) 4 6.54±0.07
L-NAME + Indo + D-glucose 5.5 mM 6.60±0.09
L-NAME + Indo + D-glucose 1.1 mM 6.59±0.10
L-NAME + Indo 15 6.63±0.05
L-NAME + Indo + L-glucose 33 mM 6.60±0.02
180 minutes L-glucose incubation___________
L-NAME + Indo 5 6.63±0.06
L-NAME + Indo + L-glucose 33 mM 6.47±0.07
63.0±3.4
69.6±4.2
67.6±4.8
74.6±2.7
80.4±1.5
61.2±3.0
72.3±4.1
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4.4 Discussion
The principal finding of this Chapter was that 44 mM D-glucose potentiated EDHF- 
type relaxations to CPA and ACh in the rabbit iliac artery, while having no overall 
effect on endothelial function in the absence of L-NAME and indomethacin. In 
experiments with CPA, this effect of D-glucose was comparable with that of arsenite, 
whereas the potentiating effect of D-glucose on EDHF-type relaxations to ACh 
contrasts with the attenuating effect of arsenite on such responses demonstrated in 
Chapter 3. EDHF-type relaxations to both CPA and ACh were potentiated following 
30 minutes exposure to 44 mM D-glucose, an effect that was sustained after 180 and 
360 minutes. Time- and concentration-dependent effects were confirmed by the 
demonstration that 33 mM D-glucose potentiated relaxation after 180 minutes 
incubation but was ineffective after 30 minutes.
It was noted, however, that control responses to ACh observed in the presence of L- 
NAME (either individually or in combination with indomethacin) for 360 minutes 
were impaired relative to corresponding preparations incubated for 30 minutes, a 
phenomenon that was not evident in experiments with CPA. This is therefore likely to 
reflect an impairment in endothelial signalling mechanisms specific to ACh, which
9 +mobilizes endothelial Ca principally via the receptor-coupled synthesis of InsP3 ,
9 -4-whereas CPA evokes SOCE by depleting the ER Ca store following inhibition of 
SERCA (Edwards et al., 2008; Garry et al., 2009). Additionally, it is unlikely that 
either the activity of Kca channels or gap junctional communication was impaired in 
preparations incubated for 360 minutes given that EDHF-type relaxations evoked by 
both ACh and CPA are electrotonic in nature in this artery (Taylor et al., 1998; 2001; 
Griffith et al., 2002; Chaytor et al., 2002; 2003; 2005; Griffith et al., 2005; Edwards 
et al., 2007; 2008; Garry et al., 2009).
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Some authors have demonstrated that the production of constrictor (Pannirselvam et 
al., 2005; Erdei et al., 2007; Cheng et al., 2007) or dilator (Alabadi et al., 2001; Shen 
et al., 2003) prostanoids may be increased in diabetes, whereas others have suggested 
that changes in prostanoid synthesis do not contribute to altered vascular 
responsiveness (Hattori et al., 1991; Malakul et al., 2008). In the presence of L- 
NAME only, control NO-independent relaxations to CPA and ACh, and their 
potentiation by 44 mM D-glucose were not significantly affected by indomethacin, 
thus excluding effects attributable to altered prostanoid synthesis in the rabbit iliac 
artery. In contrast to the effects of high glucose buffer, 30 minutes incubation with 
low concentrations of D-glucose (1.1 or 5.5 mM) did not affect EDHF-type 
relaxations evoked by ACh. Additionally, L-glucose did not affect EDHF-type 
relaxations to ACh over the 180 minute incubation period studied, thus indicating that 
the potentiating effects of D-glucose on the EDHF phenomenon are not evident with 
its metabolically inert stereoisomer. Other groups have also demonstrated that 
metabolically inert sugars have no effect on endothelium-dependent relaxations 
(Tesfamariam et al., 1990; Dorigo et al., 1997).
At the time that the effect of diabetes on the EDHF phenomenon was reviewed by 
Fitzgerald and colleagues (2005) there was evidence to suggest that EDHF-type 
relaxations were impaired by the condition, with the possible exception of murine 
arteries (Fitzgerald et al., 2005). Subsequent investigations have also demonstrated 
augmented responses in mice, rats, dogs and humans (Shi et al., 2006; Malakul et al., 
2008; Pataricza et al., 2008; MacKenzie et al., 2008). The present demonstration that 
elevated D-glucose increased maximal EDHF-type relaxations to ACh in the rabbit 
iliac artery without alterations in pharmacological potency is therefore consistent with 
findings in the STZ-diabetic rat mesenteric artery, in which an augmented maximal
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EDHF-type relaxation, sensitive to the combination of apamin+charybdotoxin, was 
found to compensate for an impaired NO-dependent response (Shi et a l , 2006). While 
the increased activity of endothelial Kca channels is thought to play an important role 
in augmented EDHF-type relaxations in diabetes, the subcellular mechanisms that 
might be involved remain unidentified (Thomsen et al., 2002; Shen et al., 2003; Shi et 
al., 2006; Malakul et al., 2008; Pataricza et al., 2008).
Several authors have postulated that increased endothelial production of H2O2 
secondary to increased generation of O2* during diabetes may compensate for NO via 
its ability to act as an EDHF, whereas others have proposed that augmentation of the 
EDHF phenomenon may be a direct result of alterations in NO bioavailability (Shi et 
al., 2006; Malakul et al., 2008; Park et al., 2008). For example, Park and colleagues 
(2008) have demonstrated that EDHF-type relaxations in coronary arterioles of db/db 
mice are abolished by catalase or apamin+charybdotoxin, whereas these inhibitors 
only partially attenuate responses in healthy animals. It was therefore suggested that 
the role of H2O2 in modulating Kca channel activity and the EDHF phenomenon may 
become increasingly significant in diabetes, and thereby contribute to the maintenance 
of dilator function when NO bioavailability is impaired. These observations appear 
consistent with the demonstration that H2O2 may contribute to the EDHF 
phenomenon in the rabbit iliac artery by promoting the mobilization of endothelial
”7+Ca stores with secondary activation of Kca channels (Edwards et al., 2008). 
Furthermore, Shi and co-workers (2006; 2007) demonstrated that augmented EDHF- 
type relaxations in the STZ-diabetic rat femoral artery are associated with increased 
endothelial H2O2 production. Indeed, it has been suggested that H2O2 may fully 
compensate for the loss of NO in arterioles isolated from patients with coronary artery 
disease via an EDHF-type mechanism (Phillips et al., 2007). Alternatively, it has been
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suggested that because NO appears to attenuate the EDHF phenomenon under control
94 -conditions by suppressing agonist-evoked endothelial Ca mobilization, impaired NO 
bioavailability in diabetes may unmask the EDHF phenomenon as a back-up 
mechanism (Bauersachs et al., 1996; Shi et al., 2006). Indeed, it has been 
demonstrated that the EDHF phenomenon may compensate for the absence of NO, 
either following chronic inhibition of eNOS or in eNOS knockout mice, and fully 
preserve endothelium-dependent relaxation (Nishikawa et al., 2000b; Brandes et al., 
2000; also see 1.9)
By contrast, the impaired function or expression of endothelial SKca channels has 
been proposed to contribute to impaired EDHF-type responses in small mesenteric 
arteries from STZ-diabetic mice (Ding et al., 2005; Burnham et a l, 2006a). 
Additionally, impaired gap junctional communication may also contribute to 
attenuated EDHF-type relaxations in animal models of type I and type II diabetes, and 
has variously been suggested to involve the reduced expression of connexins 37 and 
40 (Ding et al., 2005; Makino et al., 2008; Young et al., 2008), and impaired agonist- 
evoked cAMP accumulation (Matsumoto et al., 2003; 2004; 2005), which is known to 
play a permissive role in gap junction-dependent EDHF-type responses (Taylor et al., 
2001; Griffith et al., 2002; Chaytor et al., 2002; Griffith et al., 2005). Additionally, it 
has been demonstrated that elevated glucose may evoke PKC-mediated 
hyperphosphorylation of connexin 43 in cultured vascular smooth muscle cells, 
leading to impaired intercellular communication via gap junctions (Kuroki et al., 
1998). Furthermore, acute exposure of rat mesenteric arteries to elevated glucose 
impairs EDHF-type relaxations via a mechanism directly involving oxidative stress, 
with the combination of superoxide dismutase plus catalase restoring responses to 
control levels (Ozkan & Uma, 2005).
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Studies with isolated endothelial cells have also suggested that elevated glucose could 
in theory augment or impair the EDHF phenomenon. For example, the group of 
Graier have demonstrated that high concentrations of glucose may promote the
i
mobilization of endothelial Ca stores via a mechanism involving ROS on the basis 
that (i) elevated glucose potentiated increases in [Ca2+]i in response to the SERCA 
inhibitor thapsigargin, and (ii) this was reversed to control levels by various 
antioxidants, including vitamins C and E and the thiol reductant glutathione (Graier et 
al., 1997). Correspondingly, our group has demonstrated that glutathione monoethyl 
ester attenuates H202-promoted endothelial Ca mobilization in response to CPA 
(Edwards et al., 2008).
It was demonstrated in isolated bovine aortic endothelial cells that elevated glucose, 
via a mechanism involving OH" radicals, attenuated the sustained increase in [Ca ]i 
(attributed to SOCE) in response to thapsigargin despite an increase in the rate of the
9 .
initial increase in Ca levels (attributed to depletion of the ER store) (Pieper & 
Dondlinger, 1997; Kimura et al., 1998). Furthermore, elevated glucose has been 
shown to attenuate BKca channel currents in HEK293 (a human embryonic kidney 
cell line) and vascular smooth muscle cells via a mechanism underpinned by H2O2 , 
which was suggested to involve oxidation of cysteine 911 of the a subunit, a residue
9  1
located near the Ca bowl region of this channel (Tang et al., 2004; Lu et al., 2006). 
This mechanism was also postulated by Burnham and colleagues (2006b) to mediate
9  1
the impaired sensitivity of BKca channels to Ca in mesenteric small arterial smooth 
muscle from Zucker fatty rats (a model of type II diabetes).
There is now compelling evidence that the increased production of ROS by 
endothelial cells in diabetes originates from NADPH oxidase, and that this may 
contribute to impaired NO bioavailability and associated NO-dependent relaxations in
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animals (Kim et al., 2002; Coppey et al., 2003; Ling et al., 2005; Bitar et al., 2005; 
Hayashi et al., 2005; Tawfik et al., 2006; Su et al., 2008; Matsumoto et al., 2008; 
Shukla et al., 2008; Lopez-Lopez et al., 2008) and humans (Guzik et al., 2000; 2002). 
However, it remains to be determined whether elevated endothelial NADPH oxidase- 
derived H2O2 production in diabetes may compensate for the loss of NO by 
augmenting the EDHF phenomenon.
The data from the current and previous Chapter have demonstrated that both D- 
glucose and arsenite augment EDHF-type relaxations to CPA in the rabbit iliac artery, 
and that these responses may offset impaired NO-dependent relaxations. However, as 
highlighted in Chapter 3 with arsenic, while it has been demonstrated that the EDHF 
phenomenon acutely maintains arterial responsiveness during exposure to high 
glucose, it is uncertain whether such mechanisms are able to provide 
vasculoprotection against atheroma formation that is facilitated by NO. Subsequent 
Chapters will investigate the role of oxidative stress, in particular H2O2 , in the 
augmented EDHF-type components of relaxation evoked by both arsenite and D- 
glucose.
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CHAPTER 5
THE ROLE OF HYDROGEN PEROXIDE IN EDHF PHENOMENA 
AUGMENTED BY ARSENITE AND D-GLUCOSE
S.l Introduction
The first two experimental Chapters of this thesis characterized the time- and 
concentration-dependent effects of arsenite and D-glucose on endothelium-dependent 
relaxation in the rabbit iliac artery. It was found that EDHF-type relaxations evoked 
independently of InsP3-mediated Ca2+ mobilization (with CPA) were acutely 
augmented (after 30 minutes) by both agents (Chapters 3 and 4, respectively). By 
contrast, arsenite impaired EDHF-type relaxations evoked by ACh (Chapter 3), 
whereas D-glucose potentiated these responses (Chapter 4). These differential effects 
of arsenite suggest that it may inhibit the ACh receptor and/or interfere with 
subsequent second messenger signalling. Indeed, arsenite has previously been 
reported to inhibit muscarinic receptors directly by interfering with critical thiol 
groups on the receptor itself (Fonseca et al. 1991).
Only four studies appear to have investigated the effects of arsenite on endothelium- 
dependent relaxation, and the only relaxant employed in these studies was ACh (Lee 
et al., 2003; Bilszta et al., 2006; Jindal et al., 2007; Srivastava et al., 2007). 
Furthermore, only one of these studies investigated the effects of arsenite following 
inhibition of eNOS (Bilszta et al., 2006), while the effects of arsenite on endothelium- 
dependent relaxations following inhibition of eNOS and COX (i.e. EDHF-type) have 
not previously been explored.
99
By contrast, the effects of diabetes on endothelium-dependent arterial relaxation have 
been extensively studied. However, the high degree of variability reported in the 
literature has, thus far, obscured a clear understanding of the effects of diabetes on 
endothelial-dependent relaxation. While ROS are regarded as the major contributor to 
modulation of endothelial function in these models, particularly with reference to 
compromised NO bioavailability (Hattori et a l , 1991; Nassar et al., 2002; Kim et al., 
2002; Lopez-Lopez et al., 2008; Shukla et al., 2008), the mechanisms underlying 
modulation of the EDHF phenomenon are unclear, as evidenced by observations of 
enhanced, unchanged and attenuated responses (see Table 5.1). However, as with the 
possible heterogenous nature of the EDHF phenomenon itself (for reviews see: 
Griffith, 2004; Feletou & Vanhoutte, 2006), it is apparent that the effect of diabetes 
on EDHF-type relaxation may be vessel- and species-specific. Furthermore, disease 
duration is also likely to be an important factor (MacKenzie et a l , 2008).
Endothelial cells are capable of synthesizing ROS via a number of systems including 
NADPH oxidase, the mitochondrial electron transport chain, uncoupled eNOS, COX, 
cytochrome P4 5 0  and xanthine oxidase (Cai & Harrison, 2000; Matoba et al., 2000; 
Fleming et al., 2001; Matoba et al., 2002; Liu et al., 2003; McNally et al., 2003; 
Larsen et al., 2009). There is now compelling evidence that the increased activity of 
NADPH oxidase contributes to impaired NO-dependent relaxations in diabetes, while 
studies of isolated endothelial cells suggest that arsenite may also activate the same 
enzyme leading to increased ROS production and impaired NO bioavailability 
(Barchowsky et al., 1999; Smith et al., 2001; Bunderson et al., 2002; 2004; Lopez- 
Lopez et al., 2008; Shukla et al., 2008; Su et al., 2008). Furthermore, a recent study 
using vascular smooth muscle cells suggests that the increased production of ROS by
'y,
arsenite may also promote Ca mobilization (Li et a l, 2009). Conversely, the end-
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product of O2*’ dismutation, H2 O2 , has attracted much interest in the last decade as an 
important regulator of vascular function under normal conditions, with both NADPH 
oxidase, neuronal NOS (nNOS), the mitochondrial electron transport chain and eNOS 
having been proposed as important sources (Matoba et al., 2000; 2002; Liu et al., 
2003; Leung et al., 2006; Capettini et al., 2008; Larsen et al., 2009). Originally 
thought to be one of the most toxic ROS, H2O2 has controversially emerged as a 
“classical” EDHF, i.e. as a freely transferable hyperpolarizing factor of vascular 
smooth muscle cells (Beny & von der Weid, 1991; Matoba et al., 2000; 2002; Lacza 
et al., 2002; Yada et al., 2003; Matoba et al., 2003; Larsen et al., 2008), in addition to 
playing an important signalling role in coronary autoregulation, the myogenic 
response and reactive hyperaemia (Wolin et al., 1990; Nowicki et al., 2001; Koller & 
Bagi, 2004; Yada et al., 2006; 2008). However, some authors have recently suggested 
that endothelial H2O2 may contribute to the EDHF phenomenon via autocrine actions, 
thus questioning its role as a freely diffusible EDHF (Hatoum et al., 2005; Edwards et 
al., 2008; Hercule et al., 2009). For example, our laboratory has recently 
demonstrated that H2O2 promotes the mobilization of intracellular Ca2+ stores in 
rabbit endothelial cells and potentiate EDHF-type relaxation in the rabbit iliac artery 
(Edwards et al., 2008). Rather than serving as a classical EDHF, H2 O2 in this vessel 
promotes endothelial hyperpolarization by modulating integrated Kca channel activity 
secondary to increases in endothelial [Ca ]j. This endothelial hyperpolarization may 
then be transmitted electrotonically to underlying smooth muscle cells via 
myoendothelial gap junctions (Edwards et al., 2008). Indeed, gap junctional 
communication is integral to EDHF-type relaxation in this vessel and many other 
vascular beds (Taylor et al., 1998; Harris et al., 2000; Chaytor et al., 2001; Griffith et 
al., 2002; De Vriese et a l, 2002; Edwards et al., 2007; 2008; Garry et al., 2009). It is
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therefore plausible that the EDHF phenomenon may serve to offset impaired NO 
bioavailability in this vessel under conditions of oxidative stress via a mechanism 
involving H2O2 .
Correspondingly, a recent study has demonstrated that EDHF-type relaxations evoked 
by ACh in coronary arterioles of db/db mice are abolished by catalase or the 
combination of apamin and charybdotoxin, while these treatments only partially 
attenuate such responses in healthy animals (Park et al., 2008). Additionally, the 
group of Gutterman demonstrated that EDHF-type relaxations evoked by ACh in 
adipose arterioles of patients with coronary artery disease were augmented via a 
mechanism involving H2O2 in such a manner that impaired NO bioavailability was 
offset and overall vascular function was preserved (Phillips et al., 2007). Furthermore, 
the group of Vanhoutte proposed that the enhanced activity of Kca channels 
contributed to enhanced EDHF-type relaxation in diabetic rat mesenteric and femoral 
arteries (Shi et al., 2006). However, although these authors later demonstrated that 
endothelial H2O2 production was increased in the femoral artery of this diabetic rat 
model, they did not elucidate whether this ROS was directly involved in the 
augmented EDHF-type response (Shi et al., 2007). Several other groups have also 
reported an increased contribution of Kca channels to endothelium-dependent 
relaxation and the EDHF phenomenon in arteries from diabetic animals, although 
again it is unknown whether increased production of H2O2 contributes to these 
responses (Thomsen et al., 2002; Shen et al., 2003; Pataricza et al., 2008; Malakul et 
al., 2008; see Table 5.1).
The aim of the current Chapter was to elucidate the involvement of H2 O2 in the 
augmented EDHF-type relaxations evoked by arsenite and D-glucose that were 
previously characterized in Chapters 3 and 4. H2 O2 is hypothesized to be the most
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likely candidate for these augmented responses on the basis that (i) reduced NO 
bioavailability associated with diabetes and arsenic toxicity is caused by endothelial 
oxidative stress (Barchowsky et al., 1999; Smith et al., 2001; Bunderson et al., 2002; 
2004; also see Table 5.1), (ii) augmented EDHF-type relaxations in diabetic models 
have been proposed to involve enhanced Kca channel activity, with the recent study of 
Park et al (2008) specifically implicating H2 O2 in this modulation, and (iii) H2O2 
facilitates integrated Kca channel activity in the rabbit iliac artery (Edwards et al., 
2008). Evidence for the involvement of H2O2 would provide evidence for a 
compensatory role of the EDHF phenomenon under conditions of oxidative stress that 
are known to impair NO bioavailability.
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Table 5.1 Modulation of EDHF-type arterial relaxation in models of diabetes 
mellitus. Observations are approximately equally-weighted between enhanced, 
unaltered and reduced relaxation which is further complicated by controversy 
regarding the mechanism(s) involved. The most consistent mechanistic 
observation appears to be enhanced Kca channel activity in association with 
augmented responses. More specifically, the study of Park et al (2008) 
demonstrated this to be mediated by H2 O2 . Our group has recently confirmed 
the modulation of integrated Kca channel activity by endogenous and exogenous 
H2O2 in the R1A and the ability of exogenous H2O2 to potentiate the EDHF
2 1
phenomenon by promoting the mobilization of endothelial ER Ca stores 
(Edwards et al., 2008). Streptozotocin evokes pancreatic 6 cell necrosis, thereby 
mimicking type I diabetes; alloxan evokes 6 cell necrosis and insulin resistance 
thereby mimicking type II diabetes; db/db mice and obese Zucker fatty rats 
(OZFR) are a genetic models of type II diabetes. EDH: endothelium-dependent 
smooth muscle hyperpolarization; HG: high glucose in vitro; n/i: not 
investigated; n/a: not applicable; PDE3: phosphodiesterase 3; PKA: protein 
kinase A. *assumed by authors to be EDHF-type relaxation on the basis that NO 
activity is functionally insignificant in this artery under control conditions.
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Study Species Induction o f  diabetes Artery Relaxant E ffect on EDH F-type relaxation Attributed to:
Park e t a l. , 2008 M ouse streptozotocin coronary arterioles ACh |  (relative to NO ) H20 2 /TKc« channel activity
Pataricza e t a l., 2008 D og alloxan carotid ACh T TKc* channel activity
M acK enzie e t al., 2008* Human HG medium mesenteric A Ch/Bk T n/i
Malakul e t a l . , 2008 Rat streptozotocin aorta ACh T fK c , channel activity
Shi e t al., 2006 Rat streptozotocin femoral, mesenteric ACh t TK o channel activity
Shen e t a l., 2003 M ouse streptozotocin aorta ACh r TKca channel activity
Y o u sif e t al., 2002 Rat streptozotocin mesenteric H istam ine/A 23187 T n/i
Thom sen e t al., 2002 Rat streptozotocin sciatic nerve arterioles ACh T (duration) |K ca channel activity
Pannirselvam e t a l., 2002 M ouse db/db small mesenteric ACh T n/i
Timar-Peregrin & Guy, 2001 Rat streptozotocin cremaster arterioles ACh T n/i
Edgley e t a l. , 2008 Rat streptozotocin renal A Ch/Bk 4—► n/a
Hirabara, 2007 Rat streptozotocin mesenteric ACh 4—► n/a
Pannirselvam e t a l., 2006 M ouse C57BL/K sJ db/db sm all mesenteric A Ch/Bk 4—► n/a
Y ousif, 2005 Rat streptozotocin renal Histamine 4—► n/a
Y o u sif e t al., 2005 Rabbit alloxan renal ACh 4—► n/a
Ozkan e t al., 2005 Rat HG medium mesenteric A 23187 4—► n/a
En d o e ta l . ,  ? 995 Rat streptozotocin aorta ACh n/a
M akino e t a l. , 2008 M ouse streptozotocin coronary ACh i J,connexin 40  expression
Y oung e t al., 2008 Rat IR OZFR mesenteric ACh i jconn exin  40  expression
Burnham e t al., 2006a Rat zucker diabetic fatty sm all mesenteric ACh i(E D H ) jSKca channel activity
D ing e t a l. , 2005 M ouse streptozotocin sm all mesenteric ACh i jconn exin  37/SKca expression
Ozkan & Um a, 2005 Rat HG medium mesenteric ACh i H20 2
M atsum oto e t al., 2005 Rat streptozotocin mesenteric A C h/A 23187/C PA 1 |P D E 3  activity
M atsum oto e t a l. , 2004 Rat streptozotocin mesenteric ACh 1 jP K A  expression
M atsum oto e t a l . , 2003 Rat streptozotocin mesenteric ACh 1 |P D E 3  activity
Fukao e t a l. , 1997 Rat streptozotocin mesenteric ACh 1 n/i
5.2 Methods
Male New Zealand White rabbits were sacrificed arterial rings studied isometrically 
as described in 2.1 and 2.2. The rings were maintained at a resting tension of 1 mN 
over a 1 hour equilibration period and the buffer repeatedly replaced, with any 
subsequent alterations in baseline tension due to stress relaxation corrected. All 
preparations were then incubated with L-NAME (300 pM) and indomethacin (10 
pM), and some preparations were also incubated with catalase (2000 units ml'1; to 
scavenge H2O2) or manganese porphyrin (MnTMPyP 100 pM; to scavenge O2*' 
/H2O2), for 30 minutes. Following this, D-Glucose (total buffer concentration of 44 
mM) or arsenite (100 pM) was added for 30 minutes prior to constriction with PE (1 
pM). Once PE-induced tone had reached a stable plateau (after approximately 15 
minutes) relaxant responses were studied by constructing cumulative concentration- 
response curves to ACh (1 nM -  10 pM) or CPA (100 nM -  100 pM). Data was 
collected and analysed as described in 2.3 and 2.4.
5.3 Results.
5.3.1 Effects of arsenite and D-glucose on EDHF-type responses to CPA
EDHF-type relaxations evoked by CPA were potentiated by 30 minutes prior 
incubation with either 100 pM arsenite or 44 mM D-glucose, shifting the 
concentration-response curve to the left in each case (pICso- from 4.92±0.05 to 
5.21±0.07 and from 4.85±0.04 to 5.17±0.04; P 0 .0 0 1  and P<0.01, n=9 and 11, Figure
5.1 A and B, respectively; Table 5.2). Subanalyses revealed that arsenite potentiated 
relaxations in preparations more responsive to CPA (threshold 10 pM CPA; pICso: 
from 4.99±0.05 to 5.28±0.07; ^<0.01; n=4; Figure 5.2A; Table 5.2), whereas D- 
glucose was ineffective in such preparations (n=4; Figure 5.2B; Table 5.2). In
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preparations less responsive to CPA (threshold 30 pM) both arsenite and D-glucose 
potentiated relaxation, shifting the concentration-response curve to the left in each 
case (pICso: from 4.89±0.05 to 5.07±0.05 and from 4.78±0.04 to 5.19±0.09; P<0.05 
and PO.OOl, n=5 and 7, Figures 5.2A and B, respectively; Table 5.2). Additionally, 
100 pM arsenite potentiated relaxation in the MnTMPyP group, shifting the 
concentration-response curve to the left (pIC5o: from 4.68±0.07 to 5.05±0.05; P<0.05; 
n=8; Figure 5.3; Table 5.3). Neither the Rmax for CPA (Tables 5.2 and 5.3) nor PE- 
induced tone (Table 5.4) was affected by incubation with arsenite or D-glucose.
5.3.2 Effects of catalase on arsenite- and D-glucose-augmented EDHF-type 
responses to CPA
Catalase (2000 units m l'1) did not affect relaxations evoked by CPA, in either the 
arsenite group or the D-glucose group, under control conditions in the combined data 
(n=9 and 11; Figure 5.1 A and 5.IB, respectively) or in preparations responsive at 30 
pM CPA (n=5 and 7; Figure 5.2A and 5.2B, respectively). However, catalase 
attenuated relaxation in preparations responsive at 10 pM CPA, shifting the 
concentration-response curve to the right in both the arsenite and D-glucose groups 
(pICso: from 4.99±0.05 to 4.78±0.03 and from 5.11±0.04 to 4.79±0.05; P<0.01 for 
each; Figure 5.2A and B, respectively; Table 5.2). Catalase also reversed the 
enhancing effects of both arsenite and D-glucose in the combined data (Figure 5.1 A 
and 5.IB, respectively; Table 5.2) and in preparations responsive at 30 pM CPA 
(Figure 5.2A and 5.2B, respectively; Table 5.2). Additionally, in preparations 
responsive at 10 pM CPA, catalase reversed the enhancing effect of arsenite to a level 
comparable with preparations incubated with catalase individually (Figure 5.2A;
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Table 5.2). Neither the Rmax to CPA (Table 5.2) nor PE-induced tone (Table 5.4) was 
affected by catalase individually or in combination with arsenite or D-glucose.
5.3.3 Effects of MnTMPyP on arsenite-augmented EDHF-type responses to CPA
MnTMPyP (100 pM) attenuated relaxation at 10 pM CPA (P<0.01; n=8; Figure 5.3) 
but did not evoke a significant shift in the concentration-response curve (Table 5.3). 
MnTMPyP also reversed the enhancing effect of arsenite to a level comparable with 
time-matched control preparations (Figure 5.3), with a pIC 5o value comparable with 
either time-matched control preparations or those incubated with MnTMPyP alone 
(Table 5.2). Neither the Rmax to CPA (Table 5.3) nor PE-induced tone (Table 5.4) was 
affected by MnTMPyP alone or its combination with arsenite.
5.3.4 Effects of D-glucose on EDHF-type responses to ACh
Maximal EDHF-type relaxations evoked by ACh were potentiated by 30 minutes 
incubation 44 mM D-glucose (Rmax- from 55.6±3.4 to 77.1±2.7%; PO .O l; n=6; 
Figure 5.4), whereas the pECso value was not altered (Table 5.5). PE-induced tone 
was not affected by D-glucose (Table 5.4).
5.3.5 Effects of catalase on D-glucose-augmented EDHF-type responses to ACh
EDHF-type relaxations evoked by ACh were unaffected by catalase (2000 units ml"1) 
under control conditions (Figure 5.4; Table 5.5). Catalase reversed the enhancing 
effect of D-glucose to control levels (Figure 5.4; Table 5.5). PE-induced tone was 
unaffected by catalase alone or its combination with D-glucose (Table 5.4).
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Figure 5.1 Effect of catalase on arsenite- and D-glucose-augmented EDHF-type 
relaxations evoked by CPA. Original recordings and concentration-response curves 
showing that catalase abolished the enhancing effects of both (A) arsenite and (B) D- 
glucose. *, ** and *** denote P<0.05, P<0.01, P<0.001 compared with time-matched 
controls, n denotes the number of animals studied.
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Figure 5.2 Subanalyses showing differential effects of arsenite, D-glucose and 
catalase on EDHF-type relaxations according to the threshold of the response to CPA. 
Where the threshold was 10 pM CPA, (A) arsenite, but not (B) D-glucose, augmented 
relaxation at 10 and 30 pM CPA. In these preparations, catalase attenuated relaxation 
at 10 pM CPA under control conditions (A and B) and also reversed the enhancing 
effect of arsenite to a level indistinguishable from preparations incubated with 
catalase individually (A). Catalase was ineffective in preparations responsive at 30 
pM CPA under control conditions (A and B) but abolished the enhancing effect of 
both (A) arsenite and (B) D-glucose. *, ** and *** denote .P<0.05, P<0.01 and 
P<0.001 compared with time-matched controls, n denotes the number of animals 
studied.
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Figure 5.3 Effect of MnTMPyP on arsenite-augmented EDHF-type relaxations 
evoked by CPA. Original recording and concentration-response curves showing that 
MnTMPyP abolished the enhancing effect of arsenite. MnTMPyP attenuated 
relaxation at 10 pM CPA under control conditions. * and ** denote P<0.05 and 
^<0.01 compared with time-matched controls, n denotes the number of animals 
studied.
113
C P A  (nM)
d) 20
10 mins
— Control
—  Arsenite 100 ^M
—  Arsenite 100 fiM
+ MnTMPyP 100 pM
30 mins -O Control
♦ A r s e n ite  100 faM
MnTMPyP 100 [M 
♦  Arsenite + MnTMPyP- 2 0 i
n=8
c  20- o
-t->
03
X
J9 40- <1) a: * *
60-
80-
100
6 5 -47
log10[CPA] (M)
114
Figure 5.4 Effect of catalase on D-glucose-augmented EDHF-type relaxations evoked 
by ACh. Original recording and concentration-response curves showing that catalase 
abolished the enhancing effect of D-glucose. In this example relaxation was more 
sustained in the presence of D-glucose, whereas in time-matched preparations 
relaxation was followed by a rapid constriction towards the level evoked by PE. * 
denotes P<0.05 compared with time-matched controls, n denotes the number of 
animals studied.
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Table 5.2 Enhancing effects of arsenite and D-glucose on EDHF-type relaxations 
evoked by CPA are abolished by catalase. Subanalyses of total data were paired 
according to the threshold of relaxation to CPA in time-matched preparations. All 
experiments were performed in the presence of L-NAME (300 pM) and indomethacin 
(10 pM) and the effects of arsenite (100 pM), D-glucose (44 mM), catalase (2000 units 
ml"1) were subsequently determined. Potency (negative log IC 50) and maximal 
responses (Rmax) are given as means±SEM. *, ** and *** denote P<0.05, P<0.01 and 
P<0.001 compared with time-matched controls, f, t t  and t t t  denote P<0.05, P<0.01 
and P 0 .0 0 1  compared with arsenite/D-glucose alone, n denotes the number of animals 
studied.
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Intervention n pICso Rmax %
Control (L-NAME+Indo) (combined) 9 4.92+0.05 79.5+2.3
Arsenite 100 \iM 5.21+0.07*** 81.0+2.5
Catalase 2000 U ml'1 4.79+0.05 82.2+2.8
Arsenite + Catalase 4.80±0.04tt 77.9+3.0
Control (L-NAME+Indo) (threshold 10 jiM) 4 4.99+0.05 75.8+3.2
Arsenite 100 gM 5.28+0.07** 76.0+3.6
Catalase 2000 U ml'1 4.78+0.03* 81.8+1.8
Arsenite + Catalase 4.80±0.05*fft 75.2+5.0
Control (L-NAME+Indo) (threshold 30 gM) 5 4.89+0.05 83.1+3.7
Arsenite 100 gM 5.07+0.05* 85.5+2.4
Catalase 2000 U ml"1 4.79+0.03 82.3+4.9
Arsenite + Catalase 4.80±0.03t 85.9+3.3
Control (L-NAME+Indo) (combined) 11 4.85+0.04 82.2+3.6
D-glucose 44 mM 5.17+0.04** 85.1+2.6
Catalase 2000 U ml'1 4.74+0.08 81.1+3.7
D-glucose + Catalase 4.81+0.041 80.3+3.7
Control (L-NAME+Indo) (threshold 10 gM) 4 5.11+0.04 80.9+4.9
D-glucose 44 mM 5.15+0.06 84.7+2.6
Catalase 2000 U ml'1 4.79+0.05** 84.2+7.3
D-glucose + Catalase 4.80±0.03**tf 81.5+2.8
Control (L-NAME+Indo) (threshold 30 gM) 7 4.78+0.04 82.4+2.7
D-glucose 44 mM 5.19+0.09*** 85.3+2.4
Catalase 2000 U ml'1 4.57+0.08 75.3+6.7
D-glucose + Catalase 4.86±0.05t 79.3+3.7
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Table 5.3 Enhancing effects of arsenite on EDHF-type relaxations evoked by CPA 
are abolished by MnTMPyP. All experiments were performed in the presence of L- 
NAME (300 pM) and indomethacin (10 pM) and the effects of arsenite (100 pM) and 
MnTMPyP (100 pM) were subsequently determined. Potency (negative loglCso) and 
maximal responses (Rmax) are given as means±SEM. * denotes P<0.05 compared with 
time-matched controls, t t  denotes P<0.0\ compared with arsenite alone, n denotes 
the number of animals studied.
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Intervention n pIC 50 R-max %
Control (L-NAME+Indo) 8 4.68+0.07 78.9+2.8
Arsenite 100 juM 5.05+0.05* 84.1+3.1
MnTMPyP 100 jiM 4.59+0.07 73.3+4.5
Arsenite + MnTMPyP 4.69+0.10ft 70.7+5.6
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Table 5.4 Effects of arsenite, D-glucose, catalase and MnTMPyP on arterial tone 
induced by PE. It was determined that arsenite (100 pM), D-glucose (44 mM), 
catalase (2000 units m l'1), MnTMPyP (100 gM) or combinations of these treatments 
did not affect PE-induced tone compared with time-matched controls. Data given as 
means±SEM. n denotes the number of animals studied (data pooled from Tables 5.2,
5.3 and 5.5).
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Intervention n PE-induced tone (mN)
Control (L-NAME+Indo) 34 40.1+1.3
Arsenite 100 gM 17 37.4+3.4
D-glucose 44 mM 17 38.2+2.9
Catalase 2000 U ml"1 26 42.7+1.7
Arsenite + Catalase 9 40.8+4.9
D-glucose + Catalase 17 37.3+2.6
MnTMPyP 100 gM 8 43.6+5.5
Arsenite + MnTMPyP 8 36.3+4.8
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Table 5.5 Enhancing effects of D-glucose on EDHF-type relaxations evoked by ACh 
are abolished by catalase. All experiments were performed in the presence of L- 
NAME (300 pM) and indomethacin (10 pM) and the effects of D-glucose (44 mM) 
and catalase (2000 units ml"1) were subsequently determined. Potency (negative 
logECso) and maximal responses (Rmax) are given as means±SEM. ** denotes P<0.01 
compared with time-matched controls, f  denotes P<0.05 compared with D-glucose 
alone, n denotes the number of animals studied.
123
Intervention n pEC50 Rmax %
Control (L-NAME+Indo) 6 6.52+0.08 55.6+3.4
D-glucose 44 mM 6.57+0.06 77.1+2.7**
Catalase 2000 U ml'1 6.43+0.06 53.8+1.6
D-glucose + Catalase 6.33+0.05 59.9±3.4t
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5.4 Discussion
The principal finding of this Chapter was that both 100 pM arsenite and 44 mM D- 
glucose potentiate EDHF-type relaxation in the rabbit iliac artery via a mechanism 
that appears to involve H2O2 . Results for each experimental group were analysed 
collectively and by subanalysis of data paired according to the threshold concentration 
of CPA required to evoke relaxation. Arsenite potentiated relaxation at 3 and 10 pM 
CPA in the combined data (as found in Chapter 3), a phenomenon that did not differ 
whether the threshold for relaxation was 10 or 30 pM CPA. D-glucose potentiated 
relaxation at 10 pM CPA in the combined data (as observed in Chapter 4) and in 
preparations responsive at 30 pM CPA, but not those responsive at 10 pM CPA. The 
enhancing effects of arsenite and D-glucose were reversed by the H2O2 scavenger 
catalase to a level comparable with time-matched control preparations and those 
incubated with catalase individually in the combined data.
Under control conditions, catalase attenuated relaxation at 10 pM CPA in preparations 
with a threshold of 10 pM CPA, but not those where the threshold was 30 pM CPA or 
in the combined data, suggesting that endogenous H2O2 production may contribute to 
the EDHF phenomenon in the rabbit iliac artery, as previously reported (Edwards et 
ah, 2008). The role of H2O2 in arsenite-augmented EDHF-type relaxations was 
confirmed by the demonstration that the cell-permeable SOD/catalase-mimetic 
MnTMPyP also abolished the enhanced component of responses evoked by CPA. 
Additionally, D-glucose-augmented EDHF-type relaxations evoked by ACh 
(characterized in Chapter 4) were also reversed by catalase. Thus, endogenous H2O2 
production, in addition to receptor-independent relaxants, may also potentiate EDHF- 
type relaxations evoked by agonists acting via membrane-associated receptors in the 
rabbit iliac artery, as previously reported (Garry et ah, 2009).
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The generality of these observations is substantiated by recent studies from our 
laboratory, in which EDHF-type relaxations evoked by either CPA or ACh were 
potentiated by exogenous H2O2 (100 pM) in the rabbit iliac artery (Edwards et al., 
2008; Garry et al., 2009). It was also demonstrated in these studies that exogenous 
H2O2 promotes the mobilization of intracellular Ca2+ stores in rabbit endothelial cells, 
a mechanism that is likely to involve sensitization of the InsP3 receptor via oxidation 
on the basis that (i) H2C>2-potentiated elevations in [Ca2+]i in response to CPA 
correlated with store depletion and was reversed by the thiol reductant glutathione 
monoethyl ester, (ii) this effect was mimicked by the thiol oxidant thimerosal which is 
known to sensitize the InsP3 receptor to Ca2+ and basal levels of InsP3 (Bootman et al., 
1992; Parekh & Penner, 1995; Montero et al., 2001; Bultynck et al., 2004), and (iii) 
the endothelium-dependent CPA-potentiated component of relaxation to H2O2 was 
reversed by combined inhibition of SKca and IKca channels (with apamin+TRAM). 
The proposal that H2O2 sensitizes the InsP3 receptor was further substantiated by 
experiments showing that the phospholipase C inhibitor U-73122 did not affect the 
potentiation of EDHF-type relaxations, indicating that InsP3 synthesis was not altered 
(Edwards et al., 2008). Additionally, it has been reported that the endothelium- 
specific SERCA3 isoform is, unlike the smooth muscle SERCA2b isoform, 
insensitive to H2O2 at concentrations <500 pM, thus indicating that the effect of 100 
pM H2O2 in the rabbit iliac artery is unlikely to be due to inhibition of the SERCA 
pump (Grover et al., 1997; Edwards et al., 2008).
Furthermore, in the same study, it was shown that endogenous H2O2 promoted the 
integrated activity of Kca channels secondary to the mobilization of endothelial Ca2+ 
stores in response to CPA. Correspondingly, a triple combination of Kca blockers 
(apamin+TRAM+iberiotoxin) essentially abolished EDHF-type relaxation in
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preparations with a threshold of 30 pM CPA, whereas responses in preparations with 
a threshold of 10 pM were only attenuated to -60%  by this treatment and further 
attenuated to -40% by catalase (Edwards et al., 2008). Therefore, H2O2 may promote 
endothelial hyperpolarization in the rabbit iliac artery rather than acting as a freely 
diffusible EDHF, as has been suggested in studies of human and mouse mesenteric 
arteries, coronary microvessels of pigs, dogs and humans and piglet pial microvessels 
(Beny and von der Weid, 1991; Matoba et al., 2000; 2002; Lacza et al., 2002; Yada et 
al., 2003; Matoba et al., 2003; Larsen et al., 2008; 2009).
One previous study has investigated the effects of arsenite on vascular function in the 
absence of eNOS activity, in which NO-dependent and -independent relaxations were 
preserved despite hypereactivity to phenylephrine mediated by reduced basal NO 
bioavailability (Bilszta et al., 2006). Indeed, the only other data available are the 
inhibitory effects of arsenite on NO-dependent arterial relaxation to ACh which 
therefore reflect reduced NO bioavailability and subsequent cGMP signalling (Lee et 
al., 2003; Srivastava et al., 2007; Jindal et al., 2007). The inhibitory effect of arsenite 
on ACh relaxations observed in the current study (see Chapter 3) cannot be attributed 
to H2O2 on the basis that: (i) D-glucose-mediated enhancement of EDHF-type 
relaxation to ACh is entirely mediated by H2O2 , and (ii) exogenous H2O2 potentiates 
EDHF-type relaxation to ACh in this artery (Garry et al., 2009). The involvement of 
H2O2 in EDHF-type relaxations potentiated by arsenite is consistent with previous 
reports that it activates NADPH oxidase in endothelial cells and increases the 
production of ROS (Barchowsky et al., 1999; Smith et al., 2001; Straub et al., 2008). 
Indeed, arsenite has been reported to promote vascular smooth muscle Ca2+ 
mobilization via a mechanism involving the increased production of ROS, although a 
similar effect in endothelial cells remains to be demonstrated experimentally (Li et al.,
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2009). Studies of isolated endothelial cells have provided compelling evidence that 
elevated D-glucose increases the production of ROS, including H2O2 , and enhances 
agonist-evoked Ca2+ mobilization which could in theory potentiate the EDHF 
phenomenon (Wascher et al., 1994; Graier et al., 1996; 1997; 1998; 1999; Schaeffer 
et al., 2003; Tamareille et al., 2006). Indeed, the ability of H2O2 to enhance 
endothelial Ca2+ mobilization has been demonstrated in numerous studies conducted 
over the last twenty years, and has been variously proposed to involve increased InsP3 
synthesis or sensitization/activation of the InsP3 receptor (Lewis et al., 1988; Kimura 
et al., 1992; Doan et al., 1994; Siflinger-Bimboim et al., 1996; Shimizu et al., 1997; 
Hu et al., 1998; Saeki et al., 2000; Niwa et al., 2001; Ji et al., 2002; Zheng & Shen, 
2005; Mergler et al., 2005; Zhu et al., 2008; Hecquet et al., 2008; Edwards et al., 
2008).
While this Chapter has demonstrated the involvement of H2O2 in enhanced EDHF- 
type relaxation to CPA in an in vitro model of hyperglycaemia, the variability in the 
literature regarding modulation of the EDHF phenomenon during diabetes may reflect 
vessel- and species-specific responses to H2O2 . For example, the increased production 
of H2O2 has been reported to promote endothelium-dependent thromboxane A2- 
mediated contractions in the femoral artery of STZ-diabetic rats that are offset by an 
augmented apamin+charybdotoxin-sensitive EDHF-type component. The authors of 
this study also demonstrated the existence of augmented EDHF-type relaxations in the 
mesenteric artery of the same diabetic rat model (Shi et al., 2006). Conversely, it has 
been reported that EDHF-type relaxations to ACh are attenuated in the mesenteric 
artery of STZ-diabetic rats, despite the same method of induction of diabetes and a 
similar disease duration prior to experimental analysis (Fukao et al., 1997). These
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confounding reports may be a reflection of the strain of rat (Sprague-Dawley and 
Wistar, respectively) studied (Fukao et al., 1997; Shi et al., 2006).
ROS have been suggested to contribute to impaired EDHF-type relaxations in healthy 
rat mesenteric arterial preparations acutely exposed to a high glucose medium, with 
responses being restored by SOD+catalase (Ozkan & Uma, 2005). However, the idea 
that oxidative stress induced by elevated glucose might differentially modulate the 
EDHF phenomenon in the rabbit iliac artery and rat mesenteric artery is consistent 
with recent demonstrations that ascorbic acid potentiates EDHF-type relaxation in the 
rabbit iliac artery (Garry et al., 2009), but impairs these responses in the rat 
mesenteric artery, via its ability to generate H2O2 (Nelli et al., 2009). Furthermore, in 
many non-vascular cell types H2O2 may variably augment (Rouach et al., 2004; Saez 
et al., 2005; Ramachandran et al., 2007) or impair (Hu & Cotgreave, 1995; Upham et 
al., 1997; Cho et al., 2002) intercellular coupling via gap junctions constructed from 
connexin 43.
By contrast, EDHF-type relaxations in coronary arterioles isolated from type II 
diabetic mice are by abolished catalase or the combination of apamin+charybdotoxin, 
whereas these treatments only partially attenuate such responses in healthy mice (Park 
et al., 2008). Furthermore, Malakul and co-workers (2008) reported that an 
apamin+charybdotoxin-sensitive EDHF-type relaxant response was unmasked (i.e. 
not observed in healthy controls) in the aorta of both diabetic and 
hypercholesterolaemic rats, with the combinatorial effects of these conditions being 
an additively augmented EDHF-type response and a synergistic increase in NADPH 
oxidase activity. Several other groups have also proposed that Kca channel activity is 
increased during diabetes and may contribute to augmented EDHF-type relaxations 
that serve to compensate for impaired NO bioavailability, although the direct
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involvement of H2O2 in these responses remains to be determined (Thomsen et al., 
2002; Shen et al., 2003; Pataricza et al., 2008). Conversely, it remains to be 
determined whether oxidative stress contributes to the mechanisms that have been 
suggested to mediate the attenuation of EDHF-type relaxation in diabetes, which 
include reduced connexin and/or Kca channel expression (Ding et al., 2005; Young et 
al., 2008; Makino et al., 2008) and impaired gap junctional communication mediated 
by impaired cAMP accumulation (Matsumoto et al., 2004; 2005).
The results obtained in this Chapter have demonstrated that a mechanism involving 
H2O2 underpins the arsenite- and D-glucose- augmented components of EDHF-type 
relaxation in the rabbit iliac artery. As H2 O2 is the end-product of the dismutation of 
O2*’ anions, further analysis is required to determine the (V'-generating system 
involved in these responses. Indeed, NADPH oxidase has been reported to be directly 
activated by arsenite in endothelial cells, and its increased activity has been suggested 
to contribute to increased endothelial ROS production and impaired NO 
bioavailability in diabetes. The involvement of this enzyme in EDHF-type relaxations 
augmented by arsenite and D-glucose is the subject of the next Chapter.
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CHAPTER 6
THE ROLE OF NADPH OXIDASE IN EDHF PHENOMENA AUGMENTED 
BY ARSENITE AND D-GLUCOSE
6.1 Introduction
In the previous Chapter it was shown that arsenite and D-glucose both potentiate 
EDHF-type relaxations evoked by CPA in the rabbit iliac artery via a mechanism 
sensitive to catalase. Additionally, catalase reversed the enhancing effect of D-glucose 
on EDHF-type relaxations to ACh, with the potentiation of CPA relaxations by 
arsenite also being reversed by the cell permeable SOD/catalase mimetic manganese 
porphyrin. These data suggest that the potentiating effects of arsenite and D-glucose 
are mediated by H2O2 , which can potentiate EDHF-type relaxations to CPA and ACh
 ^1
in the rabbit iliac artery by promoting the mobilization of endothelial Ca stores 
(Edwards et al., 2008; Garry et al., 2009).
The involvement of H2O2 in the potentiation of EDHF-type relaxations by arsenite 
appears to be consistent with findings from studies with isolated endothelial cells, 
where arsenite has been demonstrated to increase the production of ROS, including 
H2O2 , by activating NADPH oxidase (Barchowsky et al., 1999; Smith et al., 2001; 
Qian et al., 2005; Straub et al., 2008). There is also evidence that the increased 
endothelial production of ROS during diabetes originates from NADPH oxidase, and 
impairs NO bioavailability and associated NO-dependent arterial relaxation (Table
6.1). However, it remains to be determined whether the associated increase in 
endothelial H2O2 levels augments the EDHF phenomenon in diabetes.
NADPH oxidases are classified according to the isoform of the large plasma 
membrane-bound catalytic subunit (NOX1-5, with NOX2 formerly known as
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gp91phox) (Brandes & Schroder, 2008). Also present is the smaller plasma membrane 
subunit, p22phox, and different cytosolic subunits, variably p40phox, p47phox, p67phox and 
the GTPase Racl, which associate with the membrane subunits to activate the enzyme 
(Dworakowski et al., 2008). NOX4 is believed to be the only constitutively active 
isoform, and does not require the cytosolic subunits for the oxidase activity, which is 
instead regulated by expression levels (Brandes & Schroder, 2008). Endothelial cells 
and vascular smooth muscle cells are widely known to express NOX2 and NOX4, 
with smooth muscle cells also thought to express NOX1 (Ray & Shah, 2005).
Under normal conditions, NADPH oxidase-derived H2O2 may contribute 
physiologically to EDHF-type dilatations evoked by bradykinin in the human 
coronary microcirculation, as indicated by the similar abilities of apocynin or gp91ds- 
tat and catalase to inhibit bradykinin-evoked endothelial H2 O2 generation and EDHF- 
type dilatations in these vessels (Larsen et al., 2008; 2009). Apocynin is a 
methoxyphenol plant extract that is widely acknowledged to inhibit NADPH oxidase 
activity in phagocytic and non-phagocytic cells (Yu et al., 2008). This compound is 
known to inhibit the association of the cytosolic subunits (e.g. p47phox, p67phox and 
Racl) with the membrane-bound subunits following intracellular bioactivation by 
ROS and peroxidase, although clear details of the mechanism of action are currently 
unavailable (Yu et al., 2008). Gp91ds-tat is a recently developed peptide inhibitor that 
specifically prevents the association of the cytosolic p47phox subunit with the plasma 
membrane-bound gp91phox subunit (Rey et al., 2001).
The aim of the current Chapter was to determine the role of NADPH oxidase in 
arsenite- and D-glucose-augmented EDHF-type relaxations. Based on the evidence 
highlighted above, it was hypothesized that the H2O2 previously found (Chapter 5) to
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underpin these augmented relaxations is the end product of NADPH oxidase-derived 
0 2*.
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Table 6.1 Oxidative stress-mediated modulation of NO/prostanoid-dependent 
arterial relaxation in experimental diabetes. Note that the majority of evidence 
supports NADPH oxidase as the ROS-generating system involved in reduced NO 
bioavailability and impaired relaxant responses. The lack of studies into the role of 
the enhanced activity of this enzyme in modulation of the EDHF phenomenon in 
experimental diabetes warrants its investigation in the current study, 
db/db: murine model of type 2 diabetes; GK: Goto-Kakizaki, rat model of type 2 
diabetes; OLETF: Otsuka Long-Evans Tokushima Fatty, rat model of obese type 2 
diabetes; streptozotocin evokes pancreatic B cell necrosis to mimic type 1 diabetes; 
alloxan evokes pancreatic B cell necrosis and insulin resistance to mimic type II 
diabetes; HG: high glucose; EDR: endothelium-dependent relaxation. *groups: 
glucose tolerant, non-glucose tolerant, diabetic glucose-tolerant
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Study Species Induction o f  diabetes Artery Stimulant E ffect on EDR Attributed to:
L opez-Lopez et al, 2008 Rat streptozotocin pulmonary ACh j N A D PH  oxidase, jN O
Shukla et al, 2008 Rabbit alloxan aorta ACh j N A D PH  oxidase, jN O
M atsum oto et al, 2008 Rat OLETF basilar ACh j N A D PH  oxidase, jN O
Su et al, 2008 M ouse db/db mesenteric ACh/shear stress 1 fN A D P H  oxidase expression, jN O
Elmi et al, 2008 M ouse db/db aorta ACh 1 cytochrom e P450-derived ROS, jN O
M oien-Ashfari et al, 2008 M ouse db/db coronary ACh j oxidative stress, jS O D  expression
Baluchnejadmojarad and Roghani, 2008 Rat streptozotocin aorta ACh 1 oxidative stress, jS O D  expression
Natali et al, 2008 Human * subcutaneous m icrovessels ACh *-* (all groups) oxidative stress evident
R eyes-T oso et al, 2007 Rat pancreatomy aorta ACh 1 oxidative stress
Tawfik et al, 2006 Rat HG medium coronary ACh 1 N A D PH  oxidase, jN O
Rosen and W iem sperger, 2006 Rat GK aorta ACh 4—* m itochondrial-derived ROS increased
Hayashi et al, 2005 Rat OLETF aorta ACh 1 N A D PH  oxidase, jN O
Bitar et al, 2005 Rat GK aorta ACh 1 N A D PH  oxidase, jN O
Ling et al, 2005 M ouse non-obese diabetic Lc7 aorta ACh 1 N A D PH  oxidase, constrictor prostanoids
Bagi et al, 2004 Rat HG medium skeletal m uscle arterioles flow -induced 1 mitochondrial ROS, jN O , |B H 4
Sercom be et al, 2004 Rabbit HG medium basilar ACh Vi |sen sitiv ity  to N O /N A D PH  oxidase, jN O
Coppey et al, 2003 Rat streptozotocin sciatic nerve arterioles ACh i N A D PH  oxidase, com plex I, jN O
Kim et al, 2002 Rat OLETF aorta ACh 1 N A D PH  oxidase
Kanie et al, 2002 Rat streptozotocin aorta ACh j endothelin-1, N A D PH  oxidase activity
Pieper et al, 1996 Rat streptozotocin aorta A C h/A 23187 jA-> hydroxyl radicals
6.2 Methods
Male New Zealand White rabbits were sacrificed and arterial rings studied 
isometrically as described in 2.1 and 2.2. The rings were maintained at a resting 
tension of 1 mN over a 1 hour equilibration period the buffer repeatedly replaced, 
with any subsequent alteration in baseline tension due to stress relaxation corrected. 
All preparations were then incubated with L-NAME (300 pM) and indomethacin (10 
pM), and some preparations were also incubated with apocynin (100 pM), for 30 
minutes. D-Glucose (total buffer concentration of 44 mM) or arsenite (100 pM) was 
then added for 30 minutes prior to constriction with PE (1 pM). Once PE-induced 
tone had reached a stable plateau (after approximately 15 minutes) relaxant responses 
were studied by constructing cumulative concentration-response curves to CPA (100 
nM -  100 pM). Data was collected and analysed as described in 2.3 and 2.4.
6.3 Results
6.3.1 Effects of arsenite and D-glucose on EDHF-type responses to CPA
EDHF-type relaxations evoked by CPA were potentiated by 30 minutes prior 
incubation with either 100 pM arsenite or 44 mM D-glucose, shifting the 
concentration-response curve to the left in each case (pICso: from 4.99±0.07 to 
5.31±0.05 and from 4.84±0.06 to 5.11±0.04; n=14 and 8; .P<0.01 and P<0.001; Figure
6.1 A and 6 .IB; Table 6.2). Subanalysis of this data revealed that arsenite also 
potentiated relaxations in preparations more sensitive to CPA (threshold 10 pM), 
shifting the concentration-response curve to the left (pICso: from 5.03±0.04 to 
5.32±0.03; P<0.01; n=9; Figure 6.2A; Table 6.2), whereas D-glucose was ineffective 
in such preparations (n=4; Figure 6.2B; Table 6.2). In preparations less responsive to
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CPA (threshold 30 pM), both arsenite and D-glucose potentiated relaxation, shifting 
the concentration-response curve to the left in each case (pICso: from 4.83±0.06 to 
5.25±0.08 and from 4.74±0.07 to 5.00±0.02; n=5 and 4; P<0.001 and P<0.05; Figure 
6.2A and 6.2B; Table 6.2). Neither the Rmax to CPA (Table 6.2) nor PE-induced tone 
(Table 6.3) was affected by incubation with either arsenite or D-glucose.
6.3.2 Effect of apocynin on arsenite and D-glucose-augmented EDHF-type 
responses to CPA
Apocynin (100 pM) did not affect relaxations evoked by CPA, in either the arsenite or 
D-glucose groups, under control conditions in the combined data (n=14 and n=8; 
Figures 6.1 A and 6.IB, respectively) or in preparations responsive at 30 pM CPA 
(n=5 and n=4; Figure 6.2A and 6.2B). However, apocynin attenuated relaxation in 
preparations that were responsive at 10 pM CPA, shifting the concentration-response 
curve to the right in each case (pICso: from 5.03±0.04 to 4.78±0.02 and from 
5.05±0.08 to 4.72±0.02; P<0.01 for each; n=9 and 4; Figure 6.2A and 6.2B; Table
6.2). Apocynin also reversed the enhancing effects of both arsenite and D-glucose in 
the combined data (Figure 6.1 A and 6.IB; Table 6.2) and in preparations responsive 
at 30 pM CPA (Figure 6.2A and 6.2B; Table 6.2). Additionally, in preparations 
responsive at 10 pM CPA, apocynin reversed the enhancing effect of arsenite to a 
level comparable with preparations incubated with apocynin individually (Figure 
6.2A; Table 6.2). Neither the Rmax to CPA (Table 6.2) nor PE-induced tone (Table
6.3) was affected by apocynin individually, or in combination with arsenite or D- 
glucose.
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Figure 6.1 Effect of apocynin on arsenite- and D-glucose-augmented EDHF-type 
relaxations evoked by CPA. Original recordings and concentration-response curves 
showing that apocynin abolished the enhancing effects of (A) 100 pM arsenite and 
(B) 44 mM D-glucose. ** and *** denote ^<0.01 and P<0.001 compared with time- 
matched control preparations incubated in the absence of arsenite, elevated D-glucose 
or apocynin. n denotes the number of animals studied.
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Figure 6.2 Subanalyses showing differential effects of arsenite, D-glucose and 
apocynin on EDHF-type relaxations according to the threshold of the response to 
CPA. Where the threshold was 10 pM CPA, (A) arsenite, but not (B) D-glucose, 
augmented relaxation at 10 and 30 pM CPA. In these preparations, apocynin 
attenuated relaxation at 10 pM CPA under control conditions (A and B) and also 
reversed the enhancing effect of arsenite to a level indistinguishable from apocynin 
alone (A). Apocynin was ineffective in preparations responsive at 30 pM CPA under 
control conditions (A and B) but abolished the enhancing effect of both (A) arsenite 
and (B) D-glucose. *, ** and *** denote P<0.05, P<0.01 and PO.OOl compared with 
time-matched control preparations incubated in the absence of arsenite, elevated D- 
glucose and apocynin. n denotes the number of animals studied.
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Table 6.2 Enhancing effects of arsenite and D-glucose on EDHF-type relaxations 
evoked by CPA are abolished by apocynin. All experiments were performed in the 
presence of L-NAME (300 pM) and indomethacin (10 pM) and the effects of arsenite 
(100 pM), D-glucose (44 mM) and apocynin (100 pM) were subsequently 
determined. Subanalyses of combined data were paired according to the threshold of 
relaxation to CPA in time-matched preparations. Potency (negative log IC 50) and 
maximal responses (Rmax) are given as means±SEM. *, ** and *** denote P<0.05, 
P<0.01 and P<0.001 compared with time-matched control preparations incubated in 
the absence of arsenite, elevated D-glucose and apocynin. f» t t  and t t t  denote 
P<0.05, P<0.01 and P<0.001 compared with arsenite/D-glucose alone, n denotes the 
number of animals studied.
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Intervention n________ pIC5o
Control (L-NAME+Indo) (combined) 14 4.99+0.07 86.2+1.9
Arsenite 100 pM 5.31+0.05** 83.4+2.1
Apocynin 100 pM 4.89+0.07 78.7+3.7
Arsenite + Apocynin 5.04±0.06f 82.9+3.1
Control (L-NAME+Indo) (threshold 10 pM) 9 5.03+0.04 87.9+3.0
Arsenite 100 pM 5.32+0.03** 85.8+3.2
Apocynin 100 pM 4.78+0.02** 79.2+5.9
Arsenite + Apocynin 4.82±0.02**ttt 83.7+2.9
Control (L-NAME+Indo) (threshold 30 pM) 5 4.83+0.06 84.4+2.1
Arsenite 100 pM 5.25+0.08*** 79.0+3.2
Apocynin 100 pM 4.81+0.03 77.3+2.8
Arsenite + Apocynin 4.97+0.0 4 |t 81.0+3.7
Control (L-NAME+Indo) (combined) 8 4.84+0.06 88.6+2.7
D-glucose 44 mM 5.11+0.04*** 88.8+2.2
Apocynin 100 pM 4.70+0.09 84.5+5.6
D-glucose + Apocynin 4.77±0.04tft 84.2+2.8
Control (L-NAME+Indo) (threshold 10 pM) 4 5.05+0.08 85.5+5.2
D-glucose 44 mM 5.12+0.02 89.7+3.5
Apocynin 100 pM 4.72+0.02** 89.7+3.4
D-glucose + Apocynin 4.76+0.03 * * ttf 84.5+5.3
Control (L-NAME+Indo) (threshold 30 pM) 4 4.74+0.07 91.7+1.0
D-glucose 44 mM 5.00+0.02* 87.9+3.3
Apocynin 100 pM 4.64+0.08 81.4+2.5
D-glucose + Apocynin 4.79+0.09t 84.0+3.7
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Table 6.3 Effects of arsenite, D-glucose and apocynin on arterial tone induced by PE 
in the presence of L-NAME and indomethacin. It was determined that arsenite (100 
pM), D-glucose (44 mM), apocynin (100 pM) or combined treatments did not affect 
PE-induced tone compared with time-matched control preparations incubated in the 
absence of these treatments. Data given as means±SEM. n denotes the number of 
animals studied (data pooled from Table 6.2).
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Intervention n PE-induced tone (mN)
Control (L-NAME+Indo) 22 38.4+3.1
Arsenite 100 pM 14 34.2+4.8
D-glucose 44 mM 8 36.3+2.9
Apocynin 100 pM 22 40.1+3.1
Arsenite + Apocynin 14 35.3+4.0
D-glucose + Apocynin 8 38.7+5.7
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6.4 Discussion
The principal finding of this Chapter was that the mechanism through which arsenite 
and D-glucose potentiate EDHF-type relaxations evoked by CPA in the rabbit iliac 
artery is sensitive to apocynin. Indeed, apocynin completely abolished the arsenite- 
and D-glucose-augmented components of relaxation. Consistent with the effects of 
catalase described in Chapter 5, subanalysis showed that the ability of apocynin to 
suppress relaxation in control preparations correlated with the threshold concentration 
of CPA required to evoke relaxation. Apocynin was thus ineffective under control 
conditions in preparations responsive to 30 pM CPA, but attenuated relaxations in 
preparations responsive to 10 pM CPA. The similar abilities of catalase and apocynin 
to attenuate control EDHF-type relaxations and their potentition by arsenite and D- 
glucose suggest that (i) the endogenous H2C>2 known to contribute to EDHF-type 
relaxations in the rabbit iliac artery under control conditions (Chapter 5; Edwards et 
al., 2008) may originate from NADPH oxidase, and (ii) the activity of this enzyme 
may be increased by arsenite and elevated D-glucose, thus potentiating EDHF-type 
relaxations to CPA via increased H2O2 production.
Studies of isolated endothelial cells have demonstrated that arsenite increases 
NADPH oxidase-derived ROS production in endothelial cells, possibly by promoting 
the translocation of Racl to membrane fractions (Barchowsky et a l , 1999; Smith et 
al., 2001). Additionally, there is strong evidence that the increased activity of 
NADPH oxidase during diabetes, which appears to be mediated by a PKC-dependent 
mechanism involving phosphorylation of Racl, contributes to endothelial dysfunction 
characterized by impaired NO bioavailability and NO-dependent relaxation (Hink et 
a l,  2001; Inoguchi et al., 2003; Ceolotto et al., 2007; Table 6.1). In contrast to this 
pathophysiological role of NADPH oxidase, it has also been suggested that ROS
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derived from this enzyme contributes to physiological signalling in the vasculature 
under normal conditions (Gao & Lee, 2005; Larsen et a l,  2009). However, while a 
number of authors have suggested that NADPH oxidase is the predominant source of 
ROS in the healthy vasculature, it is now apparent that the ROS-generating systems 
involved in endothelium-dependent relaxation may differ depending on the vessel 
under study and the mode of endothelial stimulation employed. For example, flow- 
induced dilatations in the human coronary microcirculation appears to involve H2O2 
derived from the mitochondrial electron transport chain, whereas dilatations evoked 
by bradykinin are mediated by NADPH oxidase-derived H2O2 (Liu et a l, 2003; 
Larsen et a l, 2008; 2009). By contrast, endothelial H2O2 production in response to 
ACh in mouse mesenteric arteries, which has been demonstrated to be involved in the 
EDHF phenomenon in this artery, has been suggested to originate from eNOS, 
whereas ACh-evoked endothelial H2O2 accumulation in the rat renal artery may 
derive from NADPH oxidase (Matoba et a l,  2000; Gao & Lee, 2005). Furthermore, 
shear stress-induced H2O2 production in isolated bovine aortic endothelial cells 
appears to involve xanthine oxidase (McNally et a l, 2003). Thus, the endothelial 
ROS-generating systems involved in the physiological control of arterial tone remain 
controversial, with considerable effort still required to clarify underlying mechanisms. 
Furthermore, the potential non-specific effects of the classical NADPH oxidase 
inhibitor diphenylene iodonium, which has been suggested to inhibit of ROS 
production by complex I (Li & Trush, 1998; Hutchinson et a l,  2007), cytochrome 
P450 (Zhukov & Ingleman-Sundberg, 1999), xanthine oxidase (Dambrova et a l, 2000) 
and eNOS (Stuehr et a l, 1991), have led to calls for more specific inhibitors of this 
enzyme to be employed. Additionally, there is still controversy as to whether 
apocynin forms dimers (and therefore becomes activated to specifically inhibit
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NADPH oxidase rather than act as a generalised antioxidant) in endothelial and 
vascular smooth muscle cells (Johnson et a l , 2002; Heumuller et al., 2008).
The demonstration by our laboratory that H2O2 contributes to the EDHF phenomenon 
in the rabbit iliac artery, probably by sensitizing the InsP3 receptor and promoting 
endothelial Ca2+ mobilization, and the data obtained in the current Chapter suggesting 
that NADPH oxidase may be the source of functionally relevant levels of H2O2 in this
artery, appear consistent with studies of isolated endothelial cells where the increased
2+activity of NADPH oxidase was found to evoke Ca oscillations. Here, NADPH (the 
substrate of NADPH oxidase that serves to reduce molecular O2 to O2*) potentiated 
InsP3-stimulated Ca release from internal stores via a mechanism sensitive to both 
catalase and diphenylene iodonium that was not observed in cells transiently lacking 
Racl (Hu et al., 2000).
These findings may provide a novel insight into the mechanisms that underpin the 
augmentation of the EDHF phenomenon in diabetes that has been reported in dogs, 
rats, mice and humans (Timar-Peregrin & Guy, 2001; Pannirselvam et al., 2002; 
Yousif et al., 2002; Shen et al., 2003; Thomsen et al., 2002; Shi et al., 2006; 
MacKenzie et al., 2008; Malakul et al., 2008; Pataricza et al., 2008). Additionally, it 
remains to be determined whether the beneficial effects of ascorbic acid and the 
eNOS co-factor tetrahydrobiopterin against endothelial dysfunction during diabetes, 
that are usually attributed to the restoration of NO-mediated relaxations, involve 
mechanisms attributable to their ability to generate H2O2 , which has recently been 
demonstrated to underpin the potentiation of the EDHF phenomenon by these agents 
(Garry et a l, 2009).
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CHAPTER 7
GENERAL DISCUSSION
This thesis has provided novel insights into the mechanisms through which vascular 
responsiveness may be altered in diabetes and inorganic arsenic toxicity. It was 
demonstrated that arsenite and elevated D-glucose both potentiate EDHF-type 
relaxations evoked by CPA in the rabbit iliac artery via a mechanism sensitive to 
catalase and apocynin. Differential effects of arsenite and elevated D-glucose against 
EDHF-type relaxations evoked by ACh were identified in that arsenite attenuated 
relaxation in a time- and concentration-dependent manner, whereas D-glucose 
potentiated relaxation via a mechanism that was sensitive to catalase. By contrast, 
arsenite and elevated D-glucose did not affect endothelium-dependent relaxations 
observed in the absence of L-NAME+indomethacin.
Taken together, these findings suggest that in the rabbit iliac artery arsenite and 
elevated D-glucose (i) increase NADPH oxidase-derived ROS production, (ii) 
augment the EDHF phenomenon via a mechanism involving H2O2 , while (iii) this 
augmented component may compensate for NO-dependent responses impaired by 
oxidative stress (Figure 7.1). These findings may represent an important advance in 
understanding the mechanisms by which the EDHF phenomenon is able to 
compensate for the loss of NO in diabetes. Additionally this study is the first to study 
the effects of arsenite on the EDHF phenomenon.
7.1 Hydrogen Peroxide and Compensatory EDHF Phenomena
Superoxide radicals are known to rapidly react with NO, thereby attenuating its 
bioavailability and associated NO-dependent relaxations in diabetes (see Table 6.1 for 
references). This mechanism may also contribute to impaired endothelium-dependent
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relaxations mediated by arsenic toxicity (Srivastava et a l , 2007; Jindal et a l , 2007). 
Correspondingly, there is now evidence suggesting that both arsenite (Barchowsky et 
a l , 1999; Smith et a l , 2001; Qian et al., 2005; Straub et a l , 2008) and elevated 
glucose (Kim et a l , 2002; Kanie & Kamata, 2002; Coppey et a l , 2003; Sercombe e/ 
a l , 2004; Hayashi e/ a l , 2005; Bitar e/ a l , 2005; Ling e/ a l , 2005; Tawfik e/ a/., 
2006; Matsumoto e/ a l, 2007; Lopez-Lopez e/ a l, 2008; Shukla e/ a/., 2008; Su e/ a l, 
2008) increase the activity of NADPH oxidase leading to increased ROS production 
in endothelial cells.
The possibility that elevated levels of H2O2 , produced by the dismutation of O2’ , may 
compensate for impaired NO bioavailability via its ability to contribute to or augment 
the EDHF phenomenon has been suggested in recent studies (Phillips et a l, 2007; 
Park et a l,  2008). Phillips and colleagues (2007) have provided evidence that a 
catalase-sensitive EDHF-type mechanism replaces NO in arterioles from patients with 
a history of coronary artery disease (various underlying causes), thereby preserving 
flow-induced dilatations. Additionally, Park and colleagues (2008) have shown that 
EDHF-type relaxations evoked by ACh in coronary arterioles from type II diabetic 
mice are abolished by catalase or apamin+charybdotoxin, whereas responses in 
healthy animals were only partially attenuated by these treatments. These findings led 
the authors to suggest that the contribution of H2O2 to Kca channel functionality and 
the EDHF phenomenon may become increasingly significant in diabetes, and serve to 
maintain dilator function when NO-dependent responses are impaired (Park et a l,
2008).
The generality of the effects of arsenite and elevated D-glucose demonstrated in this 
thesis is consistent with recent findings showing that EDHF-type relaxations evoked 
by CPA and ACh in the RIA are potentiated by exogenous H2O2 , which was found to
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enhance endothelial Ca mobilization and promote the opening of endothelial Kca 
channels (Edwards et al., 2008; Garry et al., 2009). This novel action of H2 O2 (in the 
context of the EDHF phenomenon) is consistent with previous studies of isolated 
endothelial cells showing that exogenous H2O2 enhances Ca mobilization (Lewis et 
al., 1988; Kimura et al., 1992; Doan et al., 1994; Siflinger et al., 1996; Shimizu et al., 
1997; Hu et al., 1998; Saeki et al., 2000; Niwa et al., 2001; Ji et al., 2002; Mergler et 
al., 2005; Zheng et al., 2005; Edwards et al., 2008; Zhu et al., 2008; Hecquet et al.,
2008), and that the enhanced activity of NADPH oxidase potentiates InsP3-evoked
94-Ca mobilization via a mechanism sensitive to catalase (Hu et al., 2000; 2002). 
Correspondingly, studies of isolated endothelial cells have demonstrated that elevated 
glucose potentiates agonist/SERCA inhibitor-evoked elevations in [Ca ]i via a 
mechanism sensitive to various antioxidants, while a number of authors have 
suggested that augmented EDHF-type arterial relaxations in diabetic animal models 
are associated with increased endothelial Kca channel activity (Graier et al., 1996; 
1997; Thomsen et al., 2002; Shen et al., 2003; Dragomir et al., 2004; Tamareille et 
al., 2006; Shi et al., 2006; Malakul et al., 2008). Additionally, arsenite-evoked Ca2+ 
mobilization has been suggested to involve ROS in vascular smooth muscle cells, 
although similar studies of endothelial cells have not yet been undertaken (Li et al.,
2009).
However, it is unlikely that the increased endothelial production of H2O2 in diabetes 
and arsenic toxicity universally augments EDHF-types relaxations on the basis of 
recent studies showing that H2O2 generated from ascorbic acid (in well-oxygenated 
buffer in the presence of trace metal ions) differentially modulates EDHF-type 
relaxations in the rabbit iliac artery (augmented; Garry et al., 2009) and the rat 
mesenteric artery (impaired; Nelli et al., 2009). Indeed, impaired EDHF-type
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relaxations evoked by ACh observed in rat mesenteric arteries acutely exposed to 
elevated D-glucose (22.2 mM for 360 minutes) are restored by SOD+catalase (Ozkan 
& Uma, 2005). It remains to be determined, however, whether ROS participate in the 
mechanisms that have been proposed to contribute to impaired EDHF-type responses 
in diabetic animals models, which include impaired expression and/or functionality of 
connexin proteins and Kca channels (Matsumoto et a l,  2003; 2004; 2005; Ding et al., 
2005; Burnham et al., 2006a; Young et al., 2008; Makino et al., 2008).
7.2 Diverse Functional Roles of Hydrogen Peroxide in Diabetes
While the results in this thesis are the first to provide evidence that H2 O2 may 
contribute to augmented EDHF-type relaxations in diabetes, previous studies have 
suggested that the increased production of H2O2 by endothelial cells, that is 
characteristic of the condition, may contribute to alterations in vascular 
responsiveness through mechanisms other than those involved in the EDHF 
phenomenon.
For example, the increased production of EDCFs, such as thromboxane A2 , has been 
suggested to contribute to impaired endothelium-dependent relaxations in diabetes in 
animals (Mayhan et al., 1991; Kobayashi et a l, 2002; Pannirselvam et al., 2005; 
Cheng et al., 2007; Erdei et a l, 2007; Shi et al., 2007) and humans (Angulo et al., 
2006), the mechanism of which has been suggested to involve H2 O2 (Cosentino et al., 
2003; Shi et al., 2007). For example, the increased production of thromboxane A2 in 
STZ-diabetic rat femoral artery is attenuated by catalase, and is functionally offset by 
an augmented EDHF-type response involving the enhanced activity of endothelial Kca 
channels (Shi et al., 2006; 2007). Additionally, Cosentino and colleagues (2003) have 
shown that elevated glucose increases thromboxane A2 synthesis in isolated
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endothelial cells via a mechanism involving enhanced NADPH oxidase-derived H2 O2 
production. Furthermore, other workers have suggested that increased ^CVm ediated 
thromboxane A2 synthesis contributes to increased basal tone in gracilis muscle 
arterioles of type II diabetic mice, and augmented noradrenaline-induced contractions 
in the STZ-diabetic rat aorta (Kobayashi et a l , 2002; Erdei et al., 2007). By contrast, 
endogenous H2O2 attenuates indomethacin-sensitive angiotensin II-induced 
contractions in the superior mesenteric artery of STZ-diabetic rats (Chin et al., 2007). 
A distinct functional role of increased H2O2 production in diabetes was proposed by 
Karasu (2000), who showed that H2O2 compensates for impaired NO bioavailability 
during ACh-evoked relaxations of aortae from STZ-diabetic rats. However, that 
author did not investigate whether an EDHF-type mechanism was involved in these 
responses. Additionally, it has been demonstrated that authentic H2O2 evokes more 
potent relaxation in aortae from STZ-diabetic rats, the mechanism of which remains 
to be identified (Pieper & Gross, 1988, Karasu et al., 1999).
7.3 Insights from Studies of the Physiological Role of Hydrogen Peroxide
The postulation in a number of recent reviews that H2 O2 could in theory play a role in 
maintaining dilator function when NO bioavailability and associated NO-dependent 
relaxations are impaired by oxidative stress (Cai et al., 2005; Ardanez & Pagano, 
2006; Rush & Ford, 2007; Bagi et al., 2009) is based on numerous demonstrations 
that this ROS may contribute physiologically to dilator signalling mechanisms. For 
example, H2O2 may contribute to the EDHF phenomenon in a number of arteries, 
either by (i) acting as a freely diffusible EDHF (Matoba et al., 2000; 2002; Kimura et 
al., 2002; Lacza et al., 2002; Matoba et a l,  2003; Miura et al., 2003; Yada et al., 
2003; Fujiki et al., 2005; Liu et a l,  2006; Yada et al., 2008; Park et al., 2008; Larsen
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et a l , 2008; 2009), (ii) by promoting the release of a chemically distinct EDHF 
(Hatoum et al,  2005), or (iii) by enhancing endothelial hyperpolarizations that are 
then transmitted to the vascular media via gap junctions (Edwards et al,  2008; 
Hercule et al,  2009; Garry et al,  2009).
Additionally, H202-evoked relaxations in mammalian vessels have been variously 
suggested to involve (i) increased NO synthesis (Yang et al,  1998; 1999; Hirai et al,  
2000; Cseko et al,  2004; Samora et al,  2008), (ii) activation of sGC (Burke & Wolin 
et al,  1987; Burke-Wolin et al,  1991; Fujimoto et al,  2001; Leung et al,  2006; 
Drouin et al,  2007), (iii) activation of PKG (Burgoyne et al,  2007), (iv) activation of 
cyclooxygenase (Wolin et al,  1987; Fujimoto et al,  2001; Thengchaisri et al,  2003),
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(v) decreased sensitivity of the smooth muscle contractile apparatus to Ca (Iesaki et 
al,  1996), and (vi) activation of hyperpolarizing K+ efflux channels (variously Kca, 
Kv and KAtp) located on vascular smooth muscle cells (Matoba et al,  2000; Fujimoto 
et al,  2001; Miura et al,  2003; Ellis et al ,  2003; Gao et al,  2003; Cseko et al,  2004; 
Rogers et al,  2006; Leung et al,  2006; Samora et al,  2008). It has also been 
demonstrated in studies of rat arteries (with an exception possibly being the femoral 
artery) that low concentrations of exogenous H2O2 may evoke endothelium-dependent 
and/or -independent arterial contractions (succeeded by relaxations at higher 
concentrations of H2O2) by increasing the synthesis of thromboxane A2 (Gao et al,  
2003; Cseko et al,  2004; Leung et al,  2006; Samora et al,  2008; Garcia-Redondo et 
al,  2009).
However, the endothelial sources of H2O2 that contribute to vascular responsiveness 
under normal conditions are poorly understood, with separate groups having variously 
proposed eNOS, nNOS, NADPH oxidase, the mitochondrial electron transport chain 
and cytochrome P450 (Matoba et al,  2000; Fleming et al,  2001; Liu et al,  2003; Gao
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& Lee, 2005; Leung et a l,  2006; Drouin et a l,  2007; Capettini et a l, 2008; Larsen et 
a l, 2009). Indeed, in the rabbit iliac artery NADPH oxidase-derived H2C>2 may 
contribute to EDHF-type relaxations evoked by CPA under control conditions 
(Chapter 6). These preliminary studies have collectively indicated that the source of 
H2O2 may depend on the mode of endothelial stimulation and the vessel under study. 
Taken together, the findings discussed in this section suggest that increased arterial 
production of H2O2 in diabetes and arsenic toxicity could in theory compensate for 
impaired NO-dependent relaxations via a number of potential mechanisms.
7.4 Compensatory EDHF Phenomena Associated with Other Cardiovascular 
Risk Factors
In addition to diabetes and the novel effects of arsenite demonstrated in the current 
study, augmented EDHF-type relaxations have also been reported in models of other 
cardiovascular disease states that are also characterized by oxidative stress and 
impaired NO bioavailability.
Consistent with studies of diabetic animal models, augmented EDHF-type relaxations 
in models of hypertension, hyperlipidaemia, chronic heart failure and ischaemia- 
reperfusion are associated with the increased activity of Kca channels (Najibi et a l, 
1994; Brandes et a l, 1997; Malmsjo et al., 1999; Bocker et a l, 2000; Marrelli, 2002; 
Moroe et a l, 2004; Sendao-Oliveira & Bendhack, 2004; Ueda et a l, 2005; Taniguchi 
et a l, 2005; Taddei et a l, 2006; Malakul et a l, 2008). For example, hyperlipidaemia 
augments EDHF-type relaxations in rabbit renal arteries via a mechanism involving 
increased production of cytochrome P4so-derived EETs, which have been proposed as 
freely diffusible EDHFs in certain artery types but are devoid of direct smooth muscle 
relaxant actions in rabbit arteries, where instead they mimic gap junction-dependent
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EDHF-type relaxations evoked by ACh (Hecker et al., 1994; Campbell et al., 1996; 
Brandes et al., 1997; Fisslthaler et al., 1999; Hutcheson et a l,  1999; Taylor et al., 
2001; Gauthier et a l, 2002; Archer et a l,  2003; Moroe et a l, 2004; Taniguchi et a l,
2005). Indeed, it has been suggested that nanomolar concentrations of 5,6-EET may 
promote SOCE in response to agonists or SERCA inhibitors in endothelial cells 
(Graier et a l, 1995; Hoebel et a l, 1997; Rzigalinski et a l, 1999; Xie et a l, 2002), 
which, through increasing intracellular Ca2+ levels, would be expected to increase the 
open state probability of all endothelial Kca channel subtypes. Furthermore, EDHF- 
type relaxations are also augmented by oxLDL in the rabbit aorta and rat mesenteric 
arteries, although the mechanisms involved have not yet been identified (Seppo et a l, 
2000; Bocker et a l, 2001).
It has also been demonstrated that the combination of diabetes (STZ-induced) and 
hyperlipidaemia (diet) cumulatively augments an apamin+charybdotoxin-sensitive 
component of EDHF-type relaxations in the rat aorta, whereas a separate group 
demonstrated that the EDHF phenomenon is impaired in small mesenteric arteries 
from STZ-diabetic ApoEC7') mice (Morikawa et a l, 2005; Malakul et a l, 2008). 
Furthermore, enhanced EDHF-type relaxations in renal arteries of spontaneously 
hypertensive rats maintained on a high cholesterol diet are associated with decreased 
smooth muscle accumulation of cGMP following agonist stimulation, which again 
suggests a compensatory role of the EDHF phenomenon under conditions where NO- 
dependent responses are impaired (Kagota et a l, 1999).
While the underlying mechanisms contributing to these augmented EDHF phenomena 
are not yet clear, Cosentino and colleagues (1998) and Landmesser and colleagues 
(2003) have suggested that H2O2 , rather than NO, mediates endothelium-dependent 
relaxations evoked by ACh in aortae from spontaneously hypertensive rats (SHR) and
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deoxycorticosterone acetate-salt-induced hypertensive mice. These groups 
demonstrated that H2O2 generated following the uncoupling of eNOS (resulting from 
ONOO -mediated oxidation of BH4) served to almost fully preserve endothelium- 
dependent relaxations, whereas supplementation with BH4 abolished the catalase- 
sensitive component of relaxation and restored NO-dependent responses (Cosentino et 
al., 1998; Landmesser et al., 2003). Furthermore, Cosentino and colleagues (1995; 
2001) also demonstrated that this compensatory role of H2O2 could be mimicked in 
BH4 -deficient mice or by depleting BH4 levels pharmacologically in wild-type mice. 
However, these groups did not determine whether the increase in H2O2 production by 
uncoupled eNOS contributed to endothelium-dependent relaxations via an EDHF-type 
mechanism. Indeed, Yada and colleagues (2008) have recently suggested that the 
increased production of H2O2 following ischaemia-reperfusion contributes to reactive 
hyperaemia via an EDHF-type mechanism in the mouse mesenteric circulation in 
vivo, while the study of Marrelli (2002) demonstrated that the potentiation of EDHF- 
type relaxations following ischaemia-reperfusion in the rat middle cerebral artery may 
involve enhanced endothelial Ca2+ mobilization.
However, as is the case with models of diabetes, augmented EDHF phenomena are 
unlikely to be universal in models of the cardiovascular risk factors discussed above, 
with other studies having demonstrated impaired responses. For example, both 
EDHF-type and NO-mediated relaxations evoked by ACh are impaired in mesenteric 
arteries from SHRs, with the latter being restored by fluvastatin (Kansui et al., 2004). 
Furthermore, in the aorta of rats with chronic heart failure impaired EDHF-type 
relaxations are restored by ACE inhibitors, which have been shown to augment the 
EDHF phenomenon by generating H2O2 (Westendorp et al., 2005; Fujiki et a l, 2005). 
Additionally, O2’ appears to underpin impaired NO-dependent and EDHF-type
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relaxations in goat cerebral arteries following ischaemia/reperfusion (Sanchez et a l,
2006), while NADPH oxidase-derived O2 ’” may contribute to impairments in the 
EDHF phenomenon in mesenteric arteries from high cholesterol-fed mice 
(Matsumoto et a l, 2006).
7.5 Stimulation-Specific Modulation of Endothelial Function by Arsenite -  
Methodical Considerations
Previous investigations of the modulation of endothelial function by arsenite have 
employed only ACh as a mode of endothelial stimulation (Lee et a l, 2003; Bilszta et 
a l,  2006; Srivastava et a l, 2007; Jindal et a l,  2008). Indeed, experiments conducted 
in Chapter 3 are, to the author’s knowledge, the first to study the effects of arsenite 
against endothelium-dependent relaxations evoked by a mode of endothelial 
stimulation other than ACh. The results demonstrated that arsenite impaired EDHF- 
type relaxations evoked by ACh in a time- and concentration-dependent manner, 
whereas responses to CPA were potentiated via a mechanism that may involve 
NADPH oxidase-derived H2O2 . These confounding effects indicate that arsenite may 
exert an antagonistic effect on the muscarinic receptor (Figure 7.1). However, it 
remains to be determined whether arsenite similarly impairs relaxations evoked by 
other endothelial agonists, such as bradykinin, histamine and ATP, and may be an 
important focus for future research. Indeed, the findings of this thesis may indicate a 
necessity to rule out such effects of arsenite in all future studies by employing 
receptor-independent modes of endothelial stimulation, such as SERCA inhibitors, in 
addition to agonists.
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7.6 Unaltered Vascular Function: Unaltered Endothelial Function?
In the experiments conducted in Chapters 3 and 4, it was apparent that arsenite and D- 
glucose augmented EDHF-type responses, but had no net effect on endothelium- 
dependent relaxations observed in the absence of L-NAME and indomethacin. Indeed, 
Sofola and colleagues (2002) reported similar findings in mesenteric arteries from rats 
maintained on a high salt diet, whereby overall responses were not altered but were 
resistant to L-NAME and abolished by apamin+charybdotoxin, thus indicating that 
the EDHF phenomenon compensated for the loss of the NO-dependent component of 
relaxation. Their study received an editorial by Katusic, who stated “more 
importantly, this observation illustrates that, in diseased arteries, ‘normal’ 
endothelium-dependent relaxations in response to acetylcholine should not be 
interpreted as i f  there is no alteration in endothelial f u n c t io n Additionally, Pataricza 
and colleagues (2008) demonstrated that while ACh-evoked relaxations of carotid 
arteries from alloxan-diabetic dogs did not differ from healthy controls overall, 
responses were attenuated by apamin+charybdotoxin, thus indicating an enhanced 
functional role of Kca channels in endothelium-dependent relaxation.
Therefore, investigations into the mechanisms that underpin endothelium-dependent 
relaxations in disease states could potentially unmask alterations in endothelial 
function that may otherwise be obscured.
7.7 Future Directions
The novel findings of the current study suggest a number of possibilities for future 
research into the compensatory role of the EDHF phenomenon in endothelial 
dysfunction characterized by oxidative stress-impaired NO bioavailability. Such roles 
for EDHF-type responses have been proposed in animal models of diabetes,
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hyperlipidaemia, hypertension, ischaemia-reperfusion and chronic heart failure, and 
while it has been suggested that the increased activity of endothelial Kca channels 
contributes to these responses, the mechanisms involved are not yet clear. 
Furthermore, the demonstration in the current study that H2O2 underpins augmented 
EDHF phenomena evoked by arsenite and elevated D-glucose may need to be 
substantiated in future studies by direct measurements of its production in endothelial 
cells.
The group of Shimokawa quantified endothelial generation of H2O2 to substantiate 
their claims that H2O2 was an EDHF. These authors employed electron spin resonance 
(ESR) spectroscopy and detected a bradykinin-evoked 2-fold increase in H2O2 
accumulation (as a stable nitroxide radical formed following the reaction of H2O2 with 
p-acetamidophenol in the presence of horseradish peroxidase using the spin trap 1- 
hydroxy-2,2,5,5,-tetramethyl-3-imidazoline-3-oxide) in the perfusate collected from 
their organ chamber experiments. The group of Gutterman also employed ESR to 
quantify mitochondrial-derived H2O2 accumulation in response to flow in human 
coronary resistance vessels (Liu et al., 2003).
Furthermore, while this thesis has demonstrated a potential role for the EDHF 
phenomenon in preserving arterial responsiveness in arsenic toxicity and diabetes in 
vitro, its significance in vivo in patients with diabetes and those at risk of arsenic 
toxicity, and its vasculoprotective role in attenuating atheroma formation (that is 
known to correlate with impaired NO bioavailaility), is unclear and requires further 
investigation. From a translational perspective, the effect of NADPH oxidase 
inhibitors, such as apocynin, against endothelial dysfunction and atherosclerosis in 
patients is unclear and requires clarification. Indeed, clinical trials exploring the 
beneficial effects of antioxidants on cardiovascular outcomes are often unsuccessful
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and have led researchers to question either the pathophysiological role of ROS or the 
specificity of the antioxidants employed (Widlansky et al., 2004; Kinlay et al., 2004; 
Kelemen et al., 2005; Magliano et al., 2006). It also remains to be determined 
whether the beneficial effects of Kca channel openers, such as the SKca and IKca 
channel opener NS309, against endothelial dysfunction, which have recently been 
afforded to the improvement of EDHF-type responses in type II diabetic rats 
(Brondum et al., 2009), include protection against atheroma formation in vivo as 
hyperpolarization of the endothelium following activation of these channels is known 
to contribute to NO formation by electrogenically favouring extracellular Ca influx 
(Feletou, 2009). Indeed, novel insights into the vasculoprotective role of the EDHF 
phenomenon have recently been provided by demonstrations that EETs, the 
production of which is increased in hyperlipidaemic rabbits and compensates for 
impaired NO bioavailbility (Brandes et al., 1997; Moroe et al., 2004; Taniguchi et al., 
2005), inhibit platelet-endothelium interactions in vitro and in vivo (Krotz et al., 
2010).
Additionally, considering that our laboratory has recently provided evidence that 
ascorbic acid and BH4 potentiate the EDHF phenomenon via a mechanism involving 
H2O2 (that is distinct from their more widely recognized ability to restore NO 
bioavailability) (Garry et al., 2009), further studies investigating their ability to 
restore EDHF-type responses in animal models of diabetes may provide a novel focus 
for their clinical potential. Indeed, BH4 prevents endothelial dysfunction in the human 
forearm circulation following ischaemia/reperfusion via mechanisms that appear to be 
distinct from its role as a co-factor for eNOS (Mayahi et al., 2007). Furthermore, the 
concentration of ascorbic acid required to potentiate the EDHF phenomenon in the 
RIA in vitro (1 mM) (Garry et al., 2009) is lower than venous concentrations (1.5-3.2
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mM) (achieved following intra-brachial arterial administration of the vitamin) that 
restore responses to ACh/methacholine in the human forearm in patients with 
hypertension or peripheral arterial disease (Sherman et al., 2000; Pleiner et al., 2008). 
Additionally, systemic administration of ascorbic acid in the rat elevates arterial 
interstitial fluid [H2O2] to 25-150 pM (with H2O2 remaining undetectable in the 
luminal compartment due scavenging by erythrocyte catalase and glutathione 
peroxidase) (Chen et al., 2007; 2008; Garry et al., 2009), which correlates with the 
potentiation of CPA- and ACh-evoked EDHF-type dilatations in perfused RIA 
preparations following selective adventitial administration of 100 pM H2O2 that 
nonetheless remains undetectable in the perfusate (Garry et al., 2009).
It should also be noted that in studies of non-vascular cells H2O2 has been shown to 
variably potentiate or attenuate intercellular communication via gap junctions 
constructed from connexin 43 (Garry et al., 2009). However, analogous studies of 
vascular gap junctions have not yet been undertaken and further analyses are therefore 
required to evaluate the effects of competing pro- and anti-oxidant mechanisms on 
myoendothelial and homocellular communication, and, indeed, the significance of 
these mechanisms in diabetes mellitus and arsenic toxicity when the production of 
ROS is elevated.
Finally, in comparison to agonist/relaxant-evoked vascular responses there is a 
distinct lack of studies investigating the modulation of endothelium-dependent 
dilatations evoked by flow/shear stress, arguably the most significant mode of 
endothelial stimulation in vivo, in models of cardiovascular disease states, which may 
also provide an important focus for future research. Indeed, the mechanisms 
contributing to endothelial control of arterial tone, such as the functionally significant 
sources of H2O2 and the relative roles of NO and the EDHF phenomenon, may differ
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during shear stress-induced responses from those evoked by agonists and SERCA 
inhibitors (see sections 1.4.3, 1.5, 1.6 and 7.3).
7.8 Concluding Remarks
This thesis has identified a novel role of H2 O2 in endothelium-dependent relaxations 
modulated by arsenite and elevated glucose, whereby this ROS may compensate for 
the loss of NO by augmenting the EDHF phenomenon. These findings may provide 
insights into the mechanisms that underpin the augmentation of the EDHF 
phenomenon in diabetes mellitus and other cardiovascular disease states characterized 
by oxidative stress and impaired NO bioavailability. Considering that the EDHF 
phenomenon has been proposed as a novel therapeutic target for the treatment of 
endothelial dysfunction and microvascular complications, and that angiotensin 
converting enzyme inhibitors, tetrahydrobiopterin and ascorbic acid may offset 
endothelial dysfunction via H202-mediated augmentation of the EDHF phenomenon, 
further insight into the mechanisms that underpin compensatory EDHF phenomena 
may provide an important focus for pharmaceutical effort.
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Figure 7.1 The role of H2O 2 in arsenite- and D-glucose-augmented EDHF-type 
relaxations in the RIA. Augmented EDHF-type relaxations contributed to 
endothelium-dependent responses that were unaltered overall, indicating that the 
EDHF phenomenon compensated for impaired NO bioavailability mediated by 
oxidative stress. The augmented components of relaxation were abolished by the 
H2O2 scavenger catalase or the NADPH oxidase inhibitor apocynin. H202-augmented 
EDHF-type relaxations in this artery are mediated by enhanced endothelial Ca‘ 
mobilization, which likely involves sensitization of the InsP3 receptor (Edwards et al., 
2008). Note that the augmentatory effect of arsenite on EDHF-type relaxations is 
masked when these responses are evoked by ACh, indicating that this agent may 
inhibit the muscarinic receptor. Abbreviations: CPA, cyclopiazonic acid; ER, 
endoplasmic reticulum; InsP3R, inositol 1,4,5-trisphosphate receptor; Kca, calcium- 
activated K+ channel; MEGJ, myoendothelial gap junction; MR, muscarinic receptor; 
SERCA, sarcoendoplasmic reticulum Ca2+ ATPase; SOC, store-operated Ca2 
channel; SOD, superoxide dismutase.
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APPENDIX
A POTENTIAL LIMITATION FOR THE USE OF CATALASE DURING NO­
DEPENDENT ARTERIAL RELAXATION
Introduction
Catalase is widely used pharmacologically for scavenging H2O2 and thus dissociating 
the role of this ROS in cellular signalling mechanisms, including those that mediate 
endothelium-dependent arterial relaxation (Wolin, 1996; Faraci, 2006). However, a 
number of reports have suggested that catalase may also reversibly bind NO to form 
ferrous-nitrosyl complexes, thus questioning its use as a specific H2O2 scavenger in 
biological systems where NO also features as an important signalling molecule 
(Brown, 1995; Kim & Han, 2000; Brunelli et al., 2001). Indeed, ferrous interactions 
underpin the principal NO signal transduction mechanism, e.g. activation of sGC 
(Cooper, 1999; Koesling, 1999). Furthermore, it has also been demonstrated that the 
binding of NO to catalase may inhibit its H202-scavenging activity (Brown, 1995; 
Mohazzab et a l , 1996; Kim & Han, 2000; Brunelli et al., 2001).
From a functional perspective, Mohazzab et al reported that physiologically relevant 
concentrations of exogenously applied NO (-50 nM) abolished endothelium- 
independent relaxant responses to H2O2 in calf pulmonary arteries by binding to 
endogenous catalase and inhibiting the formation of compound I (the active form of 
catalase produced during the metabolism of H2O2), a process necessary for activation 
of sGC and relaxation to H2O2 in this artery (Wolin & Burke, 1987; Mohazzab et al., 
1996). However, it remains to be determined whether exogenous catalase is capable 
of attenuating NO-mediated arterial relaxations.
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The aim of the current study was to characterize the effect of catalase on endothelium- 
independent relaxant responses to the NO donor MAHMA NONOate. The main focus 
was to establish whether the use of catalase during studies of L-NAME-sensitive 
endothelium-dependent relaxations can conclusively dissociate the role of H2 O2 in 
these responses.
Methods
Male New Zealand White rabbits were sacrificed and endothelium-denuded iliac 
arterial rings prepared for isometric analysis as described previously (2.1 and 2.2). 
After the successful removal of the endothelium was confirmed (see 2.2) preparations 
were incubated with catalase (500, 1000 or 2000 units ml"1) for 30 minutes. Tone was 
induced by PE (1 pM) and allowed to reach a stable plateau (taking approximately 15 
minutes) before endothelium-independent NO-mediated relaxant responses were 
studied by constructing cumulative concentration-response curves to MAHMA 
NONOate (1 nM -  10 pM). Data was collected and analysed as described in 2.3 and 
2.4.
Results
Endothelium-independent relaxations to MAHMA NONOate were maximally 
equivalent to 93.3±1.4% of the constrictor response to PE with a pECso value of 
7.32±0.06 (n= ll; Figure 1). At 500 units ml'1, catalase attenuated relaxation at a 
single concentration of MAHMA NONOate (100 nM; jP<0.01) but did not alter either 
the pEC5o value or Rmax (Figure 1A; Table 1). At 1000 units ml"1, catalase further 
attenuated relaxation, shifting the concentration-response curve to the right (pECso: 
6.97±0.09; P<0.05) but did not alter Rmax (Figure IB; Table 1). At 2000 units ml'1,
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catalase further attenuated relaxation, shifting the concentration-response curve to the 
right relative to time-matched controls (pECso: 6.71±0.08; PO.OOl) and also relative 
to preparations incubated in the presence of 500 units ml’1 catalase (^<0.05; Table 1), 
but did not alter Rmax (Figure 1C; Table 1).
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Figure 1 Mechanical studies of endothelium-denuded rabbit iliac artery rings with 
catalase and MAHMA NONOate. Concentration-response curves revealed that 
catalase attenuated endothelium-independent relaxation to MAHMA NONOate in a 
concentration-dependent manner. *, ** and *** denote P<0.05, /><(). 01 and PO.OOl 
compared to control. Note that controls are common to each graph and the effect of 
each concentration of catalase illustrated separately for clarity.
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Table 1 The effect of catalase on endothelium-independent relaxation to MAHMA 
NONOate in the rabbit iliac artery. Potency (negative log EC5 0) and maximal 
responses (Rmax) are a function of the constrictor response to PE and given as 
means±SEM. * and *** denote P<0.05 and PO.OOl compared to time-matched 
control preparations, f  denotes P<0.05 compared to preparations incubated with 
catalase 500 units m l1, n denotes the number of animals studied.
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Intervention n Rmax pEC50
Control 11 93.7±1.7 7.32±0.06
Catalase 500 units ml*1 89.2±3.7 7.03±0.10
Catalase 1000 units ml*1 87.0±3.2 6.97±0.09*
Catalase 2000 units ml'1 83.4±2.8 6.71±0.08***|
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Discussion
The results of the current study have demonstrated that increasing concentrations of 
catalase progressively attenuate NO-mediated smooth muscle relaxant responses to 
MAHMA NONOate in the rabbit iliac artery. These results are consistent with 
previous reports that catalase binds NO by forming ferrous-nitrosyl complexes 
(Brown, 1995; Kim & Han, 2000; Brunelli et al., 2001). This additional effect of 
catalase may be of particular pharmacological relevance during studies of 
endothelium-dependent arterial relaxations that are sensitive to inhibitory L-arginine 
analogues.
Catalase has been widely used in organ bath-type experiments to dissociate the role of 
H2O2 in endothelium-dependent relaxant responses, and is generally regarded as a 
specific scavenger of this ROS (Faraci, 2006). However, the present findings question 
the sole attribution of H2 O2 to the effects of catalase. By contrast, previous reports 
have shown that endothelium-independent relaxant responses to SNP are unaffected 
by concentrations of catalase that caused attenuation of responses to MAHMA 
NONOate in the current study (Leung et al., 2006; Capettini et al., 2008). A possible 
explanation may be because SNP requires intracellular bioactivation to donate NO, 
whereas MAHMA NONOate (and NONOates in general) release NO spontaneously 
at physiological pH (Wanstall et al., 2001). Thus, NO released by SNP and MAHMA 
NONOate may be differentially susceptible to extracellular interactions with catalase. 
However, Capettini et al reported that, in addition to SNP, catalase (at 2400 units ml' 
l) did not alter relaxant responses of the mouse aorta to diethylamine (DEA) 
NONOate (Capettini et al., 2008), whereas relaxations to MAHMA NONOate in the 
current study were progressively attenuated by catalase at concentrations >500 units 
ml'1. Furthermore, relaxant responses to DEA NONOate are unaltered in aortae of
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catalase-overexpressing mice (Suvorava et al., 2005). A possible explanation may be 
that the affinity of catalase for NO increases in the presence of H2O2 (Brown, 1995; 
Brunelli et al., 2001). Thus, the basal levels of H2 O2 present in such bioassays may 
determine the extent of NO binding by catalase. Indeed, overexpression of catalase in 
RINm5F cells protects against NO toxicity induced by the NO donors S-nitroso-N- 
acetyl penicillamine (SNAP) and 5-amino-3-(4-morphonilyl)-l,2,3-oxadiazolium 
chloride (SIN-1), which also release O2’' intracellularly that is later dismutated to 
H2O2 , but not DEA NONOate which donates NO but does not release ROS (Tiedge et 
a l,  1999).
In conclusion, the current study has demonstrated that catalase may be capable of 
binding NO in arterial organ bath-type experiments, thus reducing its bioavailability 
to smooth muscle. As a result, the use of catalase during the course of this thesis to 
dissociate the role of H2O2 in endothelium-dependent relaxant responses in the rabbit 
iliac artery was restricted to those insensitive to L-NAME.
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